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Introduction
In 1786 Pariy noticed the association between 
enlargement of the thyroid gland and the development of 
exophthalmos. This observation was published in 1825, 
following his death, in a collection of' his unpublished 
medical writings, but it did not receive general recognition.
In 1835 Graves re-described the syndrome which since then 
has been known as Graves' disease, but it is also sometimes 
called Basedow's disease following the detailed description 
of the condition by Basedow in 1840.
The problem of the nature of exophthalmos occurring 
in relation to endocrine dysfunction has been studied extensively 
during the past century in the fields of clinical and 
experimental medicine, and yet, despite the mass of facts 
which have been presented and the many hypotheses which have 
been evolved during that time* there is still no true under­
standing of the basic nature of the exophthalmic process.
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During the nineteenth century scientists regarded the 
nervous system as the sole co-ordinator of the functions 
of the body. It is natural, therefore, that the mechanism 
of exophthalmos should have been sought within these confines.
The dawning of the present century saw the rising 
of the concept of a chemical regulation and co-ordination of 
bodily functions. Prom this there has emerged the science 
of endocrinology which has provided a great impetus to the 
study of experimental exophthalmos by opening up an entirely 
different field of investigation.
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Aim and Scope of this Study,
It is the purpose of this thesis to correlate as many
as possible of the observations which have been made on 
endocrine exophthalmos and which contribute in any way to a 
deeper understanding of the fundamental mechanism in the 
production of endocrine exophthalmos. Certain of my own 
observations will also be included in the relevant parts of 
the text. This is, in part, a review, and it is hoped that 
every aspect of the problem will be dealt with fairly. To 
this end many conflicting views will be put forward, but it 
may be that when they are seen in their true perspective 
some of the apparently contradictory pieces of evidence will
help to build up a clearer synthesis of the disease pattern,
so that, as stated by Haines (1950) the ultimate answer to the 
problem will be achieved as a result of co-operation with other 
observers in tolerance and understanding, and as a result of a 
consideration in each programme of all the varied phases of the 
condition.
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Classification of Endocrine Exophthalmos
There is a conflict of opinion on whether the two 
main forms of endocrine exophthalmos, first, that which appears 
to be dependent solely on thyrotoxicosis (thyrotoxic exophthalmos) 
and, secondly, that which although .sometimes associated with 
thyrotoxicosis is apparently unrelated to it (thyrotrophic 
exophthalmos) , are manifestations basically of the same 
hormonal disturbance, or whether they represent separate 
entities with different mechanisms. 'The terms thyrotoxic 
and thyrotrophic exophthalmos were put forward originally by 
Mulvany (1944) •
Endocrine exophthalmos as a unitary concept
The exophthalmos of toxic diffuse goitre and the 
exophthalmos of a more progressive type which usually follows 
anti-thyroid treatment may be considered as fundamentally similar 
in nature (Rose, 1952, 1953> Devoe, 1954)> and such a concept 
has found favour by Aterman (1954a) because of his finding that 
experimentally induced exophthalmos may be of all grades of 
severity despite the fact that the same basic method is used 
in its production.
It has been suggested by Brain (1955) that the difference 
between the thyrotoxic and thyrotrophic forms of exophthalmos may 
depend on the acuteness of the pathological process, on the
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difference in the relative activities of the various hormones 
concerned in the pluri-glandular syndrome all of which are
CL
influenced hy a basic hypothalmic-pituitary disturbance, and 
on the difference in the degree of responsive activity of the 
thyroid gland. In this way the thyroid gland may be regarded 
as the controller of the pituitary gland which acts as the 
producer of exophthalmos (Martens, 1947)? an(l the differences in 
the clinical and pathological pictures of the two forms of 
exophthalmos are quantitative rather than qualitative (Soley, 1942; 
Hedges and Rose, 19555 Lamberg, 1954) with progressive 
exophthalmos as a more advanced stage of the exophthalmos of 
thyrotoxicosis (Pochin, 1945 > 1946; Dresher and Benedict, 1950), 
or that the two conditions are similar in nature due to a common 
process which acts with differing severity, mildly in the thyro­
toxic type and severely in the thyrotrophic type (Rundle and 
Pochin, 1944). Priedgood (l94l) has termed the exophthalmos of 
Graves’ disease and the malignant form of exophthalmos as 
reversible and irreversible phases of the same phenomenon.
Pathologically, Falconer and Alexander (l95l)> Ellis 
and Long (1955) an^ Iversen (1954) have failed to find any real 
distinction between thyrotoxic and thyrotrophic exophthalmos, and 
Day and ffemer (1954) have shown that there is no significant 
difference between cases of mild and severe exophthalmos in the 
rates of removal of radio-active sodium following its injection
into the orbital fat. Furthermore, although there is evidence 
of a difference in the intra-orbital tension in the various forms 
of exophthalmos of Graves' disease (Copper, 1948)? this difference 
would appear to represent a gradual variation from one case to the 
other so that the cases are not amenable to a division into two 
clear-cut categories (Kearns, Henderson and Haines, 1955)*
Endocrine exophthalmos as a dual concept
There are many protagonists of the hypothesis that there 
is a true and basic distinction between the thyrotoxic and the 
thyrotrophic forms of exophthalmos (Mulvany, 1944> 1952; Brain,
1945, 1946; Azerad, 1948; Braley, 1948, 1955; Adler, Scheie 
and Dennis, 1949; Johnson, 1949; Purves and Griesbach, 1949; 
Ruedemann, 1949; Talwalker, 1949; Hirsch, 1950; Falconer and 
Alexander, 1951; de Gennes and others, 1951; Reeh and Singer, 1955) 
a distinction which is of practical importance from a therapeutic 
point ; of view (Beierwaltes, 1948, and Schlossman, 1955)* Chandler 
(1950) also recognises two forms of exophthalmos which he calls 
dysthyroid non-congestive exophthalmos and dysthyroid congestive 
exophthalmos, and Cordes (1954) applies the terms non-progressive 
exophthalmos and progressive exophthalmos; names which describe 
the thyrotoxic and thyrotrophic forms of exophthalmos, respectively.
There is evidence that the exophthalmos which occurs as 
a primary manifestation of Graves' disease is to a large extent an 
apparent exophthalmos due to lid retraction (Braley, 1948, 1955;
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Johnson, 1949)> a*id lid retraction would appear to be a separate 
phenomenon from exopthalmos. For example, it has been shown that 
although thyroxine administration may be followed by the development 
of lid retraction it is never responsible for the production of 
exophthalmos (Brain, 1952), and conversely, that although 
successful anti-thyroid treatment in Graves' disease may cause a 
reduction in the degree of lid retraction, it is often associated 
with an increase in the degree of exophthalmos (Barr and Shorr, 19455 
Haines and Keating, 1946; Lederer and Hambresin, 1951)• There is 
also evidence that lid retraction bears a direct relationship to the 
toxicity of the thyroid gland, whereas exophthalmos bears an 
indirect relationship (Copper, 1948).
It would appear that the ocular changes of the ophthalmic 
form of Graves' disease (thyrotrophic exophthalmos) are not only 
independent of the hyperthyroid state (Bundle and Wilson, 1945) 
but are often related to a high level of thyrotrophic hormone (TSH) 
in the serum, whereas the ocular manifestation of pure thyrotoxicosis 
(thyrotoxic exophthalmos) are directly related to the hyperthyroid 
state and are associated with a high level of thyroid hoimone and a 
low level of TSH in the serum, (de Robertis, 1948; d'Angelo and 
others, 1949; Purves and Griesbach, 1949; Chandler and Hartfall, 
1952).
Further distinctions between thyrotoxic and thyrotrophic 
exophthalmos may be found from a pathological point of view 
(Rundle, Finlay-Jones and Hoad, 1955)> from an estimation of the
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degree of retro-ocular resistance which is considered to he 
normal in thyrotoxic exophthalmos hut increased in the thyro­
trophic phase (Doyne, 1945? Means and Stanbuiy, 1950> Ferguson, 
1951)? and from the response of the exophthalmos to irradiation 
of the orhit which is usually a negative response in thyrotoxic 
exophthalmos hut a positive one in thyrotrophic exophthalmos.
It is apparent, therefore, that opinion is divided on 
a classification of the exophthalmos of Graves1 disease. It is 
difficult to substantiate a purely unitary concept in view of the 
ohvious differences which exist between certain cases of exophthalmos. 
On the other hand, some observers find it difficult to accept a dual 
concept because of the fact that many cases exhibit a mixture of 
the thyrotoxic and thyrotrophic effects (Copper, 1948? Dayton, 1953)*
It seems reasonable, however, to put forward the view that 
thyroid hormone exerts a certain effect on the eye, either directly 
or indirectly through the intervention of the sympathetic nervous 
system, whereas TSH (or some other related hormone) influences the 
eye in a different manner. In this way a purely thyrotoxic form 
of exophthalmos or a purely thyrotrophic form of exophthalmos may 
be produced, although in the majority of cases there is a mixture 
of the two effects (Spaeth, 1952, 1953a), usually with a 
preponderance of one of the effects, so that certain features of 
both forms of exophthalmos may be present at the same time. Such
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a concept has "been elaborated, by Mann (1945? 1946a and b, 1950,
1951) wbo differentiates between three types of exophthalmos; first, 
exophthalmos due to thyroxine excess, secondly, exophthalmos due to 
TSH excess, and, thirdly, exophthalmos due to thyroxine and TSH 
excess. Similarly Means (1945) recognises three forms of Graves* 
disease; first, thyrotoxicosis without ophthalmopathy, secondly, 
thyrotoxicosis with ophthalmopathy, and, thirdly, a hyperophthalmo- 
pathic type which may be associated with hyperthyroidism, euthyroidism 
or hypothyroidism.
In any case the separation of exophthalmos into 
its thyrotoxic and thyrotrophic forms, even if unscientific, gives 
a useful clinical division (Porter and Walker, 1955) because they 
represent separate phases of the disease. They will be considered 
separately in this thesis.
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PART I. Exophthalmos Related to Thyrotoxicosis
(Thyrotoxic Exophthalmos).
Effects of excessive thyroid gland secretion
In thyrotoxicosis there is an excessive amount of 
circulating hormone which is secreted by the thyroid gland.
This hormone was isolated by Kendall in 1915? and in 1919 be 
termed it thyroxine. Thyroxine was synthesized by Harington(l926). 
The metabolic fate of thyroxine is de-iodination (Benua, Albert 
and Keating, 1952). Rosenberg (1951) investigated the plasma 
of six cases of hyperthyroidism, following administration of a 
therapeutic dose of radio-active iodine (i'*"^), and he found 
that practically all the labelled organic iodine in the plasma existed 
as a single substance indistinguishable from tnyroxine.
A measurement of the uptake of radio-active iodine by 
the thyroid gland may be regarded as a sensitive measure of thyroid 
gland function (Paschkis, Cantarow and Peacock, 1948)? an increase 
in uptake indicating a hyperfunction and a decrease in uptake 
indicating a hypofunction, but Albert, Tenney and Ford (1952) 
considered that the amount of thyroid hormone secreted by the gland 
is a more accurate measure of function than the amount of hormone 
accumulated in the gland. Myant, Pochin and Goldie (1949) 
measured the amount of plasma cleared of iodine per minute, and they 
regarded this as a measure of thyroid function; in thyrotoxic states 
there is an increased clearance rate.
- 11-
Ruedemann and Corrigan (1953) have emphasised that the 
measurement of the basal metabolic rate is not necessarily a true 
indication of thyroid function because it is a measurement of total 
gland function. They found that if a Geiger counter is applied 
to the surface of the thyroid gland, following the administration 
of radio-active iodine, small islands of hyperactivity may be found 
even when the basal metabolic rate is not unduly raised, and they 
considered that these islands may be of significance with regard 
to the relation of thyroid gland function to the occurrence of 
exophthalmos.
There are very few reports of pure thyroid administration 
being connected with the production of experimental exophthalmos, 
although Grobstein and Bellamy (1939) induced marked exophthalmos in 
this way in sexually immature fish (platypoecilus). Kunde (1927) 
produced slight exophthalmos with widening of the palpebral fissure 
in rabbits following administration of thyroxine. Similar 
experiments in the dog, however, gave negative results. Smelser (1937) 
showed that thyroxine causes exophthalmos in guinea-pigs, and Pochin 
(1944) demonstrated that this recession of the globe is due to a 
loss of orbital tissue. An interesting type of exophthalmos 
was found occurring spontaneously in certain young trout-fry 
(Hamre and Nichols, 1929)* It was associated with marked hyper­
plasia of the thyroid gland, muscular weakness and emaciation.
The condition could be prevented by the administration of iodine, 
and the primary upset appears to have been an excessive secretion
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of thyroid hormone with the production of muscular weakness 
and exophthalmos.
Similarly in man, treatment with thyroid hormone 
has only rarely been associated with the production of 
exophthalmos. One of the earliest of such cases was described 
by Lawford in 1900. Brain (1956) demonstrated the production 
of unilateral exophthalmos and lid retraction in a woman who 
had been on thyroid therapy for many years. The exophthalmos 
subsided on discontinuing the thyroid extract. At that time 
Brain could only find eighteen similar cases in the literature.
Justin-Besancon, Kohler and Schiff-Wertheimer (1954) found that
although thyroxine alone failed to produce exophthalmos, it did 
sensitise the eye to sympathomimetic drugs so that the joint 
administration of thyroxine and ephedrine produced some 
exophthalmos in a case of Graves’ disease.
An excessive amount of circulating thyroid hormone 
appears to be responsible for the production of two main 
effectss-
(l) Increased excitability of the sympathetico- 
adrenal system (sympathicotonia).
Gellhorn and Feldman (1941) showed that in rats the 
administration of thyroxine causes a marked increase in the
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excitability of the sympathetic nervous system. It is possible 
that thyroxine acts by sensitising the tissues to circulating 
adrenaline (Blau and McNamara, 1930)> if has been shown 
that thyroidectomy may be followed by a rapid diminution in 
sensitiveness to adrenaline (Eppinger and Levine, 1934)* It 
is believed that thyroxine may exert this effect because of its 
ability to decrease the amount of amine oxidase within the liver, 
because it is known that amine oxidase is responsible for the 
destruction of adrenaline (Spinks and Burn, 1952). In this 
way thyroxine may potentiate the action of adrenaline. The 
increased excitability of the sympathetico-adrenal system is 
termed sympathicotonia (Barger and Bale, 1910).
A profound disturbance of the sympathetic nervous 
system is a characteristic feature of Graves’ disease (Benedict, 
1935)j and, in fact, most of the manifestations of the condition, 
tremor, sweating, palpitations, etc., are sympathicotonic in 
nature (Kessel, Hyman and Lande, 1923)* Evidence of some central 
sympathetic disturbance has been shown by a pupillographic 
study in 21 out of 22 cases of hyperthyroidism (Givner, Bruger 
and Lowenstein, 1947). Brock (l94l) noted that a derangement of 
thyroxine secretion is followed by a derangement of other endocrine 
glands, particularly the adrenal medulla.
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(2) Myasthenia of striated musculature.
There is considerable evidence that thyrotoxicosis 
may be associated with weakness of the striated muscles. 
Ayer, Means and Lerman (1934) demonstrated a case which 
developed progressive weakness of all the skeletal muscles 
in association with exophthalmic goitre. Thyroidectomy 
caused an improvement in the thyrotoxicosis and in the 
myopathy. In a case described by Eagin, Pagel and Sand 
(1944) weakness of the hands and arms was associated with 
weakness of the extra-ocular muscles. Starling and others 
(1938) reported two similar cases, in one of which there 
was obvious involvement of the extra-ocular muscles, with 
an improvement of muscular power-following thyroidectomy. 
McEachern and Ross (1942) described three further cases of 
this type. An acute thyrotoxic myopathy, which is usually 
rapidly fatal, has also been reported as a rare complication 
of thyrotoxicosis (Heuer, 1916).
Lahey (1926) considered that weakness of the 
quadriceps femoris muscle is characteristically found in 
thyrotoxicosis, and he devised a clinical test to assess the 
power of the muscle in such cases. Shorr, Richardson and 
Wolff (1933) found a creatinuria in Graves1 disease, and 
Marine (1940) reported a great reduction in the phospho- 
creatine content of the striated muscles. The inability
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to retain ingested creatine indicates an upset in the 
phosphocreatine mechanism, and is further evidence of some 
abnormality of the striated musculature in thyrotoxicosis. 
The myasthenia of the striated muscles has been attributed 
to the direct action of excessive thyroid secretion on the 
muscle fibres (Brain,1938; Haines, 1939)> and Haines found 
that the muscle weakness increases on the administration of 
desiccated thyroid.
Smelser (1944) suggested that the effect of 
thyroxine on the muscles might not be a direct one on the 
muscle fibres, but that it might be an indirect one 
dependent on the change in water content of the muscles 
following thyroxine administration. He found an increase 
in oxygen consumption of the extra-ocular muscles of the 
guinea-pig treated with thyroxine, but,after allowance 
had been made for the associated alteration in water 
content of the muscles, this increase was scarcely 
significant. This may indicate that the primaiy defect 
is an altered water balance.
Rundle and Pochin (1944) showed that in 
thyrotoxicosis there is an increased fat content of the 
extra-ocular muscles and of the levator palpebrae 
superioris muscle. This increased fat content occurs 
in direct proportion to the normal fat content of the 
muscles, and this suggests that the underlying mechanism
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is an abnormal regulation of normal fat metabolism 
rather than a generalised deposition of abnormal fat.
Similar fatty changes occur within the skeletal muscles 
although to a lesser degree of intensity. More recent 
work (Pochin and Rundle, 1949) has shown that the 
increased adipose tissue is a new tissue increasing the 
total bulk of the muscles and not merely a simple 
replacement of degenerated muscle fibres. These fatty 
changes which occur in thyrotoxicosis are particularly 
striking when one remembers that it is a wasting disease 
with loss of much general adipose tissue, a finding which 
has also been reported experimentally in rats (McKay and 
Sherrill, 1941).
The muscle weakness in Graves’ disease is not 
due to any failure at the myo-neural junction, as in 
myasthenia gravis, and the weakness does not improve with 
prostigmine therapy, although, of course, myasthenia 
gravis may co-exist with thyrotoxicosis (Fraser,1937)*
Brody (1941) produced experimental evidence which conflicts 
with the concept of a normal myo-neural junction because 
he found that the ingestion of thyroxine in rats caused' a 
decreased level of neuro-muscular activity. It is difficult,
however, to assess the significance of this finding because
Brody obtained a similar decrease in neuro-muscular 
activity as a result of thyroidectomy. Thorner (1939) 
considered that Graves1 disease and myasthenia gravis are 
mutually antagonistic. He based this conception on the 
improvement which occurred in the muscle weakness, following 
the onset of thyrotoxicosis, in a case of myasthenia gravis, 
and also on the fact that he found some improvement in cases 
of uncomplicated myasthenia gravis treated with thyroid 
extract. This see-saw balance between the two conditions 
has been shown also by McEachern and Parnell (1948) and by 
MacLean and Wilson (1954)? because they found that the 
successful treatment of the hyperthyroidism which 
co-existed with myasthenia gravis caused a deterioration 
of the latter condition.
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Mechanism of thyrotoxic exophthalmos.
It has been shown, in the discussion on the 
classification of endocrine exophthalmos^that it is difficult 
to establish a purely thyrotoxic form of exophthalmos, as 
distinct from the thyrotrophic form of exophtnalmos which 
will be discussed in the next part of this thesis. In fact 
it may be that the only true thyrotoxic ocular manifestations 
are those associated with -che eyelids (lid retraction, etc.), 
as suggested by Bonamour and Rougier (l95l) an<l Philps (1953) 9 
and that exophtnalmos has a uniform hormonal basis irrespective 
of whether it occurs in a hyperthyroid or a hypothyroid 
phase, so that lid retraction and exophthalmos may have 
entirely different mechanisms (Brunton,1949)• It is certainly 
significant that there is seldom any correlation between the 
degree of exophthalmos and the height of the basal metabolic 
rate (McCullagh, Ruedemann and Gardner, 1946).
This part of the discussion is concerned, however, 
with the ways in which exophthalmos may occur as a result 
solely of thyrotoxic influences.
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There would appear to be three possible mechanisms 
in the occurrence of exophthalmos in thyrotoxicosis
(l) Exophthalmos due to smooth muscle overaction.
This theoiy is based on the known sympathicotonic 
effects of thyrotoxicosis.
It is interesting to recall that an upset of the 
sympathetic nervous system was the basis of the earliest 
theory of exophthalmos production, following the demonstration 
by Claud Bernard (1952) that section of the cervical 
sympathetic nerve trunk in the dog causes enophthalmos and 
ptosis, whereas stimulation of the cephalic end of the cut 
nerve produces exophthalmos and lid retraction. This 
observation has been repeated many times since then using 
different animals, for example, by Marine and Rosen (1934) 
in the rabbit, and by Cannon, Binger and Fitz (1915) i*1 the 
cat. Code and Essex (1935) enucleated the eye of the dog and 
then fixed a rubber balloon within the socket. On cervical 
sympathetic nerve stimulation an increased pressure was 
recorded within the balloon. Essex and Corwin (1936,1937) 
demonstrated a fallacy in certain aspects of these 
experimental findings. Many of the anaesthetics used in
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the experiments produce an enophthalmos. The exophthalmos 
which occurs on nerve stimulation is, therefore, to a certain 
extent a recovery of the eye from the enophthalmic position 
although there is also a small amount of true exophthalmos.
There is little doubt about the mechanism of 
this experimental exophthalmos in animals. It is closely 
related to the action of the smooth musculature found in 
the region of the eye, and innervated by the sympathetic 
nervous system. There are several smooth muscles to be 
considered.
Orbital muscle of Muller -
In 1858 Muller described an orbital smooth muscle 
which on contraction can produce exophthalmos.. Muller 
described this muscle in man although he mentioned the 
fact that it is better developed in the lower mammals.
It is now recognised that Muller's orbital muscle is only 
properly developed in animals which have an incompletely 
formed bony orbit and, therefore, require a powerful 
orbital muscle to help to maintain the eye in its normal 
position. In man the orbital muscle is a vestigial 
structure lying in the inferior orbital fissure. It cannot 
affect the position of the eyeball either directly following 
contraction of its muscle mass, or indirectly by impeding
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the venous outflow from the orbit (Whitnall,1952)• Poster 
Moore (1923) dissected a large series of orbits without 
finding any significant evidence of Muller's orbital muscle* 
Brunton (1938) examined this muscle in six cases of Graves' 
disease and found no evidence of any hypertrophy. There is 
no justification, therefore, for the view (Kravitz and 
Moehle, 1941) that exophthalmos in hyperthyroidism is due 
to contraction of Muller's orbital muscle.
Peribulbar smooth muscle -
This is an ill-defined mass of smooth muscle fibres 
surrounding the anterior half of the globe and closely 
associated with Tenon's capsule. This muscle band was 
described in detail by Hesser (1913)* Some of the fibres 
are attached anteriorly to the orbital septum and others 
come into association with the superior and inferior 
palpebral muscles of Muller. Posteriorly the fibres 
fade away indefinitely, although a few fibres blend with 
the fascial expansions given off by the recti muscles at 
their points of attachment to the globe (Sappey ,1069)•
Landstrom (1907) believed that the peribulbar smooth 
muscle is capable of causing protrusion of the globe.
Morley (1936) has suggested that in Graves' disease these 
bands of smooth muscle may combine to form a catapult so
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that the eyeball is projected forwards. Mufvany (1944) believed 
that the muscle is capable of exerting an effect on the globe when 
associated with weakened extra-ocular muscles. Normally the recti 
muscles have a retracting influence on the globe.
On the other hand Whitnall and Beattie (1933) 
dismissed Landstrom's muscle by merely attributing to it the function 
of retraction of the conjunctiva during movements of the eye in a 
horizontal plane. Code and Essex (1935) showed that in the dog 
Tenon's capsule plays no part in the production of exophthalmos following 
stimulation of the cephalic end of the cut cervical sympathetic nerve. 
Periorbital smooth muscle -
Russell (1936) has claimed that there is a moderate 
amount of smooth muscle within the periorbita, especially on its lateral 
aspect. The muscle fibres run in a circular direction parallel to the 
equator of the globe. She thought that there may be sufficient muscle 
in this situation to produce a certain degree of exophthalmos. The 
periorbita was examined histologically in 9 cases of Graves' disease 
but there was no evidence of hypertrophy of the muscle fibres.
There is, therefore, no conclusive anatomical evidence '
of any smooth musculature capable of producing and sustaining exophthalmos
in man, and there are no grounds for accepting the Editorial Comment
(Jour. Amer. med. Assoc., 102, 2188. 1934) that exophthalmos is simply
the result of hypertonicity of orbital smooth muscle. This is in 
keeping with observations which have been „iade in man following stimulation 
of the cervical sympathetic nerve. Benedict (1936) stimulated the
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cervical sympathetic nerve electrically during operations on the neck, 
and found no change in the position of the eye as shown by exophthal- 
mometric recordings. A similar negative result was obtained by 
Pochin (1939a) and Friedgood (l94l)»
On the other hand there are smooth muscle fibres within 
the periorbital tissues which may be implicated in the exophthalmic 
process. It is interesting that Friedgood (1941)> although he did not 
produce exophthalmos in normal subjects by cervical sympathetic nerve 
stimulation, found that exophthalmos, already present in a case of hyper­
thyroidism, increased by 3-4 mm. on similar stimulation. This may 
be evidence that there is more than one factor responsible for the 
production of exophthalmos in thyrotoxicosis.
A rapid reduction in exophthalmos in Graves1 disease 
following bilateral cervical sympathectomy has been reported 
(jonnesco, 1897)» but some of this improvement may have been due to
a decrease in the degree of lid retraction, and Juler (1913) did not
obtain any dramatic reduction in exophthalmos in a case treated in a 
similar way. Labbe* and others (1933) have shown that yohimbine, a 
sympatholytic agent, may lessen exophthalmos in certain cases, and they 
concluded that there is a sympathetic element in exophthalmos, although 
they stressed the presence of a hyperthyroid component which is not
influenced by the sympathetic nervous system.
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It has been suggested (Massoud, 1946) that sympathetic 
stimulation may cause exophthalmos by producing a state of venous 
dilatation within the orbit. This is an unlikely mechanism, 
however, in view of the different directions in which venous 
blood may drain from the orbit; forwards into the facial veins, 
downwards into the pterygoid venous plexus and backwards into 
the cavernous sinus. There is no doubt that venous congestion 
plays a part in the elaboration of the progressive type of 
exophthalmos (thyrotrophic exophthalmos) which will be dealt 
with in the next part of this thesis, but venous dilatation is 
not the initiating force.
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(2) Exophthalmos due to striated muscle weakness.
This theory is based on the known weakness of the 
striated muscles in thyrotoxicosis.
The extra-ocular recti muscles exert a retracting 
influence on the globe, and, if this is weakened,- it is natural 
that there may be a tendency towards the development of exophthalmos. 
This idea was put forward originally by Dalrymple (l834)» The 
recti muscles have been likened by Greene (1955) to the wires which 
maintain a champagne cork in position, so that exophthalmos may 
follow a reduction of their normal tonicity.
The lids also exert a restraining influence on the globe 
so that even the normal eye moves forwards about one millimetre when 
the lids are widely opened (Dayton, 1953)> and it is possible that 
this effect will be even more marked if there is an associated lid 
retraction.
Parker (1922) reported a case of hyperthyroidism in which 
complete luxation of both eyes occurred beyond the lids. Severe 
manual labour appears to have been a contributing factor in this case, 
but there must also have been a marked degree of hypotonia of the 
ocular muscles. Bundle and Y/ilson (1944a) have demonstrated by 
careful measurement that vaiying degrees of ophthalmoplegia occur in 
nearly half of all cases of thyrotoxicosis. Wilson (1935) examined 
at autopsy the extra-ocular and thigh muscles of eight cases of Graves' 
disease, and he found that the muscles were all small and degenerate.
He postulated that weakness of the ocular muscles may be a factor 
in the production of exophthalmos. Plummer and Wilder (1935) 
also suggested that weakness of the ocular muscles may allow some 
forward displacement of the globe, and it is interesting thet they 
found a positive correlation, in a series of cases of Graves' disease, 
between loss of power of the quadriceps femoris muscle and the 
presence of exophthalmos. Smelser (1938a) found a decrease in 
size of the extra-ocular muscles in guinea-pigs treated with 
thyroxine.
Figs. 1 and 2 illustrate the occurrence of ophthalmoplegia 
in two cases of thyrotoxicosis. In the case shown in fig. 1 there 
was complete paralysis of the right superior rectus muscle with 
overaction of the contralateral synergist (left inferior oblique).
There was also some paresis of the right inferior oblique. In the 
case shown in fig. 2 there was an identical affection of the left eye. 
In both cases there was an improvement in the systemic condition 
following thiouracil treatment, and also some improvement in the 
ophthalmoplegia. It may be concluded, txierefore, that to some 
extent these cases exhibit an ophthalmoplegia of thyrotoxic origin, 
although it must be remembered that in the majority of cases of 
ophthalmoplegia associated with thyroid dysfunction the condition is of 
a thyrotrophic type. This latter type of ophthalmoplegia is not 
relieved by anti-thyroid treatment (Zondek, 1951) > &nd it will be 
discussed in detail in the next part of this thesis.
FIG.1.
Eyes in 
dextro-elevation.
Eyes in 
primary position.
Eyes in 
dextro-depression.
Case of marked thyrotoxicosis showing complete paralysis of right 
superior rectus with overaction of contralateral synergist, left 
inferior oblique, and homolateral antagonist, right inferior rectus. 
There was also some paresis of right inferior oblique. Slight 
upper lid retraction (ft>L.) Some exophthalmos of right eye 
(Hertel exophthalmometer, R= 21mm., L= 18mm.). No sense of 
abnormal retro-ocular resistance.
FIG.2.
Eyes in 
laevo-elevation.
tion.
Case of moderate thyrotoxicosis showing complete 
paralysis of left superior rectus with overaction of 
contralateral synergist, right inferior oblique, and 
of homolateral antagonist, left inferior rectus.
There was also some paresis of left inferior oblique.
Some upper lid retraction (L>R). Slight exophthalmos 
of left eye (Hertel exophthalmometer, R=17 mm., L=19 mm.). 
Eo sense of abnormal retro-ocular resistance.
Eyes in 
primary posi
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A cardinal feature of thyrotoxic exophthalmos is the 
comparative ease with which the eye may be compressed backwards into 
the socket (Crawford, 1952), an effect first noticed by Cooper (1849)• 
This has been accurately demonstrated by Copper (1948) using an 
orbitonometer. Ease of compression of the eye is consistent with 
the concept of a mechanism based on extra-ocular muscle weakness, and 
it explains the disappearance of exophthalmos in some cases after 
death. It may also help to explain the quite rapid fluctuations
which $ay occur in the degree of exophthalmos (Bristowe, 1886) 
because such fluctuations would be unlikely if exophthalmos is 
determined solely by the presence of some new tissue within the orbital 
cone.
There are reports of the ophthalmoplegia in thyrotoxicosis 
benefitting from prostigmine therapy (Critchley and Cameron, 1948; 
Greene, 1949 5 Hatch, 1952), but such cases usually exhibit a co­
existent myasthenia gravis.
It is convenient to note at this point that in spite of 
the abundant evidence that a weakness of striated musculature may be 
a characteristic feature of thyrotoxicosis, the opposite point of view 
has been put forward by Daniel (1958) and Essex (1958) wilo postulated 
that there is an increased tone of the striated muscles in Graves' 
disease. Daniel (1958) suggested that this increased muscle tone may 
lead to a rise of venous pressure within the orbit with the production 
of congestive oedema and exophthalmos. It is difficult, however, to
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substantiate this theory ih the light of the other known features 
of the striated musculature in thyrotoxicosis.
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(5) Exophthalmos due to increased orbital fat.
It has been shown that in certain cases of thyrotoxicosis 
there is a persistence of exophthalmos after death (Woods, 1946), 
even when allowance is made for the normal post-mortem recession 
of about 2.5nnn. An increase in the amount of orbital fat has been 
demonstrated in some cases of thyrotoxicosis (Rundle and Pochin, 1944 5 
Pochin, 1945> 1946; bundle, 1951)• This is quite apart from the 
fatty changes which occur within the extra-ocular muscles and which 
are more marked than the purely orbital fat deposits. The increased 
fat within the orbit provides an explanation for the cases which show 
a degree of persistent exophthalmos after death.
In an interesting experiment Pochin (1949) showed ho?/ 
the adipose tissue found in the orbit may be purely secondary to the 
forward protrusion of the eye. He introduced a small perspex frame 
into the subcutaneous tissues of a rabbit. This formed a cavity 
?/hich could not be occluded by a mere displacement of the surrounding 
tissues. The cavity became filled with fluid, presumably due to the 
low hydrostatic pressure within the space, and later the fluid became 
replaced by a solid tissue. Pochin postulated that a similar process 
may occur within the orbit following forward displacement of the eye 
as a result of the weakness of the extra-ocular muscles. It may be, 
therefore, that any fat which is deposited in the orbit in thyrotoxi­
cosis is the result e.nd not the cause of the exophthalmos, and this
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concept is supported buy the fact that the fat deposit is merely 
an exaggeration of the normal adipose tissue within the orbit, and 
not a deposit of some abnormal tissue unrelated to the normal orbital 
fat (Pochin and Bundle, 1949)* On the other hand, it has been 
suggested that the laying down of fat within the orbit may be 
determined by some lipotropic hormone (Rundle, Finlay-Jones and 
Noad, 1953).
The three possible mechanisms in the production of -a 
thyrotoxic type of exophthalmos have been detailed under their 
separate headings, but it is more than likely that the exophthalmos 
is the result of a combined action of all three mechanisms so that 
the hypertonus of the orbital smooth muscles acts in conjunction 
with the hypotonus of the extra-ocular striated muscles (Spaeth,
1937; Mulvany, 1944) thereby causing some forward protrusion of 
the eye, and that this is followed by a fatty deposit within the 
orbi t.
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Other Clinical considerations of thyrotoxic exophthalmos*
Exophthalmos in thyrotoxicosis is commonly bilateral and 
symmetrical (Rundle and Wilson, 1945)? although Hedges and Rose (1955) 
have found a difference of over 3 inm* i-n the degree of exophthalmos 
in 9 out of 19 cases, and exophthalmos may even occur as a unilateral 
phenomenon (Spaeth, 19375 Covitz, 1941; Dixon, 1941; Vail, 1948)* 
Unilateral exophthalmos has been reported at an early stage of the 
disease before the appearance of any systemic manifestations (Kisner 
and Mahorner, 1947) > despite the fact that in general it is rare for 
exophthalmos to precede the more general signs of the disease (Saltzman 
and Mellicker, 1951)• There is evidence, however, that unilateral 
exophthalmos is rare if careful measurements are made of the other 
eye (Naffziger, 1948; Drescher and Benedict, 1950)5 an& Copper (1948) 
has shown that examination with an orbitonometer may reveal early 
involvement of the apparently "unaffected" eye. In certain cases 
a long interval may elapse between the early general manifestations of 
the disorder and the onset of exophthalmos (Dayton, 1953)-
There is no doubt that, provided a careful distinction 
is drawn between true exophthalmos and apparent exophthalmos (lid 
retraction), exophthalmos is not a universal feature of Graves’ 
disease; in fact it only occurred in 19 out of 134 cases (Eden 
and Trotter, 1942) , in 6 out of 17 cases (Rundle and Pochin, 1944) > 
and in 18 out of 57 cases (Donoso, 1953)* Exophthalmos is seldom 
a marked feature of thyrotoxicosis, although Stokes (1954) described 
a case of severe exophthalmos in a girl in which the exophthalmos
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subsided following the successful medical and surgical treatment 
of the underlying Graves' disease. This response of the exophthalmos 
to anti-thyroid treatment suggests that the exophthalmos was 
determined by the thyrotoxicosis, and was not, therefore, of 
the thyrotrophic variety which is the more common form of severe 
exophthalmos, and which is not under discussion in this part of 
the thesis .
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Mechanism of lid retraction in thyrotoxicosis
There ia no general agreement on the mechanism 
underlying the occurrence of I id retraction in Graves* disease, 
and two main theories have been put forward; first, that it is duo 
to an overaction of the smooth palpebral muscles, and, secondly, 
that it is due to an overaction of the striated levator palpebrae 
superioris muscle. An earlier theory (StelTwag, 1669) that 
the primary cause of lid retraction is a weakness of the orbicular!a 
oculi muscle has never found much favour and has been disproved by 
Pochin (1939b) who found a complete absence of any lid retraction 
in 15 cases of unilateral facial palsy.
There ie, of course, a certain degree of lid retraction 
in all cases of true exophthalmos as a result merely of the mechanical 
effect of the protruding globe on the eyelids, and car© must b® 
taken to exclude exophthalmos before arriving at an assessment of 
lid retraction (Payton, 1953)- This discussion is concerned only 
with lid retraction which occurs as an independent phenomenon from 
exophthalmos•
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(l) Hypothesis that lid retraction is due to overaction of the
smooth palpebral muscles of Muller.
The theory that overaction of the smooth palpebral 
muscles is instrumental in the production of lid retraction was 
put forward originally by von Graefe (I864) » and has been restated 
by many others since then (Marine and Rosen, 1934; Seitchik, 1942; 
Mulvany, 1944; Azerad, 1946; Klotz, 1948c; Braley, 1948 and 1953; 
Payton, 1953*) It is based on the following premises:-
(a) The fact that there are smooth muscles in 
the upper and lower lids - the superior 
and inferior palpebral muscles of Muller.
The superior palpebral muscle of Muller arises between 
the striated fibres of the levator palpebrae superioris muscle and 
passes downwards to be inserted by fine fibres into the upper 
surface of the tarsal plate of the upper lid.
The inferior palpebral muscle of Muller is less distinct
than the corresponding muscle of the upper lid. It arises from the
fascial sheet of the inferior rectus muscle and passes forwards as 
two lamellae one of which is inserted into the bulbar conjunctiva 
whilst the other is inserted just behind the lower edge of the tarsal 
plate.
These smooth muscles are innervated by the sympathetic 
nervous system, and their presence in the upper and lower lids 
accounts for the fact that the narrowing of the palpebral fissure on 
the affected side in a case of Horner's syndrome is due, not only 
to a drooping of the upper lid, but also to a slight elevation of 
the lower lid (fig. 3)* This narrowing of the palpebral fissure may 
altso be produced temporarily by a blockage of the cervical sympathetic 
nerve by local anaesthesia (Miller, 1953)* Conversely, it has been 
shown that stimulation of the cervical sympathetic nerve in man causes 
an obvious retraction of the upper lid and a slight retraction of the 
lower lid (Pochin, 1939a)*
(b) The fact that lid retraction is a phenomenon 
which may affect both the upper and the lower 
lids.
There is no doubt that lid retraction is an effect 
primarily apparent in the upper lid, but Mulvany (1944) Has shown 
that retraction of the lower lid may occur and, in fact, may be the 
earliest ocular manifestation of thyrotoxicosis in about 75^ of 
cases. Holloway, Pry and Wentworth (1929) also found that, although 
retraction of the upper lid is the outstanding feature of thyrotoxicosis, 
retraction may occur to a lesser extent in the lower lid. This has 
been investigated in a series of cases of Graves' disease.
FIG.5.
Case of Horner's syndrome of left eye showing 
narrowing of left palpebral fissure due to slight 
depression of upper lid and slight elevation of 
lower lid. Note slight miosis on affected side.
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Examination of lid retraction in thyrotoxicosis.
In most normal individuals, with the head held erect 
and eyes directed straight forward, the lower lid just borders on 
the lower corneal limbus. Lower lid retraction causes a distur­
bance of this relationship and an area of conjunctiva becomes 
visible between the limbus and the lower lid margin. This visible 
conjunctiva is termed the lower scleral rim, and it is illustrated in 
figs. 4-7 which show the phenomenon of lower lid retraction as it 
occurs in cases of mild thyrotoxicosis. In fig.4 there is retraction 
of both lower lids, although the retraction is more marked on the 
left side than on the right side. In fig. 5 there is an equal 
degree of lower lid retraction in the two eyes. An interesting 
feature of these cases is the fact that the size of the lower scleral 
rims did not always remain constant and that fine twitching movements 
could be seen sometimes along the length of the lower lids which caused 
an alteration in the extent of the lower scleral rims, evidence 
surely of some active muscular disturbance.
It would appear that lower lid retraction, when it 
occurs, may be only a transitory phenomenon. V.hen retraction of the 
upper lid becomes effective there is a raising of the whole level of 
the palpebral fissure of that eye and a consequent masking of any 
lower lid retraction. Upper lid retraction is, therefore, a more 
powerful and dominant force than lower lid retraction. Figs. 6 and 7>
FIG. 4»
Case of early thyrotoxicosis showing retraction of 
both lower lids (L>R). No upper lid retraction. 
No exophthalmos.
FIG. 5.
Case of early thyrotoxicosis showing retraction of 
«
both lower lids. No upper lid retraction. No 
exophthalmos.
FIG.6.
FIG.7.
FIGS.6 and 7.
Cases of early thyrotoxicosis. Each case shows
retraction of left lower lid with appearance of scleral
rim between cornea and lower lid. No obvious retraction
of right lower lid, but this effect is probably masked
by slight raising of level of right palpebral fissure 
due to retraction of upper lid. No retraction of left 
upper lid. No exophthalmos of either eye.
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showing cases of early thyrotoxicosis, illustrate this point. In 
each case the left lower lid is retracted as compared with the right 
lower lid but on the right side there is the additional feature of upper 
lid retraction and it may be this which has caused the difference in 
levels of the lower lids.
It is important in determining the presence of lower 
lid retraction to exclude any true exophthalmos. When an eye 
becomes proptosed an area of conjunctiva becomes exposed between the 
lov/er corneal limbus and the lower lid margin quite independently 
of any lower lid retraction. Figs. 8,9 an& 10 illustrate this 
occurrence, the lower scleral rims being determined by the presence 
of exophthalmos. It is also important to exclude any structural 
anomaly of the lids before attaching undue significance to the 
presence of lower scleral rims. In certain normal individuals the 
lower lid margin shoves a pronounced curve downwards in its lateral 
two-thirds, and this produces the appearance of obvious lower scleral 
rims. Figs. 11 and 12 illustrate this point.
FIG.8.
Case of established, thyrotoxicosis showing appearance of 
lower scleral rims, but in view of the occurrence of 
exophthalmos (Hertel exophthalomometer, R = 21 mm.,
L = 20 mm.), no conclusion may be reached, regarding lower 
lid retraction. There is some upper lid retraction of 
both eyes.
FIG. 9.
Case of established thyrotoxicosis showing appearance of 
lower scleral rims, but in view of the occurrence of 
exophthalmos (Hertel exophthalmometer, R = 23 mm., L =
21 mm.), no conclusion may be reached regarding lower lid 
retraction. There is some upper lid retraction, particularly 
on the right side.
FIG.10.
Case of established thyrotoxicosis showing appearance of 
obvious lower scleral rims. There is, however, exophthalmos, 
(Hertel exophthalmometer, R = 19 mm., L = 21 mm.), and this 
has determined the appearance of visible lower scleral 
rims.
FIG.11.
FIG.12.
FIGS.11 and 12.
Normal healthy individuals. The lower scleral rims are 
determined solely by the peculiar curve of the lower lid 
margins.
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(c) The fact that lid retraction may he lessened 
by a reduction in sympathetic tone.
It has been shown in certain cases of Graves’ disease 
that cervical sympathectomy causes a diminution in the degree of 
lid retraction (Edmunds, 1900; Jon^sco, 1905$ Shaw, 1929> Keynes, 1952), 
and in fact, Brain (1952) has recommended this operation in patients 
who are distressed by the persistence of the staring appearance 
despite the successful completion of the usual anti-thyroid 
therapeutic procedures.
The cervical sympathetic nerve may be blocked by local 
anaesthesia, and this causes a marked temporary reduction in lid 
retraction (McCullagh, 1955)• A reduction in sympathetic tone may 
be achieved also by the use of sympatholytic drugs, and Givner, Bruger 
and Lowenstein (1947) have noted that ergotamine causes a narrowing 
of the palpebral fissure in cases of lid retraction during the period 
of its administration.
The effect of hexamethonium iodide, a sympatholytic 
drug, has been noted on the positions of the lids in thyrotoxicosis.
It has been shown by Pston and Zaimis (1951) that hexamethonium may 
block the retraction of the nictitating membrane in the cat which 
normally follows cervical sympathetic nerve stimulation, and an 
investigation has been carried out also on the influence of this drug 
on experimentally induced lid retraction in the monkey. These 
investigations will be reported now.
Examination of influence of hexamethonium iodide on lid retraction
in thyrotoxicosis.
An investigation has been conducted on the effect of a 
sympatholytic drug, hexamethonium iodide, on the degree of lid 
retraction in three cases of early untreated thyrotoxicosis. In 
two cases the effect of the lid retraction was predominantly on 
on the lower lids, but in the other case retraction of the upper 
lids was the outstanding feature, and there was no retraction of 
the lower lids. There was no true exophthalmos in any of the cases.
The position of the lids was determined at five minute 
intervals before and after the administration of 25 mgm. hexamethonium 
iodide by intramuscular injection. The distance of each lid margin 
from the adjacent part of the corneal limbus was measured in milli­
metres, a positive value indicating retraction of the lid from the 
cornea, a negative value indicating overlapping of the lid by the 
cornea. Great care was taken to ensure that each measurement was 
made under standard conditions, with the patients' head in an upright 
position and the eyes in the primary position, so that it was possible 
to obtain a comparable series of readings. A recording of the blood 
pressure was made simultaneously in order to give further evidence of 
the effectiveness of the drug.
Figs. 15 and 14 show the effect of hexamethonium on
the upper and lower lids of the right and left eyes, respectively, of
one of the cases showing retraction of the lower lids. It is apparent 
that within 10 - Ip minutes of the administration of the sympatholytic
FIG.15.
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drug there was a decrease in the degree of lid retraction of both 
lids, and that this reached a maximum within JO - 40 minutes 
followed by a gradual return of the lids to their original 
position. It may be noted that the blood pressure recordings 
fluctuated in a similar manner to the changes in lid position.
The other case showing lower lid retraction gave a comparable 
result.
Figs. 15 and 16 show the effect of hexamethonium on 
the upper lids of the right and left eyes, respectively, of the case 
showing obvious upper lid retraction, and it is clear that the 
drug brought about a gradual reduction in the degree of upper lid 
retraction for a period of about 40 minutes. The lower lid is 
not recorded in the charts because its position did not alter to 
any significant degree during the period of observation.
It is suggested that the absence of any dramatic effect 
on the lower lid in this case is not evidence against the existence 
of a mechanism within the lower lid capable of being associated in 
the process of lid retraction. If it is accepted that upper lid 
retraction is the more powerful mechanism and that when it becomes 
effective there is a raising of the whole level of the palpebral 
fissure, then any reduction of lower lid retraction due to the 
administration of hexamethonium may be masked by the dropping of tne 
level of the palpebral fissure following tne reduction of upper lid 
retraction•
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Examination of influence of hexamethonium iodide on lid retraction
induced by sympathetic stimulation in the monkey
Three monkeys were used in the experiment and it is 
known that both lids of the monkey contain smooth muscle which is 
capable of exerting a retracting influence on the lids. The smooth 
palpebral muscle of the upper lid is shown in fig. 17*
A moderate degree of anaesthesia was produced by exposin 
the monkey to ether vapour, and then anaesthesia was completed by 
injecting chloralose through a cannula inserted into the femoral 
vein. The chloralose was dissolved in water at a temperature of 
55°C (10 mgm. chloralose per ml. water), and it was administered in 
a dose of 100 mgm. chloralose per,Kg. body weight. If the 
experiment was prolonged an additional 100 mgm. chloralose was 
given supplemented, if necessary, by 3 ml. of a nembutal solution 
(l/lOth gr. nembutal per ml. water). The nembutal was also given 
intravenously.
The anaesthetised monkey was placed in the dorsal 
position with the head extended, and the right side of the neck was 
dissected through a paramedian incision to expose the carotid sheath 
with its constituent vessels and nerve. This sheath was carefully 
lifted to reveal the underlying cervical sympathetic nerve which 
was placed on the groove of a stimulator, great care being taken to 
prevent any undue stretching of the nerve (fig. lb). The stimulator 
was designed to administer a current of 15 volts with a frequency of
FIG.17.
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Photomicrograph of a section of the upper eyelid of a 
monkey to show the presence of a smooth palpebral muscle 
in the lid adjacent to the superior fornix. X4-8.
FIG.18.
Photograph of a dissection of the right cervical region 
of the monkey to show the right cervical sympathetic 
nerve lying on the curved end of a stimulator.
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20 cycles per second and a range of one millisec. Each stimulation 
persisted for 10 seconds. Before each period of stimulation the 
nerve was carefully dried and covered hy a dry swab, hut at all other 
times its integrity was maintained hy heing moistened with normal 
saline'. The effect of stimulation of the cervical sympathetic nerve 
on the eye is shown in fig. 19> and it is apparent that it causes a 
well marked retraction of both lids, particularly the lower one, with 
an associated mydriasis.
During the period of observation the animal's head was 
placed in a clamp designed to maintain the head in a set position. The 
upper or lower lid margin of the right eye was attached to an isotonic 
lever by means of a fine suture which passed from the lid in a 
horizontal plane so that it caused slight tension on the lid. Any 
retraction of the lid resulted in a pulling on the suture with a 
corresponding movement of the recording lever. This lever was placed 
against a kymograph, set at a speed of 2 F so that 7 mm* of the tracing 
was equivalent to one minute of time.
Figs. 20 and 21 show the effect of the administration of 
one ml. hexamethonium intravenously (10 mgm. hexamethonium per ml. water) 
on the degree of lid retraction following stimulation of the cervical 
sympathetic nerve, and it is apparent that hexamethonium greatly reduces 
the ability of the stimulated nervical sympathetic nerve to induce lid 
retraction, although the effect is only transitory and passes off 
within about 10 minutes.
FIG.19.
(a) The normal monkey
(h) The effect of stimulation of the right cervical
sympathetic nerve in the monkey. Note the retraction 
of the lids, particularly the lower one, and the 
associated mydriasis.
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(d) The fact that a correlation exists between the 
degree of sympathicotonia and the degree of 
lid retraction in thyrotoxicosis.
There is no doubt that many of the manifestations of 
Graves' disease are of a sympathicotonic nature and it is, therefore, 
an attractive concept to relate the occurrence of lid retraction to 
this mechanism, particularly as an adenoma of the thyroid gland, which 
is seldom associated with signs of a sympathicotonic disturbance, is 
also seldom associated with lid retraction (Atkinson, Lisser and 
Shepardson, 1928).
Furthermore, there is often a direct correlation between 
the extent of the thyrotoxicosis and the degree of the lid retraction, 
(Levitt, 195l) and, conversely, successful surgical and medical treatment 
of Graves' disease is usually followed by a marked reduction in the 
degree of lid retraction (Ruedemann, 1951? Barr and Shorr, 1945)*
(e) The fact that lid retractxon may occur in 
sympathicotonic states, quite apart from 
thyrotoxicosis.
It has been shown that stimulation of the distal end of 
the cut cervical sympathetic nerve may produce a definite elevation 
of the upper lid and a slight lowering of the lower lid (Pochin, 1959a). 
Savin (1945) made the interesting personal observation that the
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sudden explosion of a nearby bomb produced typical thyrotoxic fascies 
with marked widening of the palpebral fissures!
Lid retraction does not occur exclusively in thyrotoxicosis. 
Friedgood (1950) observed some degree of retraction of the upper lid 
in nearly 5 of 258 cases of essential hypertension without any 
associated thyrotoxic element. He considered that this lid retraction
t•
is identical with that found in Graves' disease, and that a common 
factor is in operation, namely, spasm of the smooth muscle of the upper 
lid due to overaction of the sympathetic nervous system. Nevin and 
Kiloh (l95l) noted the occurrence of lid retraction in disseminated 
sclerosis due to irritation of the descending spinal sympathetic 
fibres. Kessel and Hyman (1925) found lid retraction in a series of 
cases showing autonomic imbalance but without any signs of thyrotoxicosis. 
In a case of periodic sympathetic spasm of the pupil, the phase of 
pupillary dilatation was related to a widening of the palpebral fissure 
(Lowenstein and Levine, 1944)* Hundle (1941) described the occurrence of 
lid retraction in a number of cases without any evidence of thyrotoxicosis 
although he stated that several of the cases developed thyrotoxicosis at a 
later date. Jackson (1949> 1950) noted that lid lag, a phenomenon 
which is dependent on a hypertonicity of the retracting influence of 
the upper lid, occurs in 5 5 of persons with peptic ulceration whereas 
it occurs only in lOfo of normal persons.
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Hypothesis that lid retraction is due to overaction of the striated 
levator palpebrae superioris muscle.
The theory that overaction of the striated levator 
palpebral superioris muscle is responsible for the production of lid 
retraction has been put forward by Pochin (1939b), and re-affirmed 
by Brain (1939) > Rundle (l95l)> Cogan (1953) > an(t Huedemann and 
Corrigan (1953)* bn fact, huedemann and Corrigan designated lid 
retraction as levator retraction. This theory is based on the 
following premises:-
(a) The fact that there is a striated muscle in the
upper lid - the levator palpebrae superioris muscle.
The levator palpebrae superioris is a powerful muscle 
which arises at the apex of the orbit from the lesser wing of the 
sphenoid above the annulus of Zinn, and runs forwards under the 
roof of the orbit to terminate in an expanded aponeurosis, the main 
part of which is inserted into the skin of the upper eyelid and into 
the lower third of the anterior surface of the tarsal plate. It is 
innervated by the oculomotor nerve, and is responsible for lifting the 
upper lid in the expression of staring, a function first attributed 
to it by Dalrymple (l834)»
(b) The fact that lid retraction is a phenomenon confined 
solely to the upper lid.
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A detailed description of lid retraction has been given 
by Pochin (1938a) who emphasised that it is only the upper lid which 
becomes elevated. In such cases when the lids are closed a prominent 
horizontal fold may be seen lying about 6 - 1 0  mm. above the lid 
margin, and this probably represents the unduly prominent superior 
border of the upper tarsal plate. Pochin has declared that in 
association with the retraction of the upper lid there is a slight 
elevation of the lower lid, and this would appear to indicate the 
absence of any effective mechanism within the lower lid capable of 
producing retraction so that the lower lid becomes elevated as a 
direct mechanical consequence of the raising of the external canthus 
following retraction of the upper lid. Francois (1951a) has also 
stated that lid retraction is confined to the upper lid only.
(c) The fact that lid retraction may be relieved
by tenotomy of the levator palpebrae superioris 
muscle.
In an isolated case of unilateral lid retraction in 
Graves1 disease, Cogan (1953) bas shown that tenotomy of the 
levator palpebrae superioris muscle relieved the appearance of lid 
retraction. Spaeth (1953b) recommended recession of the levator 
muscle in cases of marked ux3per lid retraction.
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(d)
Rundle and Pochin (1944)> in a study of the fat content 
of the ocular muscles in thyrotoxicosis, found an increased fat 
content in all the striated ocular muscles and this was most 
marked in the levator palpebrae superioris. This is consistent with 
the fact that normally the levator has a slightly higher fat content 
than the other extra-ocular muscles, because Rundle and Pochin 
found that the increase in fat was in proportion to the normal fat 
content of the various muscles. They concluded that the pathological 
change within the levator is responsible for lid retraction.
(e) The fact that lid retraction may occur in a 
state of oculomotor nerve hyperexcitability, 
quite apart from thyrotoxicosis.
It has been shown that retraction of the upper lid may 
be associated with the phase of pupillary constriction in a case of 
cyclic oculomotor paralysis (Lowenstein and Givner, 1942). It may 
also be a feature of Parinaud's syndrome or of post-encephalitic 
Parkinsonism, presumably as a result of a lesion in the mesencephalic 
diencephalon producing a hypertonicity of the levator palpebrae
superioris muscle (Francois, 1951a)«
The fact that pathological changes may occur in 
the levator palpebrae superioris muscle in 
thyrotoxicosis.
- 4 9 -
Conclusion regarding the mechanism of lid retraction in
thyrotoxicosis
There can obviously be no reconciliation of the two 
opposing hypotheses which have been put forward to account for the 
occurrence of lid retraction in thyrotoxicosis, and, on balance, 
from the evidence which has been produced, it would appear that 
spasm of the smooth palpebral musculature is the more attractive 
concept. There are, hoy/ever, certain difficulties in an acceptance 
of this hypothesis
(a) The fact that lid retraction in thyrotoxicosis
is a feature of the upper lid, whereas stimulation 
of the cervical sympathetic nerve produces retraction 
of both lids, although to a more marked degree in 
the upper lid than in the lower one.
This is a serious objection to the sympathicotonic 
hypothesis, unless the evidence which has been put forward in an 
earlier part of this thesis is accepted, namely that lower lid 
retraction occurs in the early stages of the condition and that this 
becomes masked when the more dominant upper lid retraction becomes 
effective.
(b) The fact that lid retraction in thyrotoxicosis
is not characteristically associated with mydriasis.
Brain (1939) considered that the absence of a dilated 
pupil in thyrotoxicosis conflicts with the idea that lid retraction 
is due to sympathetic overaction. The absence of mydriasis in 
exophthalmic goitre has been stressed by many observers (Holloway, 
Fry and Wentworth, 1929; Justin-Besancon, Kohler and Schi'ff- 
Wertheimer, 1934; Plummer and Wilder, 1935; Weekers and Dedoyard, 
195l)* O n the other hand Sivner, Bruger and Lowenstein (1947) 
examined the pupil in hyperthyroidism by a pupillographic method 
and found some evidence of a sympathetic disturbance although of 
a central type. It is interesting to note that Justin-Besancon and 
others (l93l) showed that intravenous ephedrine in dogs causes 
mydriasis and a veiy slight degree of exophthalmos, but if thyroxine 
is also administered a marked exophthalmos occurs which is only 
rarely accompanied by any dilatation of the pupil. Similarly 
Labb^ and others (1931) demonstrated that in a case of obesity 
treated with thyroxine, administration of ephedrine produced 
exophthalmos with only very slight pupillary dilatation. It may be 
that in thyrotoxicosis the absence of mydriasis is not necessarily 
incompatible with the presence of increased sympathetic tone.
(c) The fact that lid retraction in thyrotoxicosis 
may occur despite the presence of a lesion of 
the peripheral sympathetic pathway.
Brain (1939) reported the development of lid retraction 
in a case of thyrotoxicosis superimposed on an old-standing syringo­
myelia# The syringomyelia was associated with involvement of the 
peripheral sympathetic pathways to the eyes, as shown by the earlier 
presence of ptosis, more marked in one eye than in the other# 
Following the onset of thyrotoxicosis bilateral lid retraction 
became apparent. The eye which had shown the lesser degree of 
ptosis developed the greater degree of retraction. This case would 
appear to refute any idea of the implication of the smooth lid 
muscles in the development of lid retraction. On the other hand, it 
may be that the integrity of the sympathetic nerve pathways is not 
essential to the development of lid retraction, and that circulating 
adrenaline may act on denervated smooth muscle which has been 
sensitized by an excess of thyroxine in the circulation.
It is interesting to note that Brunton (1935) produced 
retraction of the lids in cats and dogs with intravenous ephedrine 
irrespective of whether the cervical sympathetic pathway was intact 
or not. He concluded that the effect of ephedrine is a local one 
on the sympathetic nerve endings or on the smooth muscle fibres. 
Marine and fiosen (1934) even considered that the smooth muscles of 
the eye are more sensitive to adrenaline after cervical sympathetic 
ganglionectomy, an effect which was noticed within six days of the 
operation in cats and dogs (Bacq. and Isola, 1946). Lockett (1950) 
also demonstrated a similar effect on the nictating membrane of the 
cat, and she found that pre-ganglionic or post-ganglionic sympathetic
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denervation causes a marked increase in the threshold sensitivity to 
adrenaline or to dl-noradrenaline. Paton and Zaimis (1951) noted 
that the effect of adrenaline on the blood pressure is enhanced after 
the administration of hexamethonium, and this may be another example 
of adrenaline exerting a strong influence on a temporarily 
denervated structure.
The case described by Brain may not necessarily be 
regarded, therefore, as a contradiction of the view that sympathicotonic 
influences motivate the occurrence of lid retraction in thyrotoxicosis.
The opposing hypothesis, tint lid retraction in 
thyrotoxicosis is due to overaction of tne striated levator 
palpebrae superioris muscle, is attractive in explaining the marked 
upper lid retraction which is a characteristic feature of Graves' 
disease. There is, however, a serious difficulty in an acceptance 
of this hypothesis because lid retraction in thyrotoxicosis has been 
associated with an increased fat content of the levator palpebrae 
superioris, and there is evidence that a similar increase of fat 
within the extra-ocular muscles in Graves' disease is responsible for 
varying degrees of ophthalmoplegia (Bundle and Wilson, 1944a), 
particularly as a correlation has been shown between the amount of fat 
within the muscle and the degree of ophthalmoplegia.
It is indeed difficult to see how fatty changes may 
produce spasm of one striated muscle and weakness of another similar
-53-
muscle, and, even if the pathological changes within the muscle are 
discounted, it is still difficult to reconcile hypertonicity of one 
striated ocular muscle to the exclusion of the others (Cooper, 18495 
Francois, 1951a).
It would appear more likely, therefore, that an increased 
fat content within the levator may produce a weakness of the muscle 
thus allowing a more marked- action of the smooth muscle component 
within the lid (Adler, Scheie and Dennis, 1949)* In this way 
thyroxine may play a dual role in facilitating lid retraction, first, 
by sensitising the smooth muscle to the action of circulating 
adrenaline (Mann, 1946b), and, secondly, by weakening the response 
of the striated muscle.
In any case it is difficult to ascribe a dominant role 
to pathological changes within a muscle in the mechanism of lid 
retraction. The rapidity with which lid retraction may develop in 
a case of thyrotoxicosis, and the equal rapidity with which it may 
disappear in certain cases after successful medical or surgical 
treatment of the thyroid dysfunction are more consistent with the 
response of a nervous mechanism.
It is doubtful if the single case described by Cogan 
(1955), in which lid retraction was relieved by tenotomy of the levator 
muscle, is of significance in this discussion because, irrespective 
of tne mechanism of lid retraction, such an operation is bound to be 
followed by a lowering of the lid. On the other hand, it is of interest
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to note that an injection of novocaine into the region of the 
stellate ganglion is reported hy Cogan to have caused a miosis 
without affecting the position of the lids. Spaeth (1953*0 
also described the operation of levator recession in lid 
retraction, but this did not deter him from ascribing the 
mechanism of the phenomenon to a tonic spasm of the smooth 
muscle of the lid.
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Qtlier clinical considerations of lid retraction in thyrotoxicosis.
There is evidence that lid retraction is a more common 
feature of Graves' disease than exophthalmos, and that, although 
there is some association between exophthalmos and lid retraction, 
they may occur independently or simultaneously in Graves' disease 
(Pochin, 1938b).
Eden and Trotter (1942) noted the occurrence of lid 
retraction in 72 out of 134 cases of Graves' disease, whereas 
exophthalmos was present in only 19 of the cases. Donoso (1953) 
described lid retraction in 28 out of 57 such cases, and exophthalmos 
in 18 of the cases. Shannon and Hunt (1947) have claimed that 5Ofo 
of cases of Graves' disease exhibit lid retraction without any 
evidence of exophthalmos. There certainly can be little ground for the 
statement of Knudtzon (1949) that an exophthalmometric measurement 
will confirm or refute the presence of early thyrotoxicosis. Lid 
retraction is not only an outstanding feature of Graves' disease but 
it may be one of the earliest manifestations of the disease and may 
even precede any general signs of the condition (V/erner and Spooner, 
1955). Lid retraction is usually bilateral and symmetrical but it may 
occur as a unilateral phenomenon (Dixon, 1941; Francois, 1951a).
It is important to realise that lid retraction causes an 
illusion of exophthalmos, and that judgement of exophthalmos is often 
fallacious when judged solely by direct observation (Benedict, 1936; 
Soley, 1942). This is particularly misleading when the lid retraction
- 5 6 -
is unilateral, as illustrated in fig. 22 in which the left eye 
appears to show a much higher degree of exophthalmos than the 
right eye. In fact, exophthalmometric readings showed an identical 
degree of exophthalmos in each eye, and the illusion of unilateral 
exophthalmos is due purely to the obvious lid retraction on the left 
side.
This concept is important also in assessing the state 
of the eyes following successful medical or surgical treatment of 
Graves* disease. Barr and Shorr (1945) noted an apparent reduction 
in exophthalmos follwing thiouracil treatment, and yet the exophthalmos 
was ound to have increased by 2 - 4 nun* The apparent improvement 
was due to a dramatic decrease in the amount of lid retraction.
Similar observations have been made following thiouracil treatment 
(Dobyns and Haines, 1946a, b; Haines and Keating, 1946) and following 
thyroidectomy (Dobyns, 1945; Bundle and Wilson, 1945; Dobyns and 
Haines, 1946a, b). Haffziger (194&) stated that, although most 
cases appear to show a lessening of exophthalmos following thyroidectomy, 
only 5i° of cases show an actual reduction in the degree of exophthalmos. 
This emphasises the importance of exophthalmometric observations 
before determining the state of exophthalmos (Bartlett, 1949)*
FIG.22.
Case of thyrotoxicosis with an equal degree of 
exophthalmos in each eye (Hertel exophthalmometer,
R = 19.5 mm., L = 19*5 mm.). Left eye appears more 
markedly proptosed due to retraction of the upper 
lid of that eye.
PART II - Exophthalmos Unrelated to Thyrotoxicosis 
(Thyrotrophic Exophthalmos)
Introduction
This type of exophthalmos appears to he independent of 
any increased function of the thyroid gland. In fact most cases are 
associated with a state of hypothyroidism.
In 1910 Gley found that thyroidectomy in rabbits 
resulted in the production of exophthalmos. He clearly differentiated 
this type of exophthalmos from that which followed stimulation of 
the cervical sympathetic nerve pathway. Gley offered no explanation 
for the mechanism of this exophthalmos, but Poncet (19IO) postulated 
the presence of an exophthalmos-producing factor secreted by some 
organ other than the thyroid gland. He made the prophetic remark 
that this might be the pituitary gland.
A large number of experimental and clinical observations 
have pointed to the thyrotrophic hormone of the anterior pituitary 
body as being directly concerned with the production of exophthalmos.
It is proposed to consider this aspect of the problem first, and then 
to discuss certain other endocrine glands which may also have an 
important influence on the problem of exophthalmos. The exophthalmos 
under consideration will be termed thyrotrophic exophthalmos. This
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is not a strictly accurate term, but it at least signifies a type of 
exophthalmos which contrasts with that relating to thyrotoxicosis.
Clinically thyrotrophic exophthalmos is commonly termed 
progressive exophthalmos, and this name takes account of the active 
proptosis which is associated with the condition. It is also some­
times called malignant exophthalmos, and this is a useful term because 
it emphasises the fact that, in certain cases, the ocular manifestations 
run a rapid and grave course. On the other hand it is unsatisfactory 
because strictly speaking the term malignant exophthalmos should be 
restricted to cases of proptosis due to malignant growths in the 
region of the orbit, and, therefore, unrelated to endocrine disorder.
Means (1945) has termed progressive exophthalmos the 
hyperophthalmopathic form of Graves’ disease. This is scarcely a 
euphonic term but it does emphasise that the ocular involvement 
completely overshadows any general manifestations of the condition.
Brain (1958) introduced the term exophthalmic ophthalmoplegia for a 
group of cases showing marked proptosis with obvious limitation of 
ocular movements especially those of elevation. It is noteworthy 
that exophthalmic ophthalmoplegia, when considered in a broad sense, 
need not occur exclusively in the thyrotrophic phase of Graves' disease, 
in so far as the combination of exophthalmos and muscle weakness is 
found in thyrotoxicosis but in normal usage it implies a thyrotrophic 
type of change.
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Nature of pathological process in thyrotrophic exophthalmos
Nature of pathological changes in orbital tissues.
The changes in the orbital tissues in thyrotrophic 
exophthalmos may be considered under five separate headings; increase 
in water content, increase in mucin content, increase in fibrosis, 
increase in lymphocytes and change in fat content.
1. Increase in water content.
There is widespread evidence that oedema is a characteristic 
feature of the orbital tissues in thyrotrophic exophthalmos, both 
experimentally (Smelser, 1956$ Paulson, 1959$ Aird, 1941$ Albert,
1945; Dobyns, 1946b, d, e, 1950)> &nd clinically (Foster Moore, 1920; 
Benedict, 1958$ Brain, 1958; Haines, 1959$ Means, 1940; Zondek and 
Ticho, 1945; Copper, 1948; Heinbecker, 1949$ Falconer and Alexander, 
1951; Medine, 1951$ Craig and Dodge, 1952, 1955$ Cuendet and
Cruchaud, 1955)*
Oedema in the orbit may occur as a primary effect 
following the influence of the hormone responsible for the production 
of exophthalmos (Means, 1945)? and this is suggested by the experimental 
finding that orbital oedema occurs even if the eye has been previously 
enucleated (Smelser, 1945a)• There may also be a local orbital 
tissue hypersensitivity (Heinbecker, 1949$ Hose, 1952, 1955$ Hedges 
and Hose, 1955)$ a striking tendency of the orbital tissues to take
up fluid has been noted by Naffziger (1952) in exophthalmos and the 
hydrophilic property of the tissues may persist even after decom­
pression. The finding of a high protein content of the oedematous 
fluid in experimental exopnthalmos is suggestive of an increased 
permeability of the orbital capillaries (Smelser, 1947)* This 
would appear to be dependent on some basic characteristic of the 
orbital fat because the oedema is much less evident in fat 
transplanted into the orbit from other.fat depots of the body than 
in fat transplanted into the orbit i'rom another orbit (Smelser and 
Ozanics, 1949)* Furthermore, the oedematous process is not 
distributed evenly throughout the orbit; it occurs to a much 
greater degree in the fatty tissues than in the Harderian gland 
(Smelser and Ozanics, 1955)? a^d it is more marked in the orbital 
fat than in the extra-ocular muscles (Smelser,1945*0 .
On the other hand, oedema in the orbit may occur 
as a secondary effect, perhaps as a result of the reaction within 
the connective tissues (Mulvany, 1944? Dobyns,1950)? or as a 
result of the hydrophilic properties of the mucopolysaccharides 
which are known to accumulate within the orbit in exophthalmos 
(Ropes and others, 1947; Ludwig, Boas ana Soffer,1950; Nuzum, 1955? 
Greene,1955)•
There is certainly no evidence that oedema is the result 
solely of a venous obstruction; the orbital veins are too well 
endowed with alternative pathways of drainage (Drescher and Benedict, 
1950) and thei.e is no sign of any delay in the removal of radio-active
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sodium from the orbital tissues in progressive exophthalmos (Day and
Werner, 1954)* Furthermore, oedema may occur in the lids at a
sufficiently early stage in the development of exophthalmos to
exclude a venous obstruction at the orbital septum as the determining
mechanism (English, 1950)« Undoubtedly, however, venous obstruction
plays some part in the extension of the exophthalmos in the more
advanced cases (Dobyns, 1950; Poppen, 195.5)*
It is also unlikely that orbital oedema is the result
merely of the forward displacement of the eye allowing fluid to enter
the orbit because a vacuum is created therein. It is probably unwise
therefore, to draw too close an analogy between the oedema of the
orbit in thyrotrophic exophthalmos and the oedematous fluid which
*
rapidly enters a space formed artificially within the subcutaneous 
tissues, as in the experiment of Pochin (1949)*
It may be the.t oedema of the orbit is the main factor 
in the production of exophthalmos (Means, 1940; Smelser, 1947>
Dinsmore, 1952) and that the accumulation of this fluid is responsible 
directly for the marked increase in the intra-orbital pressure which 
is a characteristic feature of such cases (Albert, 1945)* Certainly 
the orbit is closed in all directions except anteriorly so that any 
increase in the volume of the orbital contents must give rise to a 
certain degree of protrusion of the eye. Means (1945) and Shannon 
and Hunt (1947) have emphasised the importance of the oedematous changes 
by recommending that all such cases should be nursed with their heads
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in the elevated position to assist in the drainage of oedematous 
fluid. Radiation of the orbit would also appear to be effective in 
reducing oedema (Jones, 1951; Stallard, 1955)*
It should be noted, however, that some doubt has been 
cast on the role of oedema in the production of exophthalmos by 
Rundle, Finlay-Jones and Road (1953) because, although they found 
an increase in the water content of the extra-ocular muscles in 
cases of severe progressive exophthalmos, this did not appear to 
be excessive when regard was taken of the increased bulk of the 
muscles.
2. Increase in mucin content.
An increase in mucin content has been found within the 
orbital tissues in experimental exophthalmos (Lud?/ig, Boas and Soffer, 
1350), as shown by the increased hexosamine content which is a measure 
of the mucopolysaccharides, and by the increase in the amount of 
metachromatic ground substance which is a measure of hyaluronic acid. 
Hyaluronic acid is an important component of the ground substance of 
connective tissue and is probably derived from mast cells (Asboe- 
Hansen, 1950). This ground substance disappears on exposure to
hyaluronidase. The fact that Ludwig, Boas and Soffer (1950) have
shown an absence of any increase in the dried weights of the orbital 
contents in exophthalmos as compared with the normal guinea-pig orbit, 
despite the marked increase in bulk of the exophthalmic orbit, is 
further evidence of the role of mucin (or oedema) in the production of 
exophthalmos. Asboe-Hansen and Iversen (l95l) have shown that TSH
administration in guinea-pigs is followed by replacement of the 
retrobulbar fat by a loose connective tissue containing mucopolysacc­
harides and mast cells.
An increase in mucin has also been found in the orbital 
tissues clinically (Curtis, Cawley and Johnwick, 1949; Iversen, 1954 
particularly in semi-lunar spaces which form under the sarcolemma of 
the extra-ocular muscles as shown histochemically (Asboe-Hansen, 
Iversen and Wichmann, 1952). There is, however, doubt regarding the 
serum mucoprotein level in post-hyperthyroid exophthalmopathy;
Mancini and Garberi (1952) reported a normal level whereas Fromm, 
Hecker and Silva (1954) found an increase in the serum level.
Further evidence of the significance of mucin in 
endocrine exophthalmos is the influence which may be exerted on 
exophthalmos by hyaluronidase, an enzyme which causes hydrolysis of 
hyaluronic acid, with perhaps also an absorption of the breakdown 
products N-acetyl glucosamine and glucuronic acid (Grais, 1949)? add 
a consequent decrease in the water-holding abilities of the tissue 
ground substance (Nuzum, 1953)* Id experimental exophthalmos the 
injection of hyaluronidase into the orbit is followed by a transient 
increase in exophthalmos (Nuzum, 1953; Aterman, 1954a), but this is 
replaced by a definite enophthalmos (Nuzum, 1953; Aterman, 1954b) 
which persists for a short time before exophthalmos becomes re­
established.
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In clinical exophthalmos a temporary decrease in exophthal­
mos may follow retrobulbar injections of hyaluronidase (Grynkewich and 
others, 1951; Danis, 1954) a line of therapy suggested by Mills and 
Forsey (1949)> an& the consequent reduction in orbital tension may 
be sufficient to facilitate the performance of tarsorrhaphy in cases 
of severe exopthalmos (Stallard, 1955)* hyaluronidase has been found 
to assist in the diffusion of anaesthetic solutions injected into the 
retrobulbar tissues without causing any obvious ballooning of the 
tissues (Atkinson, 1949; Key and Key, 1950)? and without causing 
any rise in intraocular pressure (Key and Key, 1950). On the other 
hand, Aterman (1954b) has considered that hyaluronidase injections 
into the orbit may be dangerous clinically, because of the initial 
increase in exophthalmos which may occur, and Kadin (1950) has 
reported a case of thyrotrophic exophthalmos in v/hich an increase in 
exophthalmos and an increase in oedema followed an injection of 
hyaluronidase. In some other cases retrobulbar hyaluronidase has 
been followed by an improvement in ocular mobility without any effect 
on exophthalmos (Plessier, 1954)*
5. Increase in fibrosis.
Experimentally, it has been shown that there is a 
replacement fibrosis wit'..in the orbit of the guinea-pig in TSH- 
induced exophthalmos (Paulson, 1957; Aird, 1941? Dobyns, 1946d), 
and a similar process occurs clinically (Thomson, 1924; Thomas and 
Woods, 1936; Benedict, 1936; Me dine, 1951; Craig and Dodge, 1952, 
1953). Ihe fibrosis within the orbit may be so marked that it prevents 
any recession 01 exophthalmos even after subsidence of the acute
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exophthalmic process (Ridley, 1952) and, in fact, certain cases of 
endocrine exophthalmos have presented as a pseudo-tumour of the 
orbit (Hope-Robertson, 1947)• The fibrosis within the extra-ocular 
muscles may also be extensive (Meadows, 1952) and may account for a 
marked restriction of certain ocular movements; not only in the 
field of action of the affected muscle due to • failure of its contraction, 
but also in the opposite field of action due to a failure of relaxation 
of the fibrosed muscle (funnington, 1947; Ridley, 1952). It has 
been shown by O'Connor and Pierce (1955) and "by Falconer and 
Alexander (1951) that the fibrotic changes within the muscle do not 
assume an even distribution so that a single biopsy specimen of 
muscle tissue mgynotbe representative of the true pathological picture 
within the muscle. It would appear that the changes in the muscle 
are fundamental and are not merely the result of the stretching of the 
muscle which follows the protrusion of the eye (Grosz, 1950). It 
is interesting, therefore, that Poppen (1950) denied any absolute 
relationship between the rapidity of the development of exophthalmos 
and the degree of ophthalmoplegia. In fact, Poppen found that muscle 
palsies are more common in the cases of moderate exophthalmos than in 
the cases of severe exophthalmos.
The occurrence of fibrosis in the orbit in exophthalmos is 
one of the reasons why an orbital decompression operation must be 
carried out in severe cases at a sufficiently early stage so that the 
orbital tissues are resilient enough to take advanta.gc of the increased 
space within the orbit following the operation (Craig and Podge, 1952,
1955) • II is likely that the longer exophthalmos remains untreated 
the greater is the risk of irreparable damage to the orbital tissues 
due to scar formation (Gedda and Lindgren, 1954a, b). There is 
evidence that this process of fibrosis is lessened by radiation of 
the orbit (Jones, 1951? Chang, 1955? Gedda and Lingren, 1954a, b), 
and it may be that hyaluronidase injections are also of value in 
preventing subsequent irreversible fibrotic changes particularly 
in view of the nature of the myxoedematous process within the orbit 
(Levensohn, 1950).
4» Increase in lymphocytes.
There are many reports of the accumulation of lymphocytes 
the orbital tissues in experimental exophthalmos (Albert, 1945; Dobyns 
1946b, d) and in clinical exophthalmos (Curtis, Cawley and Johnwick, 
1949; Heinbecker, 1949; Falconer and Alexander, 1951; Medine, 1951; 
Meadows, 1952; Craig and Dodge, 1952, 1955)* These cells are highly 
radio-sensitive and this may be a factor in the improvement in 
exophthalmos which sometimes follows radiation of the orbit (Jones, 
1951.; Chang, 1955; Stallard, 1955)* Ah increase in the number of 
lymphocytes in the conjunctival tissues may follow thiouracil 
administration (Arvy and Gabe, 1950)? ana this is of interest in view 
of the increased exophthalmos which may follow thiouracil treatment.
5. Change in fat content.
There is little evidence that the thyrotrophic form of 
exophthalmos is associate! with an increase in the fat content of the 
orbital tissues, and in this respect the changes in the orbit in thyro-
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trophic exophthalmos differ from those which are more characteristic 
of a purely thyrotoxic form of exophthalmos, as discussed in an earlier 
part of this thesis. It has "been shown experimentally that TSH causes 
sapid mobilisation of fat (Dobyns, 1946c), so that there is a depletion 
of the fat depots (Dob/ns, 1946b, d), although Mann (1950) has 
stated that some fat may be deposited in the orbit following TSH 
stimulation. Poppen (1953) considered that in the solid progressive 
type of exophthalmos the fat content of the orbit is low due to the 
absorption of the fatty tissues by the other pathological events 
occurring within the orbit.
Bundle and Pochin (1944b) considered that the bulging 
of the lids which may occur in exophthalmos is due to a protrusion of 
orbital fat into the lids. It is more usual to explain this promi­
nence of the lids on an oedematous basis, but Bundle and Pochin are 
unable to reconcile the absence of pitting on pressure with pure 
oedema.
It has been shown that an important part of the patholo­
gical change which occurs in the orbital tissues in thyrotrophic 
exophthalmos is present within the extra-ocular muscles. An 
investigation has been conduction, therefore, into the vascular pattern 
of normal extra-ocular muscles with a view to determining any feature 
of the circulation which map be of significance in a consideration 
of the pathological events which characterise the exophthalmic 
process. In particular each muscle has been exmined for the possible 
presence of arterio-venous anastomoses.
Examination of vascular pattern within normal human
extra-ocular muscles.
In this investigation the vascular pattern of the 
extra-ocular muscles has been examined in six human eyes, and, 
as far as could be ascertained, each eye was free from any local 
ocular or orbital disease, so that it may be assumed that this study 
in the main represents the vascular anatomy of the normal muscle.
The eyes together with their associated orbital 
structures were removed at post-mortem examination through an 
intra-cranial approach by the following technique, which is similar 
to that used in a study of other parts of the ocular circulation 
(Ashton, 1951, 1952; Wybar, 1954a, b, c, 1956).
A sagittal incision was made in the scalp in the 
region of the vault of the skull, and, after reflexion of the 
scalp anteriorly and posteriorly, the bony cranium was removed 
by a coronal incision. The brain was then lifted out of the 
skull by incising the dura and arachnoid membranes and by severing 
the neuro-vascular connections of the brain with the extra-cranial 
structures. During this manoeuvre great care was taken to avoid any 
damage to two important structures. First, the optic nerves and 
chiasma which were left intact by cutting through the optic tract 
so that the chiasma was retained in its normal position in the base 
of the skull. Secondly, the internal carotid artery up 
to the point of origin of the ophthalmic artery and this
7/as left intact by cutting the artery after its emergence from the 
cavernous sinus at the origin of its two terminal branches, the 
anterior and middle cerebral arteries.
The orbital contents were then exposed by removing the 
anterior clinoid process, the lesser wing of the sphenoid including 
the roof of the optic canal, and the orbital plate of the frontal 
bone, and great care was taken during removal of these bony structures 
to avoid opening the periorbital sheath. The bulbar conjunctiva was 
incised round the lirnbus and, after severing the fibrous and muscular 
bands passing from the orbit to the eyelids, the whole orbital mass, 
including the extra-ocular muscles, the eyeball, the optic nerve, 
the ophthalmic artery and the cavernous portion of the internal carotid 
artery, was removed in one mass and placed in a container.
The ophthalmic artery, identified as it left the internal 
carotid artery to run under the optic nerve, was incised through 
half its circumference, and a glass cannula was inserted into the 
artery through the incision and ligatured in position (fig. 23)•
The vessels of the eye and orbit were then irrigated with tap water 
through the cannula for 60 minutes. Provided the orbital mass had been 
removed in a reasonably intact condition, this procedure was only 
associated with a gentle uniform capillary ooze, but in certain eyes 
when large superficial vessels were exposed it was necessary to ligate 
them before proceeding with the irrigation. A thorough preliminary 
irrigation was found to be an important step in the successful
FIG.25.
Cannula (c) used for 
irrigation and injection 
shown in position within 
ophthalmic artery (A).
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injection of the muscular circulation. The ocular mass was then 
placed in the refrigerator for 12 hours. After thawing, the specimen
was finally irrigated with water for 15 minutes, thus ensuring
complete removal of any small residual particles of blood clot from 
the circulation. Two methods were adopted in the subsequent injection 
and examination of the muscles:-
(l) Injection of lleoprene latex (4 eyes).
Neoprene latex 572 was prepared for injection. This
white synthetic rubber preparation, an emulsion of polymerised 2 
chlorbutadium with a partial size of 0.1 - l.^t, was obtained from the 
B. B. Chemical Company. Neoprene was normally obtained with a 
consistency similar to that of milk, but sometimes it was in a more 
concentrated form, and it was then necessary to dilute it with a 
suitable amount of water. Neoprene is unsuitable for injection when 
too concentrated because of the tendency for the formation of clots 
within the smaller vessels thus preventing complete injection of the 
circulation in its ramifications.
The cannula in the ophthalmic artery was connected to a 
Woulff’s bottle containing about 50 nil. Neoprene, and this was then 
injected into the ocular circulation under a pressure of 5 -10 lbs. 
using a small electric pump (Edward’s rotary vacuum pump and 
compressor, type IV). Neoprene was found to coagulate rapidly on 
entry into the circulation, and it was, therefore, essential to 
commence the injection at a reasonably high initial pressure. This 
was achieved by releasing- the clamps on the rubber tube connecting 
the Vi’oulfx ' s bottle to the cannula in the ophthalmic artery a fraction
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of a second after switching on the electric pump. By this technique 
Neoprene was more likely to pass right alon the whole length of 
the circulation including its fine terminal ramifications without 
causing blockage of any of the narrow vessels.
The change-over of Neoprene from a stable emulsion in 
the bottle to an irreversible colloid system within the circulation 
is probably due to a change in PH values. Neoprene is stable in 
the presence of alkali (as in the bottle) but precipitates in an 
acid medium (as in the tissues) to form a solid, resilient, acid- 
resisting and alkali-resisting substance. It is these properties 
which make Neoprene so useful in a detailed study of a densely 
vascular tissue.
Following the completion of the injection of Neoprene 
through the ophthalmic artery, the eyes were subjected to the action 
of digestive ferments. The injected orbital mass in its fresh state 
was placed in a saturated solution of pepsin in NT/lO hydrochloric acid 
for a few days at 37°C, and then for a shorter period of time in 
Vfo sodium bicarbonate at the same temperature. Neoprene is not 
susceptible to the action of digestive ferments so that a complete cast 
of the vessels within the muscle may be obtained but it was found to 
be important to stop the digestive process before it was quite complete 
otherwise, due to loss of all supporting structures, it was extremely 
difficult to identify the various vessel groups within the tangled 
network of Neoprene injected vessels.
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The partially digested orbital mass was dissected to 
reveal the individual extra-ocular muscles, and each muscle was then 
dissected under water in a large Petri dish which contained a thin 
layer of black paraffin wax. The vessel groups were identified, 
and where necessary pinned in position in the wax. (Fine glass 
pins were used in preference to steel one s because the latter cause 
contamination of the casts with rust particles after a few days under 
water). The remnants of the muscular tissue were carefully removed 
to complete the exposure of the pattern of the injected vessels within 
the muscle.
The cohesive and elastic properties of Neoprene permitted 
dissection of individual vessels and capillary areas from the main 
vascular mass, and these were studied in detail using a wide-field 
stereoscopic microscope with eye-piece lenses of XJ and XI5 , and 
objective Henses of Xl.25, X5 and X10, giving a magnification rang-e of 
X8.75 to X150 (fig. 24). Direct illumination was provided by one or 
two high-power low-voltage filament lamps (fig. 24). The initial 
stages of the dissections were carried out with ordinary plain forceps 
and sharp or blunt-pointed scissors, but thereafter the dissections 
were continued with very fine watchmaker's forceps and fine straight 
or curved spring scissors, so that it was possible to handle even the 
fine vessels individually (fig. 25).
(2) Injection of indian ink (2 eyes).
After thorough irrigation of the orbital circulation with 
water through the ophthalmic artery, 50 ml. indian ink was injected
FIG.24.
Wide-field stereoscopic microscope (N) 
with stand (S) for perspex platform (D). 
Direct illumination from two high-power 
low-voltage filament lamps (L).
PIGo25.
Dissecting instruments
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from a hand syringe. ' The eye was fixed in 10°/o formol saline, and 
then cleared "by the Spalteholz method, a technique devised originally 
for the clearing of small embryos following the intravascular 
injection of some dye substance. In this method the eyes were 
dehydrated by passing them through 80$ alcohol (l day), 90$ alcohol 
(l day), absolute alcohol (l day) and fresh absolute alcohol (l day). 
They were then placed in a mixture of benzol and absolute alcohol, 1 
part of each, (l day), pure benzol (l day), fresh pure benzol (l day), 
and finally cleared by immersion in oil of wintergreen (5 parts of 
methylated spirits to 1 part of benzyl bonzoate). The specimens 
were maintained in oil of wintergreen during examination and storage. 
The injected vessels were examined through the semi-transparent 
muscular tissue with the stereoscopic microscope and under direct 
illuminatioh.
Findings.
The arteries of the extra-ocular muscles are derived 
from the posterior ciliary arteries within the orbit and, as a rule, 
each muscle is approached in both its longitudianl borders by a 
muscular artery near the junction of the proximal one-third with 
the distal two-thirds of the muscle. Each muscular artery breaks 
up into several branches near the muscle border (figs. 26 and 27) 
and these pass to theunjfersurfa.ee of the muscle 7/here they enter its 
substance.
FIG.26.
Neoprene cast of orbital vessels showing the
arteries (A) and veins (V) of the extra-ocular
muscles.
FIG.27.
Neoprene cast of orbital vessels showing the
arteries (A) and. veins (V) of the extra-ocular muscles.
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One large branch turns as it nears the centre of the 
muscle and continues its course along an axial direction towards 
the insertion of the muscle. This artery may divide into two or 
more smaller branches during its passage down the muscle, and it 
also gives off several smaller branches which pass in a transverse 
direction to the adjacent parts of the muscle tissue, but the 
main trunk of the artery is continued beyond the insertion of the 
muscle as an anterior ciliary artery. The other muscular branches 
also tend to turn in an axial direction towards the muscle insertion 
as they reach the centre of the muscle substance, but they are smaller 
arteries and break up into their terminal arterioles without running 
the length of the muscle. These smaller arteries are closely 
associated with the transverse branches of the main axial artery, 
and they provide the muscle with a dense network of arterioles and 
capillaries. These features are illustrated in figs. 29 - 34*
The venules take origin from the capillaries (fig. 33) 
and join together to form veins ?/hich run along a course corresponding 
to that of the arteries (figs. 26, 28 - 3l)> there is no evidence,
despite careful■dissection of the vascular network of each extra­
ocular muscle in this series, bf any arterio-venous anastomosis 
except through the normal capillary channels.
There is no evidence, therefore, of any significant 
anatomical feature of the vascular circulation of the extra-ocular 
muscles which may be related directly to the exophthalmic process.
FIG.28.
. . V  S-\\V *4^
Partial dissection of Neoprene cast showing
arteries (A) and veins (V) within extra-ocular
muscle. x 7*
FIG.29.
Partial dissection of Neoprene cast showing
arteries (A) and veins (V) within extra-ocular
muscle, x 8.
FIG.30.
Dissection of Neoprene cast showing arteries (A)
and veins (V) within extra-ocular muscle, x 9*
f i g.3i
Dissection of Neoprene cast showing arteries (A)
and veins (V) within extra-ocular muscle, x 7*
FIG.32.
Dissection of Neoprene cast showing arteries (A)
and veins (V) within extra-ocular muscle, x 12.
FIG.33.
Dissection of Neoprene cast showing arteries (A)
and veins (V) within extra-ocular muscle, x 12.
FIGlM-
Indian ink injection of some vessels within 
extra-ocular muscle (Spalteholz method), x 7«
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On the other hand, there is -undoubtedly a very extensive network 
of vessels within the muscle so that it is easy to understand how 
readily the circulation may become embarrassed during any protrusion 
of the eye.
It is know that venous occlusion of muscle tissue 
results in necrosis, oedema, congestion and marked inflammatoiy 
reaction with a later proliferation of fibroblastic connective 
tissue leading to fibrosis and permanent contraction of the muscle 
(Adams, Denny-Brown and Pearson, 1954)* If siay "be that a stasis 
within the extra-ocular muscles is responsible, at least in part, 
for the pathological picture which characterises thyrotrophic 
exophthalmos•
-76-
Effect of pathological changes in orbital tissues.
The effect of the pathological changes which occur in 
exophthalmos within the orbit is to produce a hypertrophy of 
the orbital contents with a consequent rise in orbital pressure 
(Brain, 1938; Mulvany, 1944; Boyne, 1945; Juler, 1945; Rundle, 1951; 
Craig and Bodge, 1952, 1953)> &n effect which has been demonstrated
at decompression operation by the tenseness of the orbital fascia
(Rundle and Wilson, 1945; Meadows, 1952). This increase in orbital
tension has been measured accurately by Miller (1955) using a
Tybjaerg-Hansen condenser manometer connected to a needle filled with 
fluid which is inserted into the orbital tissues. It may also be 
assessed by the method of Copper (1948) who used an orbitonometer to
measure the extent of the retro-displacement of the eye following the
application of a given pressure to the front surface of the eye.
Brain (1938) considered that the muscle weakness of 
exophthalmic ophthalmoplegia is due to this increased tension within 
the muscle cone. An attempt has been made to refute this concept by
citing certain cases in which the muscle weakness preceded any sig:i
of proptosis, for example, the cases of McGregor (1940), and of 
Martin and Pennell (1941), but these cases are examples of ophthalmo­
plegia due to thyrotoxicosis and are not, therefore, strictly relevant 
to the classical syndrome of exophthalmic ophthalmoplegia which is 
thyrotrophic in nature.
-77-
The fact that the retro-displacement of the eye 
decreases in direct proportion to the degree of exophthalmos 
(Kearns, Henderson and Haines, 1953) may be regarded as evidence 
that the increase in orbital tension is the immediate mechanism, 
or proximate cause (Brunton, 1949), of exophthalmos (Danis and 
Mahaux, 1951)> although it has been shown by Copper (1948) that 
a small rise in orbital tension may occur without the production of 
obvious exophthalmos. It is possible that the lids exercise some 
effect in limiting the occurrence of exophthalmos (Rundle and Wilson, 
1945) so that the degree of exophthalmos and the degree of orbital 
tension are not necessarily equal. The importance of the orbital 
tension is stressed by Naffziger (1952, 1954> 1955) who has shown 
that the height of the orbital tension is a more important criterion 
that the degree of exophthalmos in determining the necessity for a 
decompression operation. Furthermore, the value of orbital 
radiation may be primarily that it relieves orbital tension, and 
thereby reduces the incidence of ocular complications (Lyle, 1952).
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Nature of pathological changes in extra-orbital tissues.
In a consideration of the pathological changes which 
occur in the orbit in endocrine exophthalmos it is important to take 
account of the reports of similar changes occurring in other parts 
of the body.
Experimentally, Dobyns (1946b, d, e) has shown that the 
changes which occur in the orbit of the guinea-pig following TSH 
administration are part of a generalised picture, with a depletion of 
all the fat depots in the body and a replacement of the fat by 
oedematous fluid, connective tissue and infiltrations of granulocytes, 
lymphocytes and tissue macrophages. A jelly-like appearance of the 
peritesticular connective tissues, resembling the changes within the 
connective tissues of the exophthalmic orbit of the guinea-pig, has 
been described by Asboe-Hansen and Iversen (1951) aud by Aterman 
(1954a). Smelser (1939b) found a minimal amount of oedema throughout 
the fatty tissues of the body but, apart from the orbital changes, it 
was only marked in the peritoneal fat. Smelser suggested that this 
peculiarity of the orbital and peritoneal fat is due to their 
structure and not to their location in the body •
Clinically, there are a few reports of a generalised myositis 
in association with the typical changes in the extra—ocular muscles 
in progressive exophthalmos (Terplan and others, 1951)5 but this is 
not a common finding and, for example, the temporalis muscle has been 
shown to be entirely normal despite the presence of well-marked changes 
in the extra-jocular muscles (Meadows, 1952).
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There is a most interesting association between 
progressive exophthalmos and localised areas of skin myxoedema.
These areas of skin myxoedema, like exophthalmos., are part of the 
picture of Graves1 disease (Ludwig, Boas and Soffer, 1950; 
Richtsmeier, 1952), and usually occur during the hypothyroid 
phase of the disease (Vila nova and Canadell, 1949; Bott, 1950), 
particularly after thyroidectomy (Curtis, Cawley and Johnwick, 1949; 
Rosman, 1950), although more rarely they may occur during the 
hyperthyroid phase (Watson, 1946). There is certainly no 
evidence that they are direct manifestations of a pure hypothyroidism 
(Means, 1949) and, although they have been reported in a case 
of myxoedema, this case was complicated by the co-existence of 
a pituitary tumour (Degowin, 1946). There is evidence that both 
exophthalmos and localised myxoedema are manifestations of the same 
hormonal disturbance, possibly an excessive production of TSH 
(Degowin, 1946). This will be discussed more fully in a later 
section.
The cutaneous myxoedematous patches usually have a 
distinct outline and appear symmetrically on the body particularly 
on the anterior surface of the legs. They are variable in size and 
do not pit on pressure (Vila nova ahd Canadell, 1949)- They contain 
a colourless,sticky, gelatinous substance of a mucinous nature 
(Ropes and others, 1947; Grynkewich and others, 1951)* probably
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hyaluronic acid (Watson and Pearce, 1947)* which infiltrates the 
collagenous tissues (Hanley and Philip, 1952). In addition to the 
increased, hyaluronic acid within the tissues there is also an increase 
in the water content (Watson and Pearce, 1949).
Direct injections of hyaluronidase have proved effective 
in decreasing the size of localised areas of skin myxoedema 
(Sharlit, 1949> Bott, 1950), although the effect is only temporary 
unless firm pressure is applied to the area immediately following the 
injection (Rosman, 1950; Grynkewich and others, 1951)* or unless the 
area softened hy the injection is aspirated before the tissues become 
hardened again (inch and Rolland, 1953)• In some cases the lesions 
are prone to recur even after firm padding (Mills and Foosey, 1949). 
Means (1949) Has reported a case of localised skin myxoedema in 
which the swelling dispersed following direct trauma of the affected 
area.
There is evidence, therefore, of a close relationship
between exophthalmos and localised myxoedema (Asboe-Hansen, 1954)*
but because they do not always occur together and because, even when
present together, they often do not occur to the same extent, doubt
has been cast on whether the two conditions are attributable to the 
*
same basic mechanism (Beierwaltes, 1954)* If may He, however, that 
the greater quantity of collagen in normal skin as compared with the 
normal orbit is responsible for the difference in reaction between 
the skin and eye lesions, because it is known that mucin is a
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derivative of collagen (Curtis, Cawley and Johnwick, 1949)* Further­
more, it is possible that localised myxoedema occurs more commonly 
than normally reported because, when present in a mild form, the 
skin lesions are readily overlooked (Netherton, 1949> Engel, 1953)*
t ' :  f . - ' s V- .'.- .a  ii-
,, v -? git
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Nature of Hormonal Process
There are several hormones which may exert an influence 
on the thyrotrophic form of exophthalmos. These will be considered
now.
Relation of thyrotrophic hormone (TSH) to exophthalmos.
The anterior pituitary gland secretes several hormones 
which are responsible for the regulation of the secretion of hormones
from the peripheral endocrine organs, and one of these, the 
thyrotrophic hormone (TSH), is directed towards the thyroid gland.
In 1929 Loeb and Bassett found that an extract of the 
anterior pituitary gland causes stimulation of the thyroid gland in 
the guinea-pig. In 193^ they showed that this effect is due to the 
TSH in the extract. The thyroid gland acts as a storehouse and 
distributing centre for its iodine containing hormone, and TSH 
administration causes a reduction in the amount of colloid within 
the gland, with a corresponding increase in the amount of thyroid 
hormone in the blood (Closs, Loeb and MacKay, 193l)* This closely 
resembles clinical Graves1 disease.
Billingly, O ’Bonovan and Collip (1939) considered that 
there are two fractions of the thyrotrophic hormone, both of which 
have an effect on the metabolic rate, but only one of wiiich mediates
its effect by way of the thyroid gland. Fraenkel-Conrat and 
others (1940) isolated a highly purified form of the hormone.
A major difficulty in the study of TSH is the absence 
of any biochemical test for its detection in the tissues and fluids 
of the body. Reliance has to be placed on biological assay. For 
example, Hertz and Oastler (1936) examined the histological changes 
within the thyroid gland in pituitarectomized rats after administration 
of the extract to be tested. Smelser (1938b) measured the height of the 
thyroid epithelium of day-old chicks. Rawson and Starr (1938) 
employed the same method as Smelser but using guinea-pigs.
Galli-Mainini (1942) measured the change in oxygen consumption of the 
guinea-pig thyroid gland. De Robertis and Del Conte (1944) and 
Dvoskin (1947) observed the alteration in the colloid droplets 
within the thyroid epithelium. Purves and Griesbach (1949) 
examined the height of the thyroid epithelium. D'Angelo and others 
(1951a, 1) employed the stasis tadpole technique.
These methods vary greatly in their sensitiveness to 
small amounts of TSH. They all have the disadvantage of requiring 
an elaborate technique which is difficult to control adequately. It j
is possible that some of the anomalous results, which have been .
reported, are based on a faulty assessment of TSH assay. In any case 
a biological test is unreliable in comparison with modern biochemical 
techniques (Duke-Elder and Goldsmith, 1951) and for this reason some |
of the conclusions regarding TSH may not be strictly valid. Further-
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more , in animal experiments it is apparent that starvation alone 
causes a marked reduction of TSH secretion (D'Angelo, 1951) so 
that a change in feeding habits during the experiment may give 
rise to misleading results.
There is considerable doubt regarding the possible 
influence which TSH may have on the production of Graves’ disease.
It has been found fairly consistently that there is no evidence of 
the presence of the hormone in the urine or serum in thyrotoxicosis 
(Hertz and Oastler, 1956; Rawson and Starr, 1938; Purves and 
Griesbach, 1949)? and this negative finding is difficult to reconcile 
with the straight-forward concept that TSH is the cause of Graves' 
disease.
On the other hand Marine (1935) considered that Graves' 
disease is due to an excess of TSH, either due to its over-produc­
tion, or due to insufficient formation of anti-thyrotrophic factor.
It may be that an excess of the pituitary hormone escapes detection 
because it becomes neutralised by the large amounts of thyroxine 
found in thyrotoxicosis. This possibility was shown by Rawson, 
Sterne and Aub (1942) by a tissue culture method in which they found 
that thyroid gland tissue taken from a case of thyrotoxicosis can 
inactivate twice the amount of TSH which is inactivated by normal 
thyroid tissue. Cope (1938) also considered that the absence of 
detectable TSH in Graves' disease is most likely to be due to its 
neutralisation by thyroxine. Alternatively he suggested that it 
might be due to the presence in the serum of large amounts of anti-
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thyrotrophic factor. He found, however, that serum from a case of 
thyrotoxicosis did not cause depression of metabolism and, therefore, 
the former suggestion would appear more likely.
An interesting observation was made by Collard and others
(1940). They injected TSH into two normal persons but were unable 
to detect the presence of the hormone in the urine. They considered 
however that this result cannot be due purely to fixation of the hormone 
by the thyroid gland, because the same result was obtained in cases 
which had been subjected to thyroidectomy. Cortell and Rawson 
(1944) considered that thyroxine could neutralise TSH and that 
this neutralisation occurs at an extra-pituitary level. It has been 
suggested that TSH is not detected in the urine in Graves' disease 
because iodine, which may be present in the urine in this condition, 
neutralises the hormone. This was investigated experimentally by 
Rawson and Starr (1938), but they did not find any suck masking effect.
It would appear that the basophile cells in the anterior 
pituitary are the cells producing TSH. Severinghaus, Smelser and 
Clark (1934) showed that .ttyroidectomy in the rat causes a marked 
increase in size and number of the basophile cells, and a decrease 
in acidophile cells. Zeckwer and others (1935) confirmed this 
finding, and further showed the presence of large amounts of dense 
hyaline material writhin the basophile cells.
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Ch'en and Van Dyke (1934) demonstrated an increase in 
the amount of TSH in the anterior pituitary of thyroidectomized 
rabbits. Zeckwer (1936b) confirmed this finding in the rat. She 
postulated that the accumulation of hyaline material within the 
basophile cells represents an increased secretion of the hormone. 
Zeckwer1s results ?/ere criticised on the grounds that thyroidectomy 
causes a hypofunction of the gonads, and that, therefore, the 
abnormal cells in the pituitary represent the so-called "castration 
cells" which are known to occur in the anterior pituitary following 
gonadectomy. However, in further experiments Zeckwer (1936a) 
refuted the criticism by showing that there is a clear distinction 
between the "thyroidectomy cells" and the "castration cells". On 
the other hand Nelson and Hickman (1937) considered that the two types 
of basochiles are identical, although they represent different 
phases of a secretory cycle which reacts differently to thyroidectomy 
and to castration.
There is a considerable wealth of evidence to suggest that 
exophthalmos may be attributed to the influence of TSH. This 
evidence may be grouped into two fundamental types. First, evidence 
of a direct nature wherein the actual influence of TSH has been deter­
mined, and, secondly, evidence of an indirect nature wherein the 
influence of TSH nas been assumed because of a change in the amount of 
circulating thyroid hormone.
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Direct evidence that TSH causes exophthalmos.
Experimentally, there is strong evidence to suggest that 
TSH is responsible for the production of exophthalmos and that its 
effect is independent of the thyroid gland secretion (Means, 1943). 
Albert (1945) has shown that exophthalmos occurs rapidly in the 
fundulus (common Atlantic minnow) following the injection of anterior 
pituitary extracts of various types, and he inferred that TSH is 
the causative agent because exophthalmos only occurs in those fish 
showing hyperplasia of the thyroid gland, evidence of thyrotrophic 
stimulation. This form of exophthalmos persists after death,
anaesthesia or cervical sympathectomy. Exophthalmos has been
produced also in guinea-pigs by the injection of pituitary extracts 
containing TSH (Marine and hosen, 1933? Smelser, 1937; Robyns , 1946a, d
Rawson, 1949; Ludwig, Boas and Softer, 1952), and, when these extracts
are incubated with thyroid tissue prior to injection there is a loss of 
the exophthalmic effect (Rawson, 1949; Robyns and Rawson, 1951).
This is a significant result because it is known that TSH becomes 
inactivated on exposure to a culture of thyroid tissue (Heinbecker, 
1952). Smelser (1939a) showed that this form of experimental 
exophthalmos is independent of the integrity of the sympathetic 
nerve pathways or of Muller's orbital muscle.
Aird (1940) demonstrated that TSH-induced exophthalmos 
is dependent on pathological changes in the orbit and it has been 
suggested (Curtis, Cawley and Johnwick, 1949; Kamel and Hamdi, 1949)
that TSH is a potent factor in the formation of oedema and that 
this contributes in a large extent to the production of progressive 
exophthalmos. Mann (1950) also has considered that TSH is 
responsible for orbita,l oedema and, in addition, for increased fat in 
the orbit. In this connection it is interesting that Albert (1945) 
concluded that TSH may exert a direct effect on the orbital tissues 
because he found that exophthalmos develops in the fundulus after 
local injection of the hormone into the orbit. Heinbecker (1949), as 
a result of his work on dogs, has considered that TSH shares with 
other anterior and posterior pituitary extracts an anti-diuretic 
action and that this water-retaining influence is a potent factor 
in the swelling of the intra-orbital contents, particularly, the 
muscles, connective tissues and fat, in exophthalmos. It may be 
significant that Copper (1948) found an increased sense of orbital 
resistance in Cushing's syndrome, although without any exophthalmos, 
because it is known that this is a disease of the pituitary basophile 
cells which are responsible for the secretion of TSH.
Clinically, there is further evidence that TSH causes 
exophthalmos. Stallard (195&, 1957) described an interesting case 
of thyrotoxicosis in which TSH was administered at a time when the 
basal metabolism was subnormal and the exophthalmos was mild. This 
was followed by a transient thyrotoxicosis which quickly subsided 
but with the subsequent development of severe and progressive 
exophthalmos. Leiter (1950) has shown that severe exophthalmos is
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prone to occur after thyroidectomy in those cases in which there 
are abnormally high amounts of TSH in the serum pre-operatively.
I'his is in keeping with the finding of a high level of TSH in the 
serum of certain cases of progressive exophthalmos (Galli-Mainini, 
1942;: de Robert!s, 1948; Asboe-Hansen, Iversen and Wichmann, 1952; 
Silvestrini, Melloni and Pasargiklian, 1955)? and with the finding 
of a low level of TSH in the serum of other cases of Graves' disease 
showing an absence of progressive exophthalmos (de Robertis, 1948).
In certain cases of progressive exophthalmos the increased TSH level 
has been noted in the urine instead of in the plasma (Klotz, 1948a).
ihere is an interesting association between progressive 
exophthalmos and a localised form of myxoedema affecting particularly 
the skin of the pre-tibial region (Villanova and Canadell, 1949? 
Grynkewich and others, 1951; Hanley and Philip, 1952), and it may be 
that both these lesions are due to a common factor. They tend to 
occur after the successful medical or surgical treatment of thyro­
toxicosis and the role of TSH is their production is strengthened by 
the finding of an abnormally high titre of TSH in the urine 
(Vil.a mova and Canadell, 1949)? particularly as this titre decreases 
markedly following oestrogen administration in association with a 
reduction in exophthalmos and in the size of the skin lesions.
The ability of ovarian hormones, particularly the natural 
ones (Francois, 1951), to suppress TSH production has been shown by 
Lederer (1948) and Francois (1951) and they considered that the fact
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that these hormones also reduce exophthalmos is further evidence 
of the role of TSH in the genesis of exophthalmos. .The role of the 
gonadal hormones in exophthalmos will be amplified in a later section 
but mention must be made here of the claim that parahydroxypropriophe- 
none (PHP), a synthetic oestrogen, may also be of value in reducing 
exophthalmos because of its inhibiting effect on TSH secretion 
(Perrault, 1950; Chavez Montes, 1952a, b; Okie,. Haley and White, 
1952). Fossati, Silvestrini and Meiloni (1955) described four cases 
of progressive exophthalmos treated by pituitary irradiation, and it 
is significant that the level of TSH in the blood became reduced as 
a result of this therapy.
Exophthalmos has been reported in newborn babies whose 
mothers have been treated for thyrotoxicosis by thyroidectomy 
(Keynes, 1952; Skelton and Gans, 1955),by thiouracil (Keynes, 1952), 
or by radio-active iodine (Koerner, 1954)- There is evidence that 
the reduction in thyroid function in the mother is responsible for an 
over-secretion of TSH which passes across the placental barrier to 
influence the developing foetus. Particular support is given to 
this concept by the case cited by Koerner (1954) because, in addition 
to the marked exophthalmos and puffiness of the eyelids, the baby 
exhibited an enlarged thyroid gland and an abnormally high pulse 
ratej further evidence of TSH stimulation.
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Indirect evidence that TSH causes exophthalmos.
There is evidence of a pituitary-thyroid axis whereby 
the pituitary and thyroid glands are able to exert an influence 
on one another. This concept is of great significance in a 
consideration of the role of TSH in the production of the 
exophthalmos because it indicates that a change in thyroid 
secretion may be responsible for an alteration in TSH secretion. 
Pituitary-thyroid relationship.
It has been shown that TSH causes an increase in the 
uptake of radio-active iodine by the thyroid gland (Stanley and 
Astwood, 1949? Bogoroch and Timiras, 1951; Frederickson, Forsham 
and Thorn, 1952; Epstein and others, 1955)? and also an increase in 
the rate of secretion of the thyroid hormone from the gland into 
the blood stream (Keating and others, 1945; Heinbecker, 1949;
Albert, Tenney and Ford, 1952). In an interesting experiment 
Junqueira (1947) has shown that exposure of the thyroid gland of the 
rat to TSH in vitro results in an accumulation of intracellular 
colloid within the gland.
There is also evidence that thyroid hormone is able to 
exert an influence on TSH, and it has been shown clinically that a high 
level of thyroid hormone in the blood is associated with a low level 
of TSH (de Robertis, 1948; Purves and Griesbach, 1949; Simkin,
Starr and Hancock, 1955), as demonstrated by the decreased uptake of 
radio-active iodine by the thyroid gland (Greer, 1951)•
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It is likely that this effect of thyroid hormone is 
directly on the TSH and not merely the result of an influence on the 
thyroid gland causing a decrease in its ability to respond to TSH, 
because when exogenous TSH is given during the phase of depressed 
thyroid activity following thyroxine administration, the thyroid 
gland responds in a normal manner by increasing its uptake of 
iodine (Perlmutter and others, 1952). Furthermore, when TSH is 
added to a culture of thyroid tissue the TSH becomes inactivated 
(Seidlin, 1940; Heinbecker, 1952).
This pituitary-thyroid relationship, or pituitary- 
thyroiu axis of Salter (1940), is a finely adjusted mechanism and it 
has been shown (Purves and Griesbach, 1949) that when the level of 
thyroxine in the blood becomes reduced there is a further secretion 
of TSH followed by an outpouring of thyroid hormone with a consequent 
diminution in the output of TSH until the whole cycle occurs once more. 
This chain of events has been termed an example of a "servo system" 
by Hoskins (1949) because it is one in which variations or conse­
quences of variations in the quantity of the output of the apparatus 
are fed back for the control of the system. This mutual 
relationship of the two hormones was clearly shown by Galli-Mainini
(1941). He demonstrated in the guinea-pig that an intravenous 
injection of TSH produces a rise in oxygen consumption of the thyroid 
tissue, whereas injection of thyroxine causes a lowering of oxygen 
consumption. He also showed that if certain proportions of the two
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hormones are injected simultaneously, there is no alteration in the 
oxygen consumption. The relationship leads, therefore, to a state 
of equilibrium or "homeostasis" (Cannon, 1929), and the functional 
equilibrium may be achieved by the interaction of the two hormones 
in the circulation (Means, 1959)*
The maintenance of the pituitary-thyroid axis appears 
to be independent of nervous impulses. Thyroxine can affect the 
thyrotrophic hormone level with equal facility before and after 
complete pituitary stalk section (Uotila, 1940). The transmission 
is probably purely a humoral one.
In relation to the pituitary-thyroid axis a fine 
distinction has been drawn between the use of the terms thyrotrophic 
and thyrotropic as applied to the thyroid stimulating hormone of the 
anterior pituitary. "Thyrotropic" means that the pituitary secretion 
turns specifically towards the thyroid, whereas "thyrotrophic" 
indicates that the thyroid is nurtured or maintained by the trophic 
activity of the pituitary secretion.
It is natural that a permanent reduction in the secretion 
of the thyroid gland may be followed by a prolonged rise in the amount 
of TSH in the blood and this may be regarded as an example of a release 
phenomenon (Simpson, 1945)- There is certainly no doubt that severe 
progressive exophthalmos is a relatively new disease and has followed 
in the wake of surgical and medical advances in the treatment of 
thyroid disorders (Ruedemann, 1947)* It may, therefore, be regarded 
as one of the iatrogenic diseases.
An increased TSH in the blood may be brought about by 
surgical removal of the thyroid gland (Gordon, Goldsmith and 
Charipper, 1945? Soffer and others, 1947)? and it is associated 
with a hypertrophy of the pituitary and with an increase in TSH 
within the gland. Administration of thyroid hormone restores the 
pituitary to its normal size (Marine, Rosen and Spark, 1955).
Increased amounts of TSH may also be found in the urine following 
thyroidectomy (Emerson and Cutting, 1958).
An increased TSH in the blood may follow medical treat­
ment with a goitrogen such as thiouracil (Astwood and others, 1945? 
Mackenzie and Mackenzie, 1945? Fralick, 1949? Purves and Griesbach, 
1949) which is known to cause a depressed avidity of the thyroid 
gland for iodine (d'Angelo and others, 1955) and which is an effective 
therapeutic agent in the treatment of toxic goitre (Crile, 1947? 
Jackson, 1948) by producing a state of functional thyrostasis 
(Baumann, Metzger and Marine, 1944)* Further evidence that thiouracil 
causes an increased production of TSH is found in the histological 
changes within the pituitary gland following thiouracil administration 
as shown by an increase in basophile cells (Salter, Cortell and McKay, 
1945; Sellers, Hill and Lee, 1955)? and by the fact that exposure 
to thiouracil in vitro not only restores the activity of TSH which has 
been annulled by previous exposure to iodine but also augments the 
activity of normal TSH extracts (Albert and others, 1947a, b;
Jefferies, 1949B).
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It is interesting to recall that some earlier experiments 
do not appear to he in accordance with the view that thiouracil 
increases the level of TSH because the reverse effect has been found 
(Gordon, Goldsmith and Charipper, 1945)* Further investigation by 
these observers has shown,however, that the decreased level of TSH 
is only found when the enlarged thyroid gland is able to mop up the 
excess TSH, and that an increased level of TSH is found in the blood 
when a thyroidectomised animal is used; an excess which is greater 
than may be accounted for solely by the thyroidectomy• Their 
experiments confirm, therefore, that thiouracil facilitates TSH 
production. In this connection it is of interest to note that 
Seidlin (1940) found that TSH injected into the guinea-pig is only 
recovered in quantity in the thyroidectomised animal.
A hypertrophy of the pituitary gland with an increased 
secretion of TSH is found in rats maintained on a diet of low iodine 
content ?/hich failed to provide sufficient thyroxine for normal 
metabolic demands (Gassner, Barrett and Gustavson, 1947)* This is 
a further sign of an inverse pituitary-thyroid relationship.
It follows, therefore, that any evidence which shows, 
either that a decrease in the function of the thyroid gland favours 
the production of exophthalmos or that the administration of thyroid 
hormone is in favour of the reduction of exophthalmos, may be regarded 
as an indirect indication of the responsibility of TSH in the genesis
of exophthalmos.
Exophthalmos-producing following thyroid, hypofunction.
(l) Exophthalmos following thyroidectomy.
Experimentally, there is evidence that thyroidectomy 
alone causes a slight degree of exophthalmos in the guinea-pig 
(Dobyns, 1945; Ludwig, Boas and Soffer, 1950; Williams, 1955), 
and that thyroidectomy intensifies the exophthalmos which follows 
TSH administration (Dobyns, 1946a, d; Smelser, 1947; Ludwig,
Boas and Soffer, 1950; Aterman, 1952a, 1954a); in fact Dayton 
(1952) considered that it is essential to carry out a preliminary 
thyroidectomy in order to produce experimental exophthalmos by 
TSH. Exophthalmos may occur in thyroidectomised rats fed on a 
thyroxine-free diet (Leblond and Eartly, 1952).
Clinically, there is also evidence that thyroidectomy in 
Graves' disease may be followed by an increase in the degree of 
exophthalmos (Thomas and Woods, 1956; Soley, 1942; Dobyns and 
Haines, 1946a, b; Post, 1947; Martin, 1948; Alonso, 1949;
Hunt, 1949; Netherton, 1949; Moffatt, 1951; Woods, 1951b; 
Richtsmeier, 1952; Wayne, 1954; Bergfelt, 1955)? particularly 
when in the pre-operative stage the ocular signs predominate over 
the general manifestations of the disease (Leiter, 1950), or the 
B.M.R. is low (Sturgis, 1955) °r M d  oedema is associated with the 
exophthalmos (Robertson, 1945)? or when in the post-operative stage 
there is a dramatic fall in the basal metabolic rate (Dobyns, 1945)• 
Thyroidectomy has been considered to be a greater danger in
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precipitating the occurrence of severe exophthalmos than any other 
form of treatment designed to reduce the functioning power of the 
thyroid gland (Ruedemann, 1949; Chandler, 1950), although sub-tatal 
thyroidectomy is safer than total thyroidectomy (Johnson, 1949). It 
is certainly an outstanding feature of the surgical treatment of 
Graves' disease that vei; often the only redidual manifestations 
of the condition are ocular ones (Martin, 1948).
(2) Exophthalmos following thiouracil administration.
Experimentally, there is evidence that thiouracil 
administration may he followed by exophthalmos in rats (Sellers 
and Ferguson, 1949; Baird, Sellers and Ferguson, 1950; Sellers, 
Hill and Lee, 1955; Campbell and Tonks, 1955)? although Campbell and 
Tonks have shown that the exophthalmos persists only during the 
period of administration of the goitrogen, and Rawson, Tannheimer 
and Peacock (1944) failed to produce exophthalmos by such treatment,
A rapid ana severe form of exophthalmos has been produced in marine 
teleost fish by thiouracil (Leloup and Olivereau, 1950). Cima (l95l) 
considered that although experimental exophthalmos may follow 
thiouracil administration it is less marked than after thyroidectomy.
Clinically, there is no doubt that an increase in exoph­
thalmos may follow thiouracil therapy (Givner, Bruger and Lowenstein, 
1947; Netherton, 1949; Strong, 1949; Taylor, Large and North, 1950; 
Ferguson, 1951; Hanley and Philip, 1952; Richtsmeier, 1952; Fraser 
and Wilkinson, 1955; Fernandez, Landazuri and Matas, 1954;
Wayne, 1954) and there is certainly no evidence that thiouracil
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causes a reduction in exophthalmos (Haines and Keating, 1946), 
although opinion varies on the extent of this exophthalmos and on 
how it compares with the exophthalmos which follows other anti­
thyroid measure, particularly thyroidectomy. There is no doubt 
that severe exophthalmos may follow such treatment (Bastenie, 1950), 
but it may be that it is prone to do so only in cases showing a 
progressive type of exophthalmos before treatment (Beierwaltes, 1948).
Dobyns and Haines, (1946a, b) considered that although 
exophthalmos may progress after thiouracil therpy it does so to a 
lesser degree than following thyroidectomy, and Ruedemann (1949) 
thought that malignant exophthalmos may be avoided completely by 
treating Graves' disease with goitrogens. Several series of cases 
of Graves' disease have been treated in this way without the 
occurrence of malignant exophthalmos (Gabrilove, Kerr and Soffer,
1945? McCullagh, Ruedemann and Gardner, 1946; Beierwaltes, 1948;
Wing and Asper, 1942; Donoso, 1955)? so it may be that this is the 
treatment of choice in patients who are considered to be susceptible 
to the development of severe exophthalmos following the reduction of 
the hyperthyroidism (Chandler, 1950)*
On the other hand it has been considered that thiouracil 
is just as prone to cause severe exophthalmos as thyroidectomy 
(Barr and Shorr, 1945; McCullagh and Sirridge, 1948; Fralick, 1947, 
1949; Dayton, 1955)* It has even been suggested that thiouracil 
is more liable to cause exophthalmos than thyroidectomy (Taylor,
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Large and North, 1950). Campbell and Tonks (1955) came to the 
conclusion that thiouracil is no clinical safeguard against the 
occurrence of exophthalmos aws a result of their experimental 
observations on the effect of thiouracil on exophthalmos and 
Andersson (1950) was very careful when using thiouracil in a 
case in which exophthalmos preceded the other manifestations of 
hyperthyroidism by several years.
It should be noted, in connection with the role of 
thiouracil in the production of exophthalmos, that a thiouracil- 
like action has been attributed to para-amino-salicylic aci d (PAS) 
and it is of interest that treatment with PAS may be followed by 
hypothyroidism and even by the development of exophthalmos 
(Hamilton, 1955)*
(5) Exophthalmos following thyroid gland irradiation.
A progressive form of exophthalmos may follow irradiation 
of the thyroid gland applied in the form of surface X-rays (Soley, 1942; 
Strong, 1949; Richtsmeier, 1952) or in the form of radio-active 
iodine (Blomfield and others, 1951; Wong, 1955; Haines, 1954)*
There is some evidence to suggest that this form of treatment for 
Graves' disease may be less prone to cause severe exophthalmos than 
thyroidectomy (Soley, 1942; Haik, 1944; Chandler, 1950;
Sturgis, 1955), and in a series of cases treated in this way there 
was no increase in the exophthalmos or in the sense of retro-ocular 
resistance following therapy (Ferguson, 1951)*
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It may be that irradiation of the thyroid gland is less 
prone to be followed by exophthalmos because there is no rapid reduc­
tion in the amount of circulating thyroid hormone (Wayne, 1954)? 
and this form of treatment may be especially suited to cases 
showing a susceptibility to severe exophthalmos particularly as it 
is possible to give small doses of radiation (Haines, 1954)* On 
the other hand this view is in conflict with that of Engel (1955) 
who has stated that treatment of Graves' disease with radio-active 
iodine is not the ideal form of treatment because it does not 
permit enough elasticity of management and that after administration 
of the radio-active drug: there is no further control of the response 
of the thyroid gland.
(4) Exophthalmos following sudden cessation of thyroid 
hormone therapy.
Exophthalmos of the progressive type may follow the sudden 
cessation of thyroid hormone administration after a prolonged period 
of treatment with the hormone (Behrman, 1945? 1946; Rubin and Billet, 
1954). It may be that the sudden withdrawal of exogenous thyroid 
hormone in such cases is responsible for a hypersecretion of TSH 
from the pituitary gland as part of a release phenomenon.
(5) Exophthalmos following spontaneous thyroid gland 
hypofunction.
Certain cases of Graves' disease may exhibit a spontaneous
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reduction of the thyrotoxic state, and this may coincide with the 
development of a progressive form of exophthalmos (Mann, 1946b, 1951). 
It may be that the decline in thyroxine production is associated 
with a compensatory increase in TSH secretion.
Exophthalmos-reduction following thyroid hormone administration.
Experimentally, there is evidence that thyroid hormone 
reduces the incidence of exophthalmos v/hich has been induced in 
guinea-pigs by TSH administration (Smelser, 1947; Williams, 1955) 
and by TSH and cortisone administration (Aterman, 1952a). It is 
also known that the development of a thyrotoxic state may coincide 
with a reduction in the degree of experimental exophthalmos (Aterman, 
1954a). The exophthalmos which occurs in the thyroidectomised rat 
on a thyroxine-free diet may be controlled by the administration 
of thyroid hormone (Leblond and Eartly, 1952), and the incidence of 
exophthalmos in rats following thiouracil administration is reduced 
by similar treatment (Sellers, Hill and Lee, 1955)* The exophthalmos- 
producing effect of TSH in guinea-pigs is annulled by preliminary 
incubation of the TSH with thyroid hormone (Rawson, 1949; Dobyns and
Rawson, 1951)•
Clinically Marine (1958) considered that thyroxine 
offers specific protection against the development of exophthalmos and 
there are many reports that the exophthalmos which occurs in Graves' 
disease following a reduction in the function of the thyroid gland,
either by surgical or medical means, may be lessened in degree after 
the administration of thyroid hormone (Means, 1939; Salter and 
Soley, 1944; Brain, 1945; Dobyns, 1945; Juler, 1945; Woods, 1946 
Lederer, 1950; Blomfield and others, 1951; Sloane, 1953; 
Igersheimer, 1954, 1955)* even although this may be associated with 
a slight .recurrence of the thyrotoxic state (Dobyns, 1945; Juler, 
1945);- an event not without danger because it may necessitate 
further anti-thyroid measures which in turn may lead to a renewal 
of the exophthalmic process (Engel, 1953)* It may Be that thyroid 
hormone therapy is most effective in cases of exophthalmos occurring 
in a hypothyroid phase.
Exophthalmos-reduction or exophthalmos-production following iodine
adminis t rati on.
The role of iodine in exophthalmos is most uncertain.
There is some evidence that it may be effective in reducing the 
degree of exophthalmos in some cases of progressive exophthalmos 
(Means, 1945, 1948; Givner, Bruger and Lowenstein, 1947)* although 
Zondek and Ticho (1951) failed to find this effect with di-iodotyrisine. 
Means (1945) has suggested that the value of iodine may lie in its 
ability to exert a controlling influence on metabolism, and, 
therefore, to enable larger doses of thyroid hormone to be 
administered than would otherwise be possible. There is also 
evidence that iodo-thiouracil is less prone to cause progressive 
exophthalmos than other anti-thyroid drugs because of its iodine 
content (Artunkal, 1953). A further indication of the exophthalmos- 
reducing property of iodine may be inferred from the suggestion of 
Thomas (1951) that a factor is the causation of progressive 
exophthalmos is a relative iodine lack in the body.
Plummer (1926) is an enthusiastic advocate of iodine 
therapy, and he stated that he has seen grave progressive proptosis 
begin to recede within a few hours of iodine administration. Plummer 
based his faith in iodine on his two-product theory of the thyroid 
gland. This postulates%atm Graves1 disease there are two products 
secreted by the thyroid gland; first, an excess of normal thyroid
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hormone (thyroxine), and, secondly, an excess of an abnormal 
hormone which is believed to be an incompletely iodised form of 
thyroxine. It is this abnormal hormone which Plummer considered 
to be responsible for the ocular manifestations and nervous reactions 
of the disease. He believed that the abnormal hormone loses its 
toxicity following iodine administration because the hormone then 
becomes fully iodised, and with this change in the character of the 
hormone there is an improvement in the ocular manifestations. There 
is, however, no conclusive evidence for the hypothesis of Plummer, 
and it is difficult to explain the occurrence of progressive 
exophthalmos following thyroidectomy on such a basis. It has 
been suggested that any thyroid tissue which remains after the 
operation may continue to manufacture the abnormal product, but 
there seems no reason why the residual thyroid tissue should secrete 
this hormone without also secreting the normal hormone.
It is conceivable to regard the findings which indicate 
an exophthalmos-reducing effect of iodine as further evidence of the 
role of TSH in the production of exophthalmos, because it has been 
shown that iodine may annul the influence of TSH (Albert and others, 
1946; Junqueira, 1947; Jefferies, 1949b) although this was only 
an in vitro effect.
On the other hand there is evidence that iodine, in 
certain cases of exophthalmic goitre, may cause an increase in the
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degree of exophthalmos (Haines, 1928; Thompson and Thompson, 1931)*
It is still possible, however, to use an exophthalmos-producing 
effect of iodine as an indication of the role of TSH in the production 
of exophthalmos because it may be argued that iodine, by reducing 
the outijut of thyroid hormone, may cause an indirect increase in the 
secretion of TSH. It is interesting, therefore, to note that 
Soffer and others (1947) have demonstrated a transient rise in TSH 
in the serum in cases of Graves' disease treatment with iodine.
The role of iodine in the exophthalmic process is 
undoubtedly conflicting and it would appear to be unwise in the 
present state of knowledge to draw any far-reaching conclusions 
from this aspect of the work on the wider issue of the relation 
of TSH to exophthalmos.
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It is apparent that there is a great mass of direct 
and indirect evidence to implicate TSH as the responsible factor in 
the production of exophthalmos, but there are certain difficulties 
in the full acceptance of this hypothesis and these will be detailed 
n o w .
Difficulties in hypothesis that TSH causes exophthalmos.
(1) It has been shown that experimental exophthalmos 
may follow the administration of crude anterior pituitary extracts 
containing small quantities of TSH, and yet there is evidence that 
a purified form of TSH may fail to produce exophthalmos (Lambie, 
1939; Dobyns, 1946a; Dayton, 1952; Smelser and Ozanics, 1955) •
(2) it has been shown clinically that TSH may be 
responsible for the production of exophthalmos, and yet there are 
cases in which large amounts of TSII have been administered for 
prolonged periods without the development of exophthalmos (Thompson, 
I946; Simkin and Starr, 1953; Simkin, Petit and Starr, 1954)• It 
is important to note, however, that the thyroid gland was intact in 
these cases so that the ability of the thyroid gland to respond to 
TSH stimulation may have limited the effectiveness of TSH as an 
exophthalmos-producing hormone. Furthermore, it has been noted 
experimentally that there is often no correlation between the amount 
of TSH administered and the subsequent degree of exophthalmos
(Jefferies, 1949a; Smelser and Ozanics, 1954)* TSH has never been 
isolated from the orbital tissues in experimental exophthalmos 
(Simkin, Petit and Starr, 1954)*
(3) It has been shown that a high level of TSH may be 
found in the blood of certain cases of progressive exophthalmos, 
and yet there are many cases showing a severe form of exophthalmos 
in which there is no evidence of any abnormal titre of TSH in the 
serum (Collard and others, 1940; Purves and Griesbach, 1949? 
d 1Angelo and others, 1951h; Falconer and Alexander, 1951 > Simkin, 
Petit and Starr, 1954)* or even of any disturbance in the activity 
of the thyroid gland (Medine, 195l)« There is also sometimes an 
absence of a positive correlation between the amount of circulating 
TSH and the degree of exophthalmos (Falconer and Alexander, 1951)*
Further evidence of the possible occurrence of exophthalmos 
in the absence of a high titre of TSH would appear to be derived.from 
a study of a case of myxoedema reported by Degowin (1952) in which 
exophthalmos and pretibial myxoedema followed the development of a 
pituitary tumour without any thyrotoxic manifestations, and, also 
from a study of certain cases of primary (thyroidal) myxoedema 
showing localised skin myxoedema (Gabrilove, Ludwig and Soffer, 1952). 
This is not necessarily a valid conclusion, however, because in 
primary myxoedema the thyroid gland is in s. refractory state so that
it is not capable of responding to TSH stimulation. The absence 
of thyrotoxicosis in such cases may not be evidence, therefore, of 
the absence of circulating TSH.
There are, of course, other cases of hypothyroidism in 
which there is a deficiency of pituitary secretion in addition to the 
deficiency of thyroid hormone (Marine, 1935)* and the absence of 
exophthalmos in such cases is no argument against the role ofTSH 
in exophthalmos production (Greene, 1955)* On the other hand, 
Dobyns and Haines (1946a, b) have claimed that the administration 
of thyroid hormone to cases of myxoedema with pituitary insufficiency 
may be followed by a reduction in the prominence of the eyes and 
from this it is argued that the effect of thyroid hormone cannot be 
on TSH thereby casting a doubt on the role of TSH as an exophthalmos- 
producer. It may not be correct, however, to assume that there is 
a complete cessation of TSH secretion in cases of this type.
(4) It has been shown that a high level of TSH in the 
blood may be associated with exophthalmos, and yet a marked titre of 
TSH may be found in the serum in certain cases of hypothyroidism 
(Hertz and Oastler,- 1936; Collard and others, 1940* Galli-Mainini, 
1942; McCullagh, Ruedemann and Gardner, 1946; de Robertis, 1948; . 
Schrire, 1948; d'Angelo and others, 1949; Purves and Griesbach,
1949)* and of acromegaly (Galli-Mainini, 1942; McCullagh, Ruedemann 
and Gardner, 1946; d'Angelo and others, 1949* 1951b), without the
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occurrence of exophthalmos (Haines, 1939; Savin, 1943).
Similarly, exophthalmos associated with a high level of TSH 
may become greatly reduced without any apparent change in the 
TSH titre (d'Angelo and others, 1951b).
It should be noted that Copper (1948) has described the 
occurrence of exophthalmos in acromegaly, although it would appear 
to be distinct from .thyrotrophic exophthalmos because it is 
associated with a diminished sense of retro-ocular resistance. In 
this connection it is interesting to remember that acromegaly is a 
disorder of the acidophile cells of the anterior pituitary, whereas 
TSH is a product of the basophile cells.
Non-toxic goitre is also never associated with the 
development of exophthalmos (Soley, 1942). Rawson, Graham and 
Riddell (1943) have shown that this type of thyroid tissue is unable 
to inactivate TSH, whereas normal thyroid gland tissue can inactivate 
a certain amount of the hormone. This may be evidence that non­
toxic goitre is associated with some increase in the level of TSH 
in the blood, and yet exophthalmos does not occur in the condition.
(5) It has been shown that thyroidectomy in Graves' 
disease may be followed by a rise in the titre of TSH in the serum, 
and yet, although exophthalmos may develop or become accentuated 
post-operatively, the occurrence of severe exophthalmos following 
thyroidectomy is a rels,tively rare event (Cattell, 1934J Ky&n* 1949)*
-110-
and in some large series of cases may even be absent (Dollerup,
Hansen and M/igaard, 1953)* In fact, Savin (1943) declared that 
there is some recession in the degree of exophthalmos in 70fo of 
cases after thyroidectomy, and Fischer (1948) found an increase 
in exophthalmos in only 5i° of cases post-operatively. On the other 
hand, Hunt (1947)* Shannon and Hunt (1947) and Pagliarani and 
Cavicchi (1950) thought that 50fo of such cases show a temporary 
increase in exophthalmos during the immediate post-operative period, 
and Lamberg (1954) put the figure as high as 72G/o, but, of course, 
these figures do not refer to the occurrence of severe exophthalmos. 
The rarity of progressive exophthalmos following thyroidectomy 
certainly presents a distinct difficulty in the acceptance of the 
hypothesis that TSH is the exophthalmos-producing hormone (Huke- 
Elder and Goldsmith, 1951* McCullagh, 1953* Oastler, 1953)*
Zondek and Ticho (1945) put forward the unusual suggestion 
that exophthalmos following thyroidectomy is unrelated to pituitary 
secretion. They postulated that the normal thyroid hormone has a 
dehydrating influence, and that its sudden removal allows a water 
retaining factor to become dominant. This concept is completely 
at variance with the hypothesis that TSH is an exophthalmos-producing 
factor.
In the experimental field Jefferies (1949a) considered 
that thyroidectomy is not followed by exophthalmos, a view supported
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by Aird (1940) and Pochin (1944) but Jefferies amplified this by the 
statement that thyroidectomy does not intensify the exophthalmos 
produced by TSH alone, so that he concluded (Jefferies, 1952, 1953) 
that any apparent increase in exophthalmos following thyroidectomy 
is due purely to an increase in body weight; a conclusion which is 
a contradiction of most other accepted experimental observations, 
details of which have been given in an earlier part of the thesis.
(6) It has been shown that thyroid hormone may exert 
a restraining influence on TSH, and yet, although it may exert a 
beneficial effect on certain cases of exopthalmos, it is often 
singularly ineffective (Means, 1945; Beierwaltes, 1948; Cole, 1951; 
Falconer and Alexander, 1951; McCullagh, 1953; Simkin, Petit and 
Starr, 1954)* A reduction of TSH may be noted in the blood 
following thyroid administration without any decrease in the degree 
of exophthalmos (Falconer and Alexander, 1951 )• There is also
evidence that, although some improvement may be found in exophthalmos 
as a result of thyroid therapy, no correlation exists between the 
amount of thyroid hormone administered and the degree of reduction - 
of exophthalmos obtained (Hedges and Rose, 1953)* Jonnson (1947)* 
however, doubted the ability of thyroid hormone to exert any inhibiting 
action on the pituitary gland.
It may be that thyroid hormone is:, able to exert an effect 
on exophthalmos quite apart from an influence on TSH and such a concept 
would appear to be necessary to explain the reduction in exophthalmos 
which may follow thyroid hormone administration without any apparent
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reduction in the high level of TSH in the serum. Thyroid hormone 
has a diuretic and dehydrating influence (Gaunt, Cordsen and Lilling, 
1944; Curtis, Cawley and Johnwick, 1949; Heihbecker, 1949) and this 
effect may be operative on the oedematous orbital tissues in 
exophthalmos (Chandler and Hartfall, 1952). Thyroid hormone also 
has a depressing influence on the number of circulating lymphocytes 
(Heinbecker, 1949)*, and it causes a decrease in the amount of 
metachromatic staining material which is believed to be of a muco- 
proteinous nature and which occurs in localised myxoedema (Gabrilove, 
Ludwig and Soffer, 1952) although it has no effect on the normal 
mast cells of the dog (Devitt, Pirozynski and Samuels, 1953)* 
Conversely, a deficiency of thyroid hormone results in an accumula­
tion of mycopolysaccharides in the skin tissues (Werner, Hamilton 
and Frantz, 1951)•
Furthermore, it has been suggested by Aterman and 
Greenberg (1954) that any beneficial effect of thyroid hormone on 
exophthalmos is due to the hormone preventing the build-up of 
excessive quantities of adrenocortical steroids owing to the 
greater utilisation of these steroids following the increase in 
the basal metabolic rate.
(7) It has been shown that iodine may act as an 
exophthalmos-producing factor or as an exophthalmos-reducing factor 
and their evidence has been brought forward to show that iodine
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favours the secretion of TSH or lessens the effect of TSH, 
respectively, and yet there is also evidence that iodine fails 
to alter the level of TSH in the serum (Smelser, 1938a-; Paulson, 
1939? Simkin, Starr and Hancock, 1953)*
(8) It has heen shown that there is a claim that
parahydroxypropriophenone (PHP) may he effective in reducing the 
secretion of TSH so that it causes a reduction in exophthalmos, 
and yet there are several reports in which PHP has proved to he
of no value (Schaffenhurg and others, 1951; Weekers and Dedoyard, 
1951; Brady and Hedges, 1952; Hedges and Rose, 1953; Wong, 1953;
Danis, 1954)» c>r hest of little value (Pagliarani, 1952). On
the other hand this may not necessarily he a point against the 
influence of TSH on exophthalmos because douht has heen cast on 
the ability of PHP to act as an inhibitor of TSH; PHP fails to 
affect the collection of iodine by the thyroid gland of the rat or 
chick (Money and others, 1951b), and it also fails to produce any 
histological changes within the pituitaiy gland (Schaffenburg and 
others, 1951)*
(9) It has been shown that there is evidence that TSH 
causes exophthalmos, and yet it is surprising that exophthalmos is 
seldom associated with evidence of increased activity of the thyroid 
gland in view of the known action of TSH as a stimulator of the
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thyroid. gland (prunty, 1949)* Of course, in many cases the thyroid 
gland is absent, following- surgical removal, or in a refractory 
state, following medical treatment, but there are other cases in 
which there has been no previous surgical or medical treatment. It 
may be that, as suggested by Priedgood (1934)> there is an 
establishment of an antibody reaction to the thyroid stimulating 
effect of TSH without the extablishment of a similar reaction to the 
exophthalmos-producing factor. It is doubtful, however, if this 
interpretation may be applied to the clinical sphere (Prunty, 1949)*
It is apparent, therefore, that, despite the many 
experimental and clinical findings which point to TSH as the hormone 
responsible for the production of exophthalmos, it is not possible 
at this stage to fully substantiate such a hypothesis, so that, 
as Albert (1952) has stated, the evidence which supports the view 
that TSH produces exophthalmos is equivocal and circumstantial.
It is natural that attention should have been directed to other 
hormones in an attempt to cast more light on the basic nature of the 
hormonal upset. On the other hand the importance of TSH must not 
be overlooked in a search for other: hormones because there is little 
doubt that TSH plays an important role in exophthalmos-production
(Oastler, 1953) or at least that it acts as an accessory in the 
crime (Greene, 1955)» acting perhaps in conjunction with a 
gonadal factor (Marine and Rosen, 1936)* It has been suggested, 
however, that the association of an increased TSH with exophthalmos 
in certain cases may merely be because they are both manifestations 
of the same unknown primary lesion (Purves and Griesbach, 1949)*
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Relatlon of some unknown Pituitary Hormone to Exophthalmos.
(Exophthalmos-producing substance, EPS.)
There is a great deal of evidence to suggest that the 
pituitary gland plays a decisive role in the production of 
exophthalmos even if the relation of TSH to exophthalmos is 
discounted (Dinsmore, 1952). Certain cases of progressive 
exophthalmos are associated with an enlargement of the sella 
turcica and an abnormal glucose tolerance test (Zondek and Ticho,
1945) or with acromegaly (Worster-Drought, 1927> 1934; Brain, 1943; 
Copper, 1948; Vail, 1949)* An interesting case of myxoedema 
has been reported in which exophthalmos developed in the later 
stages of the condition following the onset of a pituitary tumour 
(Begowin, 1952). Bardram (1944) found an increase in the output 
of gonadotrophic hormone in the urine in three cases of progressive 
exophthalmos presumably evidence of increased pituitary activity. 
Iglesias (1948) reported a bitemporal constriction of the visual fields 
in one-third of a series of cases of hyperthyroidism, evidence of 
hypophyseal disturbance, although such an unusual finding must be 
regarded with a certain amount of caution. Piper (1952) noted a 
rapid increase in height in a five year old who developed thyrotoxi­
cosis and exophthalmos, presumably all effects of an excessive 
pituitary secretion.
Furthermore, there is evidence that irradiation of the 
pituitary body may he follo?/ed by some reduction in the degree of 
exophthalmos (Mandeville, 1934; Ginsburg, 1939; Mann, 1946a, b;
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Ravdin, Rose and Maxwell, 1949; Beierwaltes, 1951; Van Manen, 1951; 
Zondek and Ticho, 1951; Hermann, 1952; Juler, 1952; Gedda and 
Lindgren, 1954a, b; Igersheimer, 1954* 1955; Brain, 1955; Munoz 
and Barca, 1955)» although it is emphasised by Beierwaltes (1955) 
that the response to irradiation may be delayed for many months.
'■‘•his effect on exophthalmos may be the result of a reduction in the 
secretion of the pituitary hormone responsible for exophthalmos, 
and it is interesting that Dinsmore (1952) found a direct 
association between the reduction of exophthalmos and a drop in 
the serum count in cases treated in this manner. It has been 
claimed that irradiation is effective in re-establishing a synergy 
between the hypophysis and the subthalmic region (Berkman, 1954).
On the other hand, doubt has been cast on the ability 
of pituitaiy irradiation to influence exophthalmos (Hedges and 
Rose, 1953)9 and in certain series of cases treated in this way 
the effect has been a negative one (McGregor, 1940; Cole, 1951; 
Jones, 1951; Keyes and Parisi, 1953)* Irradiation of the 
pituitaiy may not be followed by any histological changes within 
the gland (Kelly and others, 1951), and although it may produce 
a slight fall in the sperm count, it does not influence menstruation 
(McCullagh, Ruedemann and Gardner, 1946). It has even been 
suggested that any beneficial effect of pituitary irradiation is due 
to a scattering of the rays into theorbit where they are able to 
exert a reducing influence on the swollen orbital tissues
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(Stallard, 1955)* If should be noted, however, that despite their 
negative findings with irradiation, IvlcCullagh, Ruedemann and Gardner 
(1946) appeared to confirm the role of the pituitary in 
exophthalmos-production because they found a marked reduction in 
exophthalmos following electro-cauterisation of the pituitary.
It has been suggested that the pituitary secretes an 
exophthalmos-producing factor or substance (EPS.) which is distinct 
from the thyroid-stimulating factor (TSH) (Robyns, 1946a; Klotz, 
1948c; Purves and Griesbach, 1949i Jefferies, 1949a, 1952, 1953; 
Simkin and Starr, 1953; Smelser and Ozanics, 1955)* and this is 
supported by the hypothesis of Schrire (1948) that the different 
components of Graves' disease, the creatinuria, the increased basal 
metabolic rate, the exophthalmos, etc., may be the responsibility 
of different hormones.
There are several observations which support the concept 
of a separation of the EPS and TSH effects. Crude preparations of 
the pituitaiy gland containing TSH produce exophthalmos and thyroid 
hyperplasia in guinea-pigs, and yet purified TSH does not cause any 
significant degree of exophthalmos although it retains its full 
thyroid-stimulating property (Robyns, 1946a). Oestrone has been 
shown to cause a limitation of the effect of TSH on the thyroid 
gland without influencing the effect of TSH on exophthalmos (Gassner, 
Barrett, and Gustavson, 1947)* Iodination of a pituitaiy extract 
at PH 5 - 6 may cause an inactivation of the thyroid-stimulating
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and exophthalmos-producihg effects of TSH, hut when this iodination 
is carried out at PH 4.2 there is a loss of practically all the 
thyroid-stimulating effect without any reduction of the exophthalmos- 
producing effect (Jefferies, 1949h). Antibodies develop in the 
serum to the thyroid-stimulating property of TSH (Collip and Anderson, 
1934* Friedgood, 1934; Scowen and Spence, 1936; Loeser, 1937)>
hut not to the exophthalmos-producing fraction (Friedgood, 1934;
SO
Pochin, 1944)*A"tkat the establishment of the antigen-antihody 
reaction is not associated with any regression of exophthalmos 
(Friedgood, 1934; Pochin, 1944)* It may he that the exophthalmos- 
producing factor is non-protein in nature so that it does not excite 
the formation of antibodies (Friedgood, 1934)* But in any case this 
study of antibody reaction may be construed as evidence that some 
factor other than TSH is responsible for exophthalmos (Friedgood, 194l)» 
On the other hand, there is little doubt that TSH and EPS 
are closely allied to one another (Smelser and Ozanics, 1954)* and 
Sawson, (1949) Ras demonstrated that both the TSH and EPS effects are 
annulled on incubation in vitro with thyroid tissue. There is evidence, 
however, that the two factors may co-exist in the serum in inverse 
proportions to one another (Robyns and Stedman, 1953)* and this finding 
provides an explanation of the apparently anomalous cases in which there 
is a low titre of TSH in the serum in severe exophthalmos and a high 
titre in the serum in mild exophthalmos. An interesting expermiment 
has been carried out by Robyns and V.ilson (1954) in which serum from
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cases of progressive exophthalmos, containing known quantities 
of EPS, was injedted into the common Atlantic minnow with 
the production of an exophthalmos which was roughly in 
proportion to the degree of exophthalmos in the donor.
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Relation of hypothalamus to exophthalmos.
In a consideration of the role of the pituitary in 
exophthalmos it must be remembered that any change which occurs 
in the pituitary gland may be initiated by a stimulus from the 
diencephalon, and this.-is borne out by the fact that shock or 
fright (Mann, 1947)* or even purely psychogenic sources of emotion 
(Simpson, 1945)* may predispose to the development of progressive 
exophthalmos. A most interesting case has been recorded by 
Rosman (1950) of localised skin myxoedema following thyroidectomy 
in which, some time after the condition had been greatly improved 
by local hyaluronidase injections, there was a dramatically sudden 
return of the skin lesion immediately after a severe emotional 
shock. Brull (1953) described a case of Graves' di.sease without 
any exophthalmos in which exophthalmos developed after a bereavement.
Marine and Rosen (1933) sought to implicate the hypo­
thalamus in the production of experimental exophthalmos. It was 
found that administration of methyl cyanide to rabbits results in the 
production of exophthalmos (Marine, Spence and Cipra, 1932), and 
Marine and Rosen (1933) considered that this exophthalmos is closely 
related to that which they produced by the administration of TSH 
to the .thyroidectomised animal. They postulated that methyl cyanide 
causes inhibition of tissue oxidation, and that this affects the 
hypothalamic autonomic, nerve centres, which in turn stimulate the 
anterior pituitary so that there is an increased secretion of TSH.
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they suggested that the upset of tissue oxidation may also have 
a direct stimulating effect on the anterior pituitaiy. The 
increased amount of TSH produces two effects. First, it causes 
thyroid hyperplasia, and secondly, it causes stimulation of the 
hypothalamus. The hypothalamic excitation results in contraction 
of the smooth muscles in the orbit and eyelids with the production 
of exophthalmos.
Marine and Rosen (1934) postulated that the exophthalmos 
which follows thyroidectomy in experimental animals is produced by 
the same mechanise. The thyroidectomy causes a depression of the 
oxidative processes within the tissues, which in turn sets up a 
similar chain of events to those which follow methyl cyanide 
administration. They stressed the necessity for a state of thyroid 
insufficiency before it is possible for the exophthalmos to become 
established. They regarded the thyroid hyperplasia which follows 
.methyl cyanide administration as signifying a state of exhaustion of 
the thyroid gland with a consequent decline in its secretion.
On the other hand Salter (1940) considered that the 
depression of tissue oxidation due to cyanide acts in the same v/ay 
as various stimuli like cold, fear, lactation, etc., by causing 
an activation of the thyroid gland. On this interpretation the 
hyperplasia of the thyroid gland noted by Marine would indicate an 
excessive secretion of thyroid hormone. Uotila (1939) regarded 
the thyroid hypertrophy which follows exposure to cold as being due
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to a marked increase in the secretion of TSH. He considered 
that this efiect on the pituitaiy is mediated by the hypothalamus, 
and that it is dependent on the integrity of the connecting 
nervous pathways between these two regions. He showed that 
under ordinaiy enviromental conditions the influence of the 
hypothalamus on the pituitary is a humoral one, but that in 
abnormal circumstances there is. an additional nervous influence.
It is, therefore, possible that following methyl 
cyanide administration there is an increase in the production of 
TSH. This is borne out by the observations of Marine, Rosen ana 
Spark (1935) who found similar histological changes within the 
anterior pituitary gland after methyl cyanide as after thyroidectomy. 
These changes are related to an increased secretion of TSH.
The exophthalmos produced by methyl cyanide differs, 
however, radically from the so-called thyrotrophic exophthalmos. 
Marine, Rosen and Cipra (1933) found that exophthalmos does not 
occur if the cervical sympathetic pathways have been cut prior to 
the administration of methyl cyanide. This contrasts sharply with 
the findings of Smelser (1936, 1937) IBat exophthalmos could be 
produced, by administration of TSH to thyroidectomised guinea-pigs, 
without any dependence on the integrity of the sympathetic nerve 
pathways .
Furthermore , the exophthalmos produced by methyl 
cyanide does not appear to be dependent on definite histological
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changes within the orbit. In fact, Marine (1938a) considered that 
any orbital changes, for example, oedema or congestion, are purely 
secondaiy to the exophthalmos. Another contrasting feature is 
that iodine when given concomitantly with methyl cyanide protects 
against the development of exophthalmos.
It would appear that the exophthalmos produced by 
Marine and his associates has certain characteristics of thyrotoxic 
exophthalmos with its dependence on an increase in sympathetic tone. 
Marine, Spence and Cipra' (1932) found that the development of exoph­
thalmos was accompanied by a marked nervousness of the rabbit, and 
that there was obvious hyperaemia of the suprarenal medulla.
Smelser (1938a) considered that this type of exophthalmos is un­
related to the pituitaiy hormones.
There is no doubt that a vast amount of evidence has 
accumulated whi.ch implicates the anterior pituitary gland in the 
production of endocrine exophthalmos, although, as yet, it cannot be 
regarded as conclusive (Benedict, 1950). It is, however, peculiar 
that exophthalmos is seldom a feature of primaiy pituitaiy disease 
or of destructive lesions in the neighbourhood of the pituitaiy 
gland, and it is natural that attention should have shifted to other 
endocrine centres, notably the adrenal cortex and the gonads. These 
will be considered now.
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Relation of adrenocorticotrophic hormone (ACTH) and of adrenocortical 
hormone (cortisone) to exophthalmos.
There is undoubtedly a close relationship between the 
thyroid and adrenal glands, and it is natural that the adrenal cortex 
and its associated pituitaiy hormone should have been investigated 
as possible factors in the genesis of endocrine exophthalmos*
Thyroid-adrenal relationship.
The evidence regarding the nature of the thyroid-adrenal 
relationship is conflicting and each suggested type of relationship 
will be examined separately.
1. There is evidence that an increase in the function 
of the thyroid gland is followed by a decrease in the function of 
the adrenal gland.
Experimentally, the administration of thyroxine to rats 
produces a hyperthyroid state which is followed, after a short 
initial phase of increased adrenocortical function, by a marked 
reduction in adrenocortical function (Wallach and Reineke, 1949)*
In dogs the experimental production of Graves1 disease may be 
associated with adrenal atrophy (Heinbecker, 1952).
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Clinic ally , thyrotoxicosis may he associated with a 
deficiency of adrenocortical function (Marine, 1930a; Blomfield 
and others, 1951)* and the increased number of circulating 
lymphocytes which is found in hyperthyroidism may be evidence of 
a similar deficiency (Siams, Pfeiffenberger and Heinbecker, 1951).
The occurrence of pigmentation of the eyelids in certain cases of 
thyrotoxicosis may have a similar explanation in view of the known 
association between pigment deposits in the si.in and hypoadrenalism 
in Addison's disease (Boggart, 1949). Begbie (1868) mentioned 
in a footnote to his translation of a paper of Virchow's on "struma 
exophthalmica", that he had seen a case of pigmentation of the skin 
in Graves' disease. It has been postulated that there is an increased 
need for adrenocortical steroids in thyrotoxicosis so that a state 
of thyro-adrenal equilibrium is achieved only when the thyroid and 
adfenal hormones are present in optimum concentration (Aterman 
and Greenberg, 1954)*
2. There is evidence that an increase in the function 
of the thyroid gland is followed by an increase in the function of the 
adrenal gland.
Hoskins (1910) produced hypertrophy of the adrenal 
cortex on administering thyroid extract to guinea-pigs. Gaunt,
Cord sen and Liling (1944) and Viral la ch and Reineke (1949) induced the
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same effect in rats using thyroxine and they showed that the 
hypertrophy was associated with an increased output of adreno­
cortical hormones, although the latter authors found that this 
effect was only a temporary one and was followed "by a hypofunction of 
the adrenal cortex. Deane and Greep (1947) showed that the 
increased function of the adrenal cortex following experimental 
hyperthyroidism in rats, was limited to the zona fasciculata. It 
has been noted during the production of exophthalmos in guinea-pigs 
by the administration of TSH that there is an associated hypertrophy 
and hyperplasia of the adrenal cortex (Marine, Baumann, and Roseij, 
1934; Scowen and Spence, 1934; Aird, 1940)*
3. There is evidence that a decrease in the function of 
the thyroid gland is followed by a decrease in the function of the 
adrenal gland.
Experimentally, it has been shown that thiburacil 
adminstration in rats induces a hypothyroid state which is associated 
with an involution of the adrenal cortex (Baumann and Marine, 1945) 
an effect which is particularly marked in the zona fasciculata and 
zona glomerulosa (Deane and Greep, 1947)*
4. There is evidence that an increase in the function 
of the adrenal gland is followed by a decrease in the function of
the thyro i d gland.
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Experiment ally, it has been shown by Aterman (1954) that 
cortisone is able to depress the thyrotoxic state normally induced 
by TSH.
Clinically, it has been shown that ACTH or cortisone 
may induce a hypothyroid state (Wolfson and others, 1950, 1951), as 
illustrated by the reduction in the uptake of iodine by the thyroid 
gland (Reiss and others, 1950; Rawson, 1951), By the fall in the 
serum protein-bound iodine (Frederickson, Forsham and Thorn, 1952), 
and by the rise in serum cholesterol (Adlerberg, Schaefer and Orachman, 
1950)» When the dose of cortisone is massive there maybe a marked 
suppression of thyroid function (Frederickson, 195l)» A similar 
effect has been found after the liberation of endogenous ACTH as a 
result of exposure to low oxygen pressure (Verzaf, Sailer and 
Vidovic, 1952J. The administration of ACTH or cortisone in Graves' 
disease may be folloY/ed by some reduction in the hyperfunction of the 
thyroid gland (Chandler and Hartfall, 1952; Brain and others, .1955), 
an effect which had been noted earlier with a more crude extract of 
the adrenal cortex (Shapiro and Marine, 1921; Marine, 1930b).
5. There is evidence that an increase in the function 
of the adrenal gland is followed by an increase in the function of 
the thyroid gland.
It has been shown by Reiss, Forsham and Thorn (1949) 
that an increase in the amount of available adrenocortical steroid,
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whet her as a. result of increased endogenous production following 
ephedrine stimulation or as a result of exogenous administration, 
is followed by an increased uptake of iodine by the thyroid gland 
due presumably to thyrotrophic stimulation. Similarly it has been 
noted in cats that the administration of cortisone may be followed 
by histological signs of increased thyroid gland activity.
There is evidence that epinephrine may act as a stimulus 
to adrenocortical secretion (Long, 1947), and in this respect it is
similar to the effect obtained with ephedrine (Reiss, Forsham and
Thom, 1949)* II is believed that the stimulus to adrenocortical 
secretion is provided by an increased liberation of ACTH following 
a stimulation of the anterior pituitary gland (Solomon and Shock,
1950) or following stimulation of the cerebral cortex (Simms,
Pfeiffenberger and Heinbecker, 1951)*
6. There is evidence that a decrease in the function 
of the adrenal gland is followed by an increase in the function 
of the thyroid gland.
Marine and Baumann (1921) found that removal of the 
adrenal cortex in rabbits is followed by a sustained increase in the 
basal metabolic rate, and, clinically it is known that Addison's 
disease may lead to the production of Graves' disease (Heinbecker,
1952), although such an association is regarded as a rare event 
(Frederickson, 1951 )•
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It is apparent that in the main these observations show 
an inverse relationship between the thyroid and adrenal glands, 
whereby an increased activity of the one is associated with 
a decreased activity of the other. The mechanism of this 
association has been considered by Heinbecker (1952) to be an 
interference with the neural mechanism regulating the hypothalamico- 
hypophyseal system, so that, for example, a hyperthyroid state leads 
to a diminution of ACTH secretion with consequent impairment of 
adrenocortical function. This is in keeping with an earlier 
observation (Heinbecker, 1950) of an increase in the basophilic cells 
and a decrease in the eosinophilic cells of the pituitary in Graves' 
disease, evidence of an increased TSH and decreased ACTH secretion 
respectively, so that the thyroid function is raised whilst the adrenal 
function is lowered. Rawson (1951) thought the over-responsiveness 
of the thyroid gland to alarming stimuli in adrenal deficiency may be 
due to an increased sensitivity of the thyroid gland to TSH.
On the other hand, certain of the observations which have 
been detailed above conflict with the concept of an inverse thyroid- 
adrenal relationship, although a closer examination of some of these 
apparent anomalies may provide an explanation in keeping v/ith the 
main conclusion.
In the first place, the finding that a decrease in the 
function of the thyroid gland was followed by a decrease in the 
function of the adrenal gland may have been due to the fact that
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the thiouracil, which produced the hypothyroid state, led to an 
increased secretion of TSH and consequently to a decreased 
secretion of ACTH with the production of a hypoadrenal 
condition.
In the second place, the finding that an increase in 
the function of the thyroid gland is followed by an increase in 
the function of the adrenal gland requires careful scrutiny because 
it has been shown (Wallach and Reineke, 1949) that such an effect 
is only temporary and leads after a short time to a decrease 
in the function of the adrenal gland.
In the third place, the finding that an increase in the 
function of the adrenal gland is followed by an increase in 
the function of the thyroid gland also requires further examina­
tion because Reiss and others (1950) have shown that such an 
increase is short-lived and is replaced within a few days by a 
decrease in the function of the thyroid gland. Furthermore, 
they showed that, whilst small amounts of adrenal hormone may 
produce an increased secretion of TSH, large amounts of the 
hormone have an inhibitory effect on TSH. Simkin, Starr and 
Hancock (1954) have shown also that, although cortisone 
administration in rats causes a slight increase in TSH in the 
serum, the effect is only temporary and is followed by a decrease 
in TSH in the serum. Another explanation of the apparent 
anomaly may be that the increase in the thyroid gland function
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is the result of the increase in the amount of available cortisone 
leading to a diminished need for ACTH production with consequently 
an increased secretion of TSH.
These anomalies certainly serve to emphasise the 
difficulties which are inherent in any study of inter-related 
hormonal functions.
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An examination of the part played by the adrenal gland 
and its associated pituitary hormone in the field of endocrine 
exophthalmos reveals a confusing and contradictory pattern of event. 
The various claims which have been put forward are discussed under 
the following heading: -
A. Evidence that ACTH and cortisone affect production of 
exophthalmos.
1. An exophthalmos-producipg effect.
2. No exophthalmos-producing effect.
B. Evidence that ACTH and cortisone influence developing 
exophthalmos.
1. An exophthalmos-reducing effect.
2. An exophthalmos-increasing effect.
3» Ro exophthalmos-reducing or exophthalmos-
increasing effect.
A. Evidence that ACTH and cortisone affect production of
exophthalmos.
1. An exophthalmos-producing effect.
Experimentally, there is only scanty evidence that ACTH 
and cortisone are responsible by themselves for the production of 
exophthalmos. Williams (1953) found that cortisone alone causes 
exophthalmos in guinea-pigs, and Campbell and Tonks (1955) obtained 
a similar effect in rats. A minimal degree of exophthalmos in
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association with a slight hypertrophy of the orbital fat and 
an increase in the size of the Harderian gland was found by Smelser 
and Ozanics (1955) following the administration of ACTH or cortisone 
to guinea-pigs.
2. No exophthalmos-producing effect.
Experimentally, Aird (1940) and Jefferies (1949c, 1952,
1953) found no evidence to suggest that ACTH administration is associa­
ted with the production of exophthalmos, and Dayton (1952) confirmed 
this finding. Smelser and Ozanics (1951, 1954) also failed to produce 
exophthalmos with cortisone or ACTH and they concluded that ACTH 
is not the exophthalmos-producing factor, and that it does not exert 
any influence of this factor. It must be noted, however, that, 
as shown above, Smelser and Ozanics (1955) have contradicted this 
negative finding at least to a certain extent in a more recent paper. 
Aterman (1954a) failed to produce exophthalmos in the intact or 
thyroidectomised animal by cortisone administration; the cortisone 
was given by systemic and by intra-orbital injection.
Clinically, there does not appear to be any evidence that 
the administration of ACTH or cortisone is followed by the 
development of exophthalmos (Berson and Yalow, 1952), except in the 
presence of some other endocrine dysfunction which favours the 
production of exophthalmos. This will be considered later.
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B • Evidence that ACTH and cortisone influence developing
exophthalmos.
1. An exophthalmos-reducing effect.
Experimentally, there is no conclusive evidence that 
ACTH or cortisone cause a reduction in the degree of exophthalmos, 
hut it is interesting to note that Ludwig, Boas and Soffer (1952), 
although they failed to find any effect of the hormone on the 
exophthalmos produced hy TSH administration, did find a diminution 
in the abnormally high hexosamine and water content of such 
exophthalmic tissues. It may be, therefore, that ACTH and cortisone 
exert an affect on the orbital tissues but not an extent detectable 
by ordinaiy exophthalmometric measurements. A reduction in the 
volume of the orbital contents of the normal rat after cortisone 
administration has been found by Boas and Scow (1954)*
Clinically, a decrease in the degree of exophthalmos 
following ACTH administration has been reported by Hill and others 
(1950) in four cases of Graves' disease, and by Lederer and Hambresin 
(1950) and Collier (1954) in isolated cases. A similar effect has 
been shown with cortisone by Cole (1951)> Bennett (1954) and 
Villiaumey (1954), snd with the combined administration of ACTH and 
cortisone by Chandler and Hartfall (1952) in three out of five 
cases, by Rubin and Billet (1954) in an isolated case, and by Brain 
and others (1955) in a few cases particularly when the exophthalmos
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was of recent origin or had suddenly and rapidly progressed. It 
has heen noted that when there is a marked reduction in exophthalmos 
following administration of these hormones, the therapy must he 
continued for prolonged periods if an exacerbation is to be avoided 
(Koepf, 1950* Kinsell, Partridge and Foreman, 1953; Collier, 1954)*
There is evidence that ACTH and cortisone may exert an 
important reducing effect on chemosis and on lid oedema in certain 
cases even when there is no obvious effect on the degree of 
exophthalmos (Thorn and others, 1950; Woods, 1951; Harsl^f and 
Sorensen, 1954; Brain and others, 1955).
2. An exophthalmos-increasing effect.
Experimentally, there is evidence that ACTH and cortisone 
augment the response of other hormones in the production of 
exophthalmos. Aterman (1951, 1952a) and Pagliarani and Cavicchi 
(1953) have shown that the combined administration of cortisone and 
TSH to guinea-pigs increases the amount of exophthalmos produced by 
TSH alone, or even produces exophthalmos in certain animals when the 
dose of TSH is insufficient by itself to cause exophthalmos. A 
similar effect with ACTH has been shown by Smelser and Ozanics (1954) 
and Pisano (1955), and, in a later paper, Smelser and Ozanics (1955) 
noted that the TSH fraction need be present only in a minimal amount. 
Campbell and Tonks (1955) found that the exophthalmos produced by 
cortisone in rats is more marked when thiouracil is given with the 
cortisone.
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Clinically, evidence has been put forward to suggest 
that ACTH and cortisone may cause an increase ih the degree of 
exophthalmos already present (Zondek and Ticho, 1951), and a case 
has been described (Dayton, 1952) in which an orbital decompression 
had to be performed shortly after the administration of ACTH. It 
has been suggested by Braley (1955) that ACTH may produce exophthalmos 
particularly in susceptible individuals, and Aterman (1952b) thought 
that the occurrence of exophthalmos following infection or trauma 
may point to the additional implication of the adrenocortical steroids 
in the mechanism responsible for the exophthalmos. A similar 
conclusion, based on the results of their experimental work in 
which exophthalmos followed cortisone administration in rats, has 
been put forward by Campbell and Tonks (1955) who felt that clinical 
exophthalmos may be exacerbated by stress due to an effect of the 
adrenocortical steroids. Charleux, Lacrosaz and Dombre (1953) 
described a case of Graves' disease in wnich exophthalmos became 
aggravated five days after systemic treatment with ACTH.
3. No exophthalmos-reducing or exophthalmos-increasing
effect.
Experimentally, Ludwig, Boas and Soffer (1952) found that 
ACTH and cortisone do not inhibit the formation of exophthalmos 
produced by the administration of TSH, and Dayton (1952) also found 
that the exophthalmos of intact and thyroidectomised guinea-pigs 
produced by TSH administration is not influenced by the subsequent 
administration of ACTH.
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Clinically, there is a considerable weight of evidence 
to show that progressive exophthalmos is uninfluenced by ACTE 
administration (Means and Stanburg, 1950; Salassa, 1950; Olson, 1951; 
Scheie and others, 1951; Terplan and others, I95I; Engel, 1952; 
Moffatt, 1952; Simkin,Petit and Starr, 1954) or by cortisone 
administration (Salassa, 1950; Thomas, 19515 Jefferies, 1952, 1955; 
Inch and Rolland, 1955 > Keys and Parisi, 19555 Brini, 1954?
Simkin, Petit and Starr, 1954)* Furthermore, certain cases from the 
series reported under the heading of an exophthalmos-reducing effect 
must be included in this negative category because not all these 
cases demonstrated a reduction in exophthalmos. Dollfus (1954) 
injected hydrocortisone into the orbital tissues in a case of 
oedematous exophthalmos without any effect.
On the other hand, it must be emphasised that many of the 
cases which fail to show a reduction of exophthalmos following AGTH 
and cortisone administration are not entirely unresponsive to the 
hormone because they may show a reduction in the degree of lid oedema 
and of chemosis (Woods, 1951a), together with a lessening of pain. 
(Plessier, 1954)*
In order to assess the significance of these conflicting 
claims an attempt will be made to examine the basic hypotheses which 
lie behind them.
-139-
•K• Examination of hypothesis that ACTH and cortisone have an 
exophthalmos-producing effect.
(l) ACTE and cortisone may increase the effectiveness 
of TSE.
In a case of thyrotoxocosis Werner (1950) found a slight 
increase in the basal metabolic rate following ACTH administration, 
and it may be that this represents an augmentation of the effectiveness 
of TSE. Similar effects have been reported following cortisone 
administration, for example, histological changes in the thyroid 
gland suggestive of TSE stimulation (Higgins, Woods and Kendall,
1951? Halmi, 1952), a rise in the level of the protein-bound 
iodine in the serum (Halmi and Barker, 1952), and a slight but 
temporary rise in the level of TSE in the serum (Simkin, Starr and 
Hancock, 1954)*
There is evidence that this effect of ACTH and cortisone 
is mediated through the pituitary, and not merely a direct influence 
on the thyroid gland, because an increase in the basal consumption 
of oxygen, following ACTH and cortisone administration, has been 
found in two cases of spontaneous myxoedema despite the refractory 
state of the thyroid gland (Beierwaltes and others, 1950)• On the 
other hand it would appear that the cortisone-induced augmentation 
of the TSE response is evident only when the thyroid hormone is 
■inhibited simultaneously (d*Angelo and others, 1955)? for example 
by thiouracil administration.
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It is interesting to note, therefore, that the stimulating' 
efiect of cortisone on the thyroid gland is particularly marked 
when given in conjunction with TSH (Halmi, 1952), and it may be 
that cortisone not only plays a part in increasing the production of 
TSH (Smelser and Ozanics, 1955), But also plays a permissive role 
in the field of action of TSH (Smelser and Ozanics, 1954)*
(2) ACTH and cortisone may increase the volume of 
the orbital tissues.
In the field of experimental exophthalmos it has been 
postulated by Aterman (1952a) that cortisone may produce exophthalmos 
by an effect on the connective tissues of the orbit, and, although 
the nature of this effect is not specified, it has been presumed 
that it is a generalised one on all the connective tissues of the 
body (Aterman and Greenbeig , 1955)* Aterman (1952a) considered 
that the effect of the adrenocortical steroid s is paramount in the 
production of exophthalmos, and he postulated that the more marked 
exophthalmos of the thyroidectomised animal as compared with the 
intact animal is due to the greater availability of these steroids 
after thyroidectomy; on the grounds that thyroidectomy decreases 
the normal utilisation of the steroids. in a later paper 
Aterman (1954a) suggested that cortisone may increase the water 
content of the orbit by augmenting the amount of the water-binding
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mucopolysaccharides in the orbital tissues or by changing their 
degree of polymerisation. An increase in the sodium content 
of the extra-ocular muscles has been found by Campbell and Tonks 
(1955)? although without causing any change in their weight or in 
their water content.
It must be remembered, however, that the occurrence of 
exophthalmos in the experimental animal is by itself no proof of 
the existence of a change in volume of the orbital tissues unless 
such a change is demonstrated chemically or histologically, or 
unless proof is given that there has been no change in the 
relative eyeball-orbit growth rates. It is well known that 
hormones may alter differentially the growth rates of certain 
structures of the body. For example, thyroidectomy in rats 
causes a retardation of body growth without affecting the growth 
of the eyeball or brain (Scow and Simpson, 1945) and hypophysectomy 
in rats causes a similar effect (Walker and others, 1952). Cortisone 
administration to chick embryos causes a retardation of body growth 
but does not alter the rate of eyeball growth (Evans, 1955)*
Boas and Scow (1954) applied this concept df differential 
rates of body growth to a study of the exophthalmos which occurs in 
rats following cortisone administration, and they found that the 
exophthalmos follows an inhibition of head and body growth so that 
the orbit becomes smaller than normal although there is no change in 
eyeball growtn. The exophthalmos is due simply to the inability of
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an eye of normal size to be contained within the abnormally small 
orbit, and}in fact,Boas and Scow showed that there is even a 
reduction in the volume of the orbital contents in such animals.
These findings have been verified by Essex (1955) and Williams (1955).
Clinically, Sayer and others (1949) found an inhibition 
of a water diuresis in one case following ACTH administration, and 
Palassa (1950), who noted an increase in the degree of periorbital 
oedema and chemosis in one of t,-ree cases treated with ACTH and 
cortisone, spggested that this may be related to the fullness of the 
face and pitting oedema which may follow administration of these 
hormone s.
In addition to the glucocorticoids of the adrenal 
cortex there are the minerocorticoids which are known to have an 
influence on fluid accumulation within the body, and it has been 
postulated, therefore, that an adrenocortical hormone may play some 
part in the production of exophthalmos, particularly in causing 
orbital oedema (Benedict, 1958)- Desoxycorticosterone (BOCA)
has been investigated as a possible exophthalmos-producing agent 
because of its effect on the accumulation of fluid (Jefferies, 1949c; 
Smelser and Ozanics, 1951) and because of its slight lymphocytopoietic 
effect (Higgins, Woods and Kendall, 1951)? But there is no evidence 
that BOCA is associated in any way with the production of experimental 
exophthalmos (Jefferies, 1949c; Smelser and Ozanics, 1951)•
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A further suggestion has been put forward that ACTH 
and cortisone may produce exophthalmos by a mobilisation of fat from 
the body depots to the orbit, an idea elaborated by Jefferies (1949c) 
because of certain known facts. Fry (1937) had found that fatty 
infiltration of the liver occurred on administration of an 
anterior pituitary extract to intact rats, but not when adrenalec- 
tomised rats were used, and Baker and others (1948) had shown that it 
was the ACTH fraction which produced the fatty infiltration. The 
fat which accumulated in the liver came from the body fat depot. 
(Barrett, Best and Ridout, 1938)* Furthermore Jefferies (1949c) 
had shown that the administration of a pituitary extract containing 
•TSH to guinea-pigs resulted in exophthalmos and in fatty infiltration 
of the liver. He did not find any positive correlation between these 
two effects of the extract despite their close relationship, but 
they were equally affected when the extract was selectively 
inactivated by exposure to iodine (Jefferies, 1949h). It was 
reasonable to postulate in view of these considerations that ACTH 
might influence the production of exophthalmos by inducing fatty 
changes within the orbit, but the result of the experimental 
investigation proved to be negative (Jefferies, 1949c)• The 
implication of ACTH in the mobilisation of depot fat has also been 
postulated by Levin and Farber (1950), although they thought that 
some other pituitary hormone acts as a trigger substance initiating 
the reaction.
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B- Examination of hypothesis that ACTH and cortisone have an 
exophthalmos-reducing effect.
(l) ACTH and cortisone may decrease the 
effectiveness of TSH.
ACTH and cortisone have been shown to cause a decrease 
in the collection of radio-active iodine by the thyroid gland 
(Money and others, 1950, 1951? Bogoroch and Timiras, 1951)> 
a decrease in the serum protein-bound iodine in patients with 
collagen disease (Hardy, Riegel and Erisman, 1950), an inhibition 
of the increase in protein-bound iodine normally found after TSH 
administration(Woodburg, Ghosh and Sayers, 195l), a fall in the 
basal metabolic rate in hyperthyroidism (Engel, 1950) although such 
a fall may be only temporary (Moseley and Merrill, 1950), and a 
decrease in the thyrotoxicosis induced in guinea-pigs by the 
administration of TSH (Aterman, 1954a). These findings suggest 
that the effectiveness of TSH is diminished by ACTH and cortisone, 
and it is tempting to postulate that this is the mechanism which 
is responsible for the reduction of exophthalmos following treatment 
of endocrine exophthalmos with these hormones (Brain, 1952? Chandler
and Hartfall, 1952)«
Evidence that ACTH and cortisone are able to decrease
the secretion of TSH from the pituitary has been put forward by Hill
-145-
and others (1950), Thorn and others (1950), and Thorn (1951) 
because they found that the depression of iodine accumulation in 
the thyroid gland and the fall in the level of protein-bound iodine 
in the serum, following ACTH and cortisone administration, are 
counteracted by the additional administration of TSH. This view 
is supported by Heinbecker (1952) who found a degranulation of the 
basophile cells of the pituitary in dogs receiving cortisone in 
association with a diminution in thyroid activity, and by Simkin, 
Starr and Hancock (1952) who demonstrated a partial suppression of 
TSH in the serum after cortisone therapy.
On the other hand, there is some evidence to suggest that
the decreased effectiveness of TSH following ACTH and cortisone
administration may operate at an extra-pituitary level because ACTH 
and cortisone may reduce the effects of exogenous TSH in the hypo- 
p&ysectomised animal (Verzar and Vidovic, 1952; Epstein and others 
1953), although this finding does not exclude an effect on the 
hypophysis of the intact animal. There is an increased rate of 
renal clearance of iodine following cortisone administration(Airert, 
Tenney and Ford, 1952; Benson and Yalow, 1952> Kuhl and Ziff, 1952)>
and it may be, therefore, that cortisone causes a decrease in the
accumulation of iodine in the thyroid gland by exerting an effect 
on the glomerular filtration rate (Halmi and others, 1953)* This
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finding, however, does not exclude an effect of cortisone on TSH 
because the increased excretion of iodine in the urine may represent 
a failure in the iodine concentrating mechanism of the thyroid gland 
as a result of a suppression of TSH secretion (Bogoroch and 
Timiras, 195l)»
Perry (l95l) claimed that ACTH may operate directly 
on the thyroid gland. Aterman (1954a) also explained on an extra- 
pituitary basis his finding of a reduction in the TSH-induced 
thyrotoxicosis in guinea-pigs following cortisone administration, 
and he postulated that the cortisone and thyroid hormones are 
directly antagonistic to one another. This view,however, is 
contra dicted by Bersen and Yalow (l952) who considered it 
unlikely that cortisone produces thyroid inhibition by a direct 
effect on the gland because such an effect would favour a 
secondary increase in TSH secretion with the possible production 
of exophthalmos, an effect which did not occur in their investigation.
(2) ACTH and cortisone may decrease the volume 
of the orbital tissues.
There seems little doubt that, despite the contradictoiy 
evidence regarding the influence of ACTH and cortisone in the fields 
of clinical and experimental exophthalmos, these hormones ought to be 
able to exert a reducing effect on exophthalmos by virtue of their 
known action of decreasing the bulk of new-forming tissues such as 
found in the exophthalmic orbit (Browne, 1950; Olson, 1951)• In
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this connection it is of interest to note that Smelser and Ozanics 
(1951? 1955) expressed a similar view despite their finding 
experimentally of the production of exophthalmos with these hormones*
It has been suggested by Thorn and Forsham (1950) that 
ACTH and cortisone reduce chemosis by a direct effect on the orbit, 
although there is no evidence that injectionsof cortisone into the 
orbit relieve exophthalmos (inch and Rolland, 1955)• There is 
evidence, however, that local administration of cortisone produces 
a temporary improvement in areas of localised skin myxoedema, a 
condition of the skin which has many similar features to endocrine 
exophthalmos (inch and Rolland, 1953)*
There are several ways in which ACTH and cortisone may 
cause a reduction in the volume of the tissues of the exophthalmic 
orbit:-
First, ACTH and cortisone may act by reducing the 
amount of oedema within the orbit.
Experimentally, it has been shown that ACTH and cortisone 
cause a reduction in the oedema which is usually found in the orbital 
tissues in exophthalmos due to TSH administration (Ludwig, Boas and 
Soffer, 1952), and clinically such a mechanism has been suggested 
by Collier (1954)? Igersheimer (1954? 1955) and Brain and others (1955)• 
Indeed, it would appear to be essential to postulate that the 
removal of oedematous fluid plays an important part in the reduction 
of exoohthalmos by ACTH and cortisone in order to account for the
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extremely rapid improvement which may occur in certain cases treated 
in this way (Ruben and Billet, 1954), and in order to explain why 
the most dramatic effect is found usually in cases of recent onset 
(Brain and others, 1955)*
Secondly, ACTH and cortisone may act by reducing the
volume of ground-substance within the orbit.
Experimentally, it has been shown that ACTH and cortisone 
cause a reduction in the hexosamine content of the orbital tissues 
which is normally increased in exophthalmos due to TSH administration 
(Ludwig, Boas and Soffer, 1952), and clinically the same authors 
have demonstrated a reduction in the hexosamine level in the serum 
in certain of the collagen diseases (Boas, Ludwig and Soffer, 1952)• 
It has been postulated %y^Smilton and Frantz (1951) that a 
deficiency of adrenal steroids may be directly responsible for the 
accumulation of mucopolysaccharides in the tissues. It is 
interesting, therefore, that a reduction in the size of the localised 
areas of skin myxoedema in association with a decrease in the amount 
of gelatinous myxoedematous infiltrate follows ACTH therapy (Werner, 
Hamilton and Frantz, 1951) and cortisone therapy (inch and Rolland,
!955)> although the effect persists only during the period of
administration of the hormones.
There is evidence that the mast cells of the tissues 
are the site of production of hyaluronic uciu, an important component
of the ground substance of connective tissue, and it is of 
significance that a reduction in the number of mast cells within 
the tissues in association with a decrease in the amount of 
nyaluronic acid may be found after cortisone administration in 
rats (Cavallero and Braccini, 1951) snd after ACTH and cortisone 
administration in humans, rabbits, mice and guinea-pigs (Asboe- 
Hansen, 1952). Stuart (1951) demonstrated a similar effect of 
cortisone on the mast cells of the connective tissues. This would 
appear to be another indication of the reducing effect which ACTH and 
cortisone may have on the ground substance of connective tissues, 
although -Devitt, Pirozynski and Samuels (1953) have shown an absence 
of any effect of cortisone on the normal mast cells content of the dog. 
On the other, hand Bloom (1953) showed a dramatic regression of a 
mast-celled tumour in the dog treated with cortisone, so that cortisone 
certainly appears to affect the mast cells when they are present in 
abnormal amounts.
Thirdly, ACTH and cortisone may act by reducing the amount 
of neo-fibrosis within the orbit.
It has been shown experimentally that cortisone may cause 
a striking depression of the activity of the connective tissues in 
the process of wound healing (Plotz and others, 1950), and a similar 
effect has been shown with ACTH (Ragan and others, 1949)* This 
diminished response 01 the fibroblastic tissue has also been 
demonstrated clinically by observing the rate of healing of biopsy
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wounds in patients receiving ACTH (Baxter, I95I; Sauer and others,
I95l)» It would appear, therefore, that ACTH and cortisone may he 
of value during the evolution of exophthalmos in reducing the 
amount of scar tissue within the orbit, and thus diminishing the 
degree of exophthalmos and the extent of the residual ophthalmoplegia. 
It must be emphasised, however, that these hormones are able to 
exert an effect only on new-forming fibrous tissue so that they 
must be administered in the early stages of the condition.
Fourthly, ACTH and cortisone may act by reducing the extent of 
the lymphocytic infiltration within the orbit.
There is evidence that the accumulation of lymphocytes 
within the orbit in endocrine exophthalmos is the result of an 
adrenal hypofunction and it is interesting, therefore, that 
cortisone therapy may be associated with a reduction in the 
number of circulating lymphocytes (Long, 19475 Simms, Pfeiffenberger 
and Heinbecker, 1951), and in the number of lymphocytes within 
the tissues (Dobriner and others, 1950; Werner, Hamilton and 
Frantz, 1951). It may be that the reducing effect of cortisone 
on lymphocytic infiltration contributes to a reduction in the 
degree of exophthalmos in certain cases.
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Conclusion regarding relation of adrenocortiootrophic and 
adrenocortical hormones to exophthalmos.
It is clear that at present no dogmatic conclusion 
may "be advanced on the role of the adrenocortical gland and its 
associated pituitary hormone in the process of endocrine 
exophthalmos.
The effect of these hormones on TSH secretion is 
conflicting; some evidence shows that they favour an increased TSH 
secretion whereas other evidence shows that they favour a decreased 
TSH secretion. Furthermore, to add to the confusion there are 
claims that cortisone does not influence TSH secretion; as shown by 
an absence of any significant change in the serum iodine level 
(Werner, 1950)> an absence of any change in the iodine content of 
the thyroid gland (Botkin and Jensen, 1951; Migeon and others, 1952), 
and an absence of any histological change within the thyroid and 
pituitary glands (Winter, Silber and Stoerk, 1950), following 
cortisone administration.
In any case, even if the true effect of the adrenal 
hormones on TSH secretion is established, there is no clear-cut 
evidence that this will affect the concept of endocrine exophthalmos 
unless it is known to what extent TSH represents the exophthalmos- 
producing factor.
The effect of ACTH and cortisone on the pathological 
changes which characterise the exophthalmic orbital tissue would 
appear to be more clearly established, and it is reasonable to 
advocate the administration of these hormones particularly in the 
early stages of the exophthalmos before the onset of irreversible 
fibroti£ changes within the orbital structures. It is perhaps 
unfortunate that earlier experimental work gave evidence of an 
exophthalmos-producing effect of ACTH and cortisone, because it is 
now believed that this effect is due to the abnormal differential 
rates of growth between the eyeball and the orbit, a state of affairs 
confined to animals. This finding serves to emphasise the 
importance of exercising caution before relating experimental 
observations to clinical experience, particularly in view of the 
obvious structural differences between the orbit of man and the orbit 
of animals. In man the orbit is closed except anteriorly, whereas 
in animals the lateral orbital wall is grossly deficient. In this 
way a rise of intra-orbital pressure is more readily effective in 
man (Dobyns, 1950). Furthermore, there is no counterpart in the 
human to Harder's gland which plays so prominent a role in the 
production of exophthalmos in the guinea-pig, the animal most 
favoured for the experimental study of exophthalmos. There is, 
however, evidence that exophthalmos may occur in the guinea-pig even 
after removal of Harder's gland (Smelser, 1942).
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It is also important to realise that, quite, apart from
the obvious diiierences between animal and human conditions, there are
also lundamental differences between the various species of animals
in their reactions to certain hormones. For example, Bangham (1951)
studied the influence of cortisone on wound healing’ and demonstrated
in
that, although there is a delay in wound healingAthe rabbit, there is 
no obvious effect of the hormone on wound healing in the guinea-pig or 
in the rat. This species difference is also brought out in an 
investigation on the influence of cortisone on corneal vascularisation 
in the guinea-pig and in the rabbit (Wybar and Campbell, 1952), and 
tnese findings are reported in a separate appendix at the end of 
the thesis.
This species difference is also illustrated in the 
production of exophthalmos by the administration of TSH. Most of 
the experimental work on exophthalmos has been carried out in 
guinea-pigs and I have confirmed the production of a progressive 
type of exophthalmos in intact and thyroidectomised guinea-pigs 
following TSH administration. The same hormone, however, was 
administered to intact and thyroidectomised rabbits and monkeys 
without the production of a satisfactoiy degree of exophthalmos.
(it was intended to study the effect of cortisone on exophthalmos in 
the rabbit and monkey and to compare the results with those obtained 
in the guinea-pig. This was not carried out, however, in view of the 
difficulty in obtaining an adequate exophthalmos.)
To a certain extent, therefore, it would appear to 
be essential to form basic conclusions on the nature of 
exophthalmos from clinical observation, although, it must be 
remembered that in clinical experience the results of an 
empirical form of treatment are difficult to assess (Duke- 
Elder and Goldsmith, 1951)> particularly as endocrine 
exophthalmos is a condition which may be characterised by 
spontaneous remission (Said, 1952; Greene, 1955)*
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Relation of gonadal hormones to exophthalmos*
There is evidence that the gonads are implicated in the 
production of exophthalmos, particularly in view of the fact that 
progressive exophthalmos is a much more frequent occurrence in 
the male than in the female despite the greater incidence of 
Graves' disease in the female than in the male (Brain, 1945, 1946)
Female gonads.
Thyroid-ovarian relationship.
It is well known that there is a pituitary-ovarian axis 
just as there is a pituitary-thyroid axis, and in this way the 
ovarian and thyroid glands are related to one another through 
the influence of the pituitary gland, although it is also 
possible that the thyroid gland and the ovary may exert a direct 
effect on one another without the intervention of the pituitary 
(Salter, 1948). The relationship between the ovary and thyroid 
gland would appear to be an inverse one, and this is borne out 
by the fact that thyrotoxicosis is more likely to develop during 
a hypogonadal phase (Lederer, 1948&J Keynes, 1952), and also by 
the fact that the degree of thyrotoxicosis may be diminished by 
treatment with ovarian hormones (de Gennes, 1951)*
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Influence of oestrogen on exophthalmos
(l) An exophthalmos-reducing effect.
Experimentally, there is evidence that oestrogen 
may decrease the degree of exophthalmos produced in guinea- 
pigs by thyroidectomy or by TSH administration (Smelser and 
Ozanics, 1951)? and these authors have suggested that the 
greatly diminished incidence of progressive clinical exophthalmos 
in the female than inthe male may be attributed to the presence 
of endogenous oestrogen in the female. Furthermore, exophthalmos 
in Graves1 disease has been noted to diminish during pregnancy 
(Givner, Bruger and Lowenstein, 1947)? and to increase following 
the termination of the pregnancy (Paschkis and Cantarow, 1947)* 
Exophthalmos may become more severe during menstruation (Savin, 
1943; Muller, 1949). It is natural, therefore, that the 
administration of oestrogen has been found to be effective in 
reducing the degree of exophthalmos in certain cases of endocrine 
exophthalmos (Savin, 1945,* Paschkis and Cantarow, 1947,* Klotz, 
1948b; Lederer, 1948; Paufique and Guinet, 1948; Vilanova and 
Canadell, 1949; Lederer and Hambresin, 1951? Okie, Denee and 
Daley, 1951? Okie, Daley and White, 1952), particularly in cases 
in which the exophthalmos followed the menopause or ovariectomy 
(lederer, 1948b) . It is interesting thc»t in a series of 5
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female cases successfully treated in this way, one had been 
ovariectomised, two were menopausal and one suffered from psychical 
amenorrhoea (Paufique and Guinet, 1949? Paufique, Guinet and 
Papillon, 1950).
(2) No exophthalmos-reducing effect.
On the other hand oestrogen therapy has been shown to 
be ineffective in many cases of endocrine exophthalmos (Moffatt, 
1943; Brain, 1945, 1946; Hedges and Rose, 1953? Carra, 1954) 
and there are many other cases in which it is difficult to prove 
any association between the administration of oestrogen and a slight 
reduction in the degree of exophthalmos, particularly as other 
forms of therapy were also being applied and as progressive 
exophthalmos is known to suffer spontaneous remission.
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In order to assess the significance of these conflicting 
claims an attempt will be made to examine the basic hypotheses which 
lie behind them.
A* Examination of hypothesis that oestrogen has an exophtha^mos-
reducing effect.
(l) Oestrogen may decrease the effectiveness of TSH.
Aron and Benoit (1932) showed that oestrogen may cause 
an inhibition of TSH secretion in the guinea-pig. This action 
was postulated by Marine (1938a) who suggested that the greater 
resistance of the female than of the male rabbit to the development 
of exophthalmos is due to the protecting influence of oestrogen 
on the anterior pituitary gland. This effect was verified his­
tologically by Nelson and Hickman (1937) and by Leblond, Albert 
and Selye (1942) who demonstrated that oestrogen administration 
in rats prevents the characteristic changes which are found in the 
pituitary basophile cells following .thyroidectomy, and which are 
due to an excessive secretion of TSH. Similarly, Franck (1937) 
found a reduction in the number of basophile cells on oestrogen 
administration. The depressing influence of oestrogen on the 
anterior pituitary is a selective one, however, and it has been
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shown to cause a stimulation of the acidophile cells (Cramer and 
Horning, 1938; Abarbanel, 1944; Baker and Everett, 1947). On 
the other hand it is possible that oestrogen may exert its effect 
at an extra-pituitary level because it has been shov/n by Gassner, 
Barrett and Gustavson (1947) that oestrogen controls the effect of 
the excessive secretion of TSH which occurs in rats on a low 
iodine diet without affecting the pituitary hypertrophy which 
follows the dietaiy deficiency.
The antagonism which exists between oestrogen and 
TSH has been demonstrated in an interesting experiment by Cramer 
and Horning (1938). They showed that injections of TSH can prevent 
the carcinogenic effects which normally follow prolonged oestrogen 
administration in certain mice.
Kippen and Loeb (1936) found that gonadectomy in guinea- 
pigs causes an increased production of TSH. Howland and Sharpey- 
Schafer (1940) showed that at the menopause there is a failure of 
oestrogen production with a consequent excessive secretion of 
pituitary gonadotrophic hormone which can be controlled by oestrogen 
administration. Rundle (l94l) postulated that associated with the 
hypersecretion of gonadotrophic hormone there may be an increased 
secretion of TSH, and a similar increase of gonadotrophic hormone 
and TSH may occur during menstruation.
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It is reasonable, therefore, to postulate that oestrogen 
therapy may be beneficial in the treatment of Graves' disease by 
reducing the secretion of TSH (de Gennes and others, 1951), and 
that this may be the effective mechanism in the cases in which there 
is a decrease in the degree of exophthalmos after such treatment 
(Okie, Daley and White, 1952).
(2) Oestrogen may decrease the volume of the orbital 
tissues.
Smelser and Ozanics (l95l) have shown that massive do&es 
of oestrogen may cause a decrease in the degree of exophthalmos 
produced in guinea-pigs by thyroidectomy or by TSH administration, 
and that this decrease is associated with a reduction in the amount 
of stainable oedematous infiltrate within the orbital fat. The 
fact that this effect may occur in the thyroidectomised animal 
even when no TSH is administered has been considered by Smelser 
and Ozanics to be proof of the influence which oestrogen is able 
to exert directly on the orbital tissues, quite apart from any 
influence which it may exert on TSH secretion. It must be 
remimbered, however, that this conclusion may not be wholly valid 
because thyroidectomy alone may be responsible for an increased 
secretion of TSH, and oestrogen may affect this endogenous TSH.
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® • llgamination of hypothesis that oestrogen has no exophthalmos-
reducing effect.
(1) Oestrogen may increase the effectiveness of TSH.
It has been shown that oestrogen administration in rabbits 
may cause a stimulation of the anterior hypophysis with the 
production of a thyrotoxic state as a result of an excessive 
secretion of TSH (Zondek, 1945)* Heinbecker (1949) also believed 
the oestrogen facilitates the secretion of TSH from the hypophysis, 
and that this may account for the higher incidence of hyperthyroidism 
in the female than in the male. The stimulating effect of oestrogen 
on the hypophysis was noted by Baker and Everett (1947), although 
this effect was selective on the acidophile cells. Baker and Everett 
considered that the action of oestrogen is independent of the thyroid 
gland because it occurs even in the thyroidectomised animal.
(2) Oestrogen may increase the volume of the orbital 
tissues.
It is interesting to note that Smelser and Ozanics (l95l)> 
despite their finding of a reduction in the bulk of the orbital 
tissues in experimental exophthalmos following oestrogen administration, 
subscribed to the view that in general oestrogen should act by 
favouring the accumulation of oedematous material, and Simpson (1945)*
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put forward the view that oestrogen is unsuitable in the treatment 
of exophthalmos because it has the property of causing a fluid 
retention.
Aykroyd and Zuckerman (1938) demonstrated that the 
active sexual phase in female rhesus monkeys is associated with 
swelling of the sexual skin, as a result of the accumulation of 
considerable amounts of intercellular and intracellular fluid, and 
of the swelling of connective tissue elements. This effect 
follows oestrogenic stimulation, and the female hormone has been 
isolated from the fluid in the swollen area (Fisher, Krohn and 
Zuckerman, 1936). Similarly, Obal (1950) showed that oestrogen 
causes an increase in the amount of intercellular mucoid material 
with complete inhibition of hyaluronidase activity.
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Conclusion regarding relation of oestrogen to exophthalmos.
It is difficult to reconcile the opposing views which 
have been put forward on the influence of oestrogen on TSH 
secretion, hut it must he remembered that different oestrogenic 
substances have been shown to exert a variable effect on the 
iodine uptake of the thyroid gland; some oestrogens cause an 
increased uptake whereas others cause a decreased uptake (Money 
and others, 1951s-)* Furthermore, a variable effect may be 
evident even with the same oestrogenic substance when it is 
administered in low and in high concentrations (Money and others,
1952), although at times small doses may •prove to be entirely 
ineffective (Paschkis, Cantarow and Peacock, 1948)* On balance, 
however, it is most likely that oestrogen may diminish the effective­
ness of TSH, and it may well be of value in the treatment of 
exophthalmos.
Similaily, it is difficult to reconcile the reducing 
effect which oestrogen is supposed to exert on the orbital 
tissues with the increasing effect of the hormone on the 
other tissues of the body. The reported influence on the 
orbital tissues is certainly atypical. •
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Male gonads.
Influence of androgen on exophthalmos.
Marine, Rosen and Cipra (1953) found that exophthalmos 
occurs more readily in male than in female thyroidectomised 
rabbits following administration of methyl cyanide, and it has 
been shown that this exophthalmos may be prevented by preliminary 
gonadectomy (Marine and Rosen, 1936), and that it may be increased 
by administration of androgen (Marine, 1938b). On the other hand 
there is no further experimental evidence to support this concept, 
and it has been shown that the exophthalmos which occurs in 
thyroidectomised guinea-pigs following TSH administration is 
unaffected by a lack of androgen (Dobyns, 1946a; Smelser and Ozanics, 
1951 )> or by an excess of androgen (Smelser and Ozanics, 19'5l)*
There is only scanty evidence to suggest that androgen 
affects TSH secretion, and, although Money and'others (1950) have 
shown that androgen may cause an increase in the secretion of TSH, 
the effect is a variable one because it may produce a diminished 
secretion of TSH merely by being administered in a different 
concentration(Money and others, 1951a). Furthermore, it has been 
shown that androgen fails to prevent the histological changes which 
occur in the basophile cells of the pituitary following thyroidectomy 
in the rat (Leblond, Albert and Selye, 1942).
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In the clinical sphere it has been postulated that there 
is an additional gonadotrophic factor, as well as a thyrotrophic 
factor, in the production of exophthalmos. This hypothesis would 
provide an explanation for the absence of exophthalmos in the 
hyp othyroid states of cretinism and myxoedema, because in these 
conditions there is an associated hypogonadalism. It also gains 
weight from the observation of Brain (1945) that the ratio of males 
to females who develop progressive exophthalmos following 
thyroidectomy is 3 or 4 to 1. When account is taken of the fact 
that thyrotoxicosis is very much more common in the female than in 
the male, approximately in the ratio of 9 to 1, this sex difference 
in the occurrence of progressive exophthalmos is very striking.
In contrast to the concept that a gonadotrophic hormone 
influences the production of exophthalmos, it has been postulated that 
androgen may exert a beneficial effect on the course of progressive 
exophthalmos (Simpson, 1945? Mann, 1946a, b; Basto, 1950) because 
it is supposed to partially inhibit the secretion of T3PI. On the 
other hand androgen is often ineffective in the treatment of such
cases (Donoso, 1953)*
It is difficult to draw any conclusions at the present
time on the basic role of androgen in the exophthalmic process.
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A few reports have appeared from time to time which 
seek to implicate certain other glands or certain forms of vitamin 
deficiency in the exophthalmic process. These are mostly 
of a fragmentary and inconclusive nature but they will be 
considered briefly now.
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Relation of thymus to exophthalmos.
The hormonal activity of the thymus is imperfectly 
understood, but there is no direct evidence that it is related 
to the production of exophthalmos. Bryan, McDonald and Clagett
(1948) examined the thymus in cases of exophthalmic goitre and of 
myosthenia gravis. They found an increase in glandular tissue 
in many of the cases of exophthalmic goitre, but there was rarely 
any lymphoid hyperplasia. In myasthenia gravis, an increase in 
glandular tissue was rare, but lymphoid hyperplasia was more 
common. The thymus, therefore, presents a different picture 
in the two conditions.
Dudgeon and Urquhart (1926) demonstrated enlargement 
of the thymus in 3 out of 8 cases of exophthalmic goitre showing 
atrophic changes and the formation of lymphorrhages in the ocular 
and skeletal muscles. Brain (1943) commented on the fact that 
hyperthyroidism and myasthenia gravis may very occasionally co­
exist. It may be that thymic over-activity is a link between
the two conditions.
Rawson, Sterne and Aub (1942) showed that, in vitro,
■fciie thymus is able to neutralise a certain amount of TSH. It is 
not known what significance, if any, may be attached to this finding.
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Relation of -parathyroid. to exophthalmos.
Heinbecker (1950) described the occurrence of a 
parathyroid adenoma in two cases in which there was an associated 
depression of thyroid gland function, due, it was suggested, to 
an inhibiting effect of the adenoma on the hypophyseal basophile 
cells. The removal of the adenoma was followed by a phase of 
hyperthyroidism with an associated exophthalmos as a: result 
perhaps of a temporary overaction of the basophile cells. It 
is difficult, however, to draw any conclusion from these two 
cases regarding an influence of the parathyroid gland on 
exophthalmos, and it is possible that the effect described was 
the result purely of the change in thyroid gland function following 
the local influence of the parathyroid growth.
-169-
Relation of vitamin H to exophthalmos*
Emerson (1949) has shown that vitamin protects 
rats against the toxic effects of large doses of thyroid hormone, 
so that the hyperthyroid animal presumably has an increased need 
for vitamin A similar protecting influence has been found
with liver residue, the so-called anti-thyrotoxic factor of the 
liver (Ershoff, 1950). There is no evidence, however, that these 
isolated findings are related to exophthalmos.
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Relation of vitamin C to exophthalmos.
There is an abundance of ascorbic acid (vitamin C) 
in the adrenal cortex, and it is known that this concentration 
undergoes a cyclic rise and fall in relation to adrenocortical activity 
There is, therefore, a relationship between ascorbic acid and the 
adrenocortical hormones.
It is interesting to note that Marine, Rosen and 
Cipra (1955) found that ascorbic acid causes a marked inhibition 
of the experimental exophthalmos which normally follows methyl 
cyanide- administration. Marine, Baumann and Rosen (1934) 
considered that this is due to the fact that ascorbic acid directly 
or indirectly counteracts TSH. On the other hand Robyns (1946a) 
found that ascorbic acid does not influence the exophthalmos which 
follows TSH administration in thyroidectomised and in non-thyroidecto- 
mised guinea-pigs, and he concluded that ascorbic acid does not have 
any effect on TSH. Aterinan (1954a) has shown that ascorbic acid 
protects guinea-pigs to a certain extent against the production of 
thyrotoxicosis following TSH administration. Aterman considered 
that this only indicates that thyrotoxicosis is aggravated by an 
ascorbic acid deficiency and it cannot be concluded that ascorbic 
acid is an a n t i -thyrotoxic substance.
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Kelation of vitamin E to exophthalmos.
Grosz (1950) has suggested that vitamin E may be of 
value in cases of exophthalmic ophthalmoplegia because of the 
beneficial effect of the vitamin in certain systemic dystrophies 
of the striated musculature. There is no evidence, however, 
that vitamin E exerts any influence on exophthalmos or on 
exophthalmic ophthalmoplegia (Givner, Bruger and Lowenstein, 1947 
Cima, 1950).
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Relation of dental cement to exophthalmos.
Kupfer (1954) has declared that the absence of dental 
hypercementosis in certain cases of hyperthyoidism suggests that 
these cases are prone to develop malignant exophthalmos. This 
conclusion was arrived at by the finding that hypercementosis 
occurred in 14i° of normal persons, in 60yo of hyperthyroid patients 
without malignant exophthalmos, and in only 7a!° of hyper/thyroid 
patients with malignant exophthalmos. It is impossible, however, 
on the data presented in Kupfer*s paper to elaborate of this 
concept, particularly as no details are given of the state of 
the hyperthyroidism. It is unlikely that the patients with malignant 
exophthalmos were all in a hyperthyroid phase because 70^ had been 
subjected to thyroidectomy, and it would be interesting to know 
whether any of them had evidence of hypercementosis during the 
pre-operative hyperthyroid phase.
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.Q.ther clinical considerations of thyrotrophic exophthalmos.
In the absence of any uniformly satisfactoiy procedure 
for the treatment of progressive exophthalmos, it is important 
to try and prevent the occurrence of the condition as far as 
possible. This can best be done by exercising great care in the 
selection of cases of Graves' disease suitable for surgical or 
medical treatment (Plessier, 1954)* Salter and Soley (1944) 
considered that thyroidectomy should be avoided in all cases of 
thyroidectomy should be avoided in all cases of thyrotoxicosis 
associated with only a small rise in metabolism. Ruedemann (1949) 
considered that rest and thiouracil therapy are safer procedures 
in such cases than removal of the thyroid gland.
Means (1945) recommended that thyroidectomy should be 
avoided in all cases of Graves' disease in which there are signs 
of a thyrotrophic type of exophthalmos. It is not always easy, 
however, to detect the early manifestations of thyrotrophic 
exophthalmos particularly when they are superimposed on a thyrotoxic 
condition. It is in this sphere that the orbitonometer (Copper, 1948)
may prove of great value, because it is pbssible to detect with 
this instrument an early rise of intra—orbital resistance.
Certainly thyroidectomy should be avoided in any case in which the 
presenting feature is an oedematous form of exophthalmos (Shannon 
and Hunt, 1949; Paufique, 1954) > e.nd there is no doubt that
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exophthalmos is particularly prone to occur when there is an 
early dominance of the eye signs over the general manifestations 
of the diease (Givner, 1950).
If, however, progressive exophthalmos develops it 
is essential to maintain the integrity of the eye during the 
active phase of the condition, particularly as progressive 
exophthalmos is usually a self-limiting entity even in the 
absence of any specific treatment (Mann, 1947; Falconer and Alex­
ander, 195l)j with a tendency for the eyes to show some spontaneous 
recession within 6 - 1 2  months of the onset of the condition. 
Conjunctival infection or corneal ulceration must be guarded 
against by appropriate local treatment. If the cornea is not 
adequately protected by the lids, a tarsorrhaphy should be 
performed, but as has been pointed out by Pfeiffer (1950) it is 
necessaiy to perform the tarsorrhaphy before the intra-orbital tension 
becomes excessive. King (1952) has suggested that the tarsorrhaphy 
is more effective if preceded by a generous lateral canthotomy. The 
pressure of inflated bags placed over the eyes may also be of 
value in certain cases (Horrax, 1952).
These measures may fail in the more severe cases, and 
it may be necessaiy to protect the integrity of the eye and the 
optic nerve by performing an orbital decompression operation 
(Haffziger, 1933, 1952, 1954, 1955; Poppen, 1950; Offret, 1954; 
Jackson, 1955), although Hollingsworth (1952) considered that a
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simple direct incision into the orbit may prove equally effective 
in certain cases. On the other hand the results of orbital 
decompression are sometimes disappointing (Mason, 1947; Law, 1952).
Undoubtedly, a rational and successful method of 
treatment of endocrine exophthalmos must await a deeper under­
standing of the basic hormonal processes.
■5 v ' : ,t Arch.* S'-S, '( ? A-.: » * :■ f . ■ *
y. yg/'hO- A;; i.-~ ‘ ; i ' ■ * <: A--.-.
(iAAly Kr;d::Arl;A>!ry.;;'v i ,
, . ; y /  y y r y ; .  y  .  . y ,  g ,  ,  P A - I a K X A  ; A  • ' A ,  >  ^  ■ A  A X f  A I K ’ A y  A  *
-  , --- >5"!-:: ;■? r.i y'A ff'r y. :i A AA •" - ? ~ V v  j O ->
' ; - 4 ;  , ; ' t h y y - :  ,  A t ,  7 * 1 *  •
• - % - v-a. */?''■ ■ ■.
.jr ' — A- 'A- « • *
Ar'vA C>S XXAKOW* * .
bibliography
ABARBANEL, A.R. (1944). Endocrinology, 35, 207.
ADAMS, R.D. , DEMY-BROWN, D., and PEARSON, C.M. (1954).
Diseases of Muscle. A study of pathology. P.B. Hoeber, Inc.
New York.
ADLER, P.El .  ,  SCHEIE, H.G. ,  and DENNIS, R. (1949)- J.Michigan
med. Soc., 48, 852.
ADLERSBERG, D., SCHAEFER, L., and ORACHMAN, S.R. (1950)-.
J.Amer. med. Assoc., 144, 409.
AIRD, R.B. (1940). Arch. Ophthal., 24, 1167.
_________ . (1941)* Ann. int. Med., 15, 564-
ALBERT, A. (1945)- Endocrinology, 37, 389-
  (1952). Ann. Rev. Physiol., 14, 481.
ALBERT, A., RAWSON, R.W., MERRILL, P., LEMON, B., and
RIDDELL, C. (1946). J.biol. Chem., 166, 637.
ALBERT, A., RAWSON, R.W., MERRILL, P., LSNNON, B., and
RIDDELL, C. (1947a). Endocrinology, 40, 299.
ALBERT, A., RAWSON, R.W., MERRILL, P., LENNON, B., and
RIDDELL, C. (1947b). Ibid., 40, 303-
ALBERT, A., TENNEY, A., and FORD, E. (1952). Ibid., 50, 324-
ALONSO, V. (1949). Arch. Soc. optal. hispano-amer., 9, 907.
ANDERSSON, B. (1950). Acta med. Scand., 137, 254-
D'ANGELO, S.A. (1951). Endocrinology, 48, 361-
D ’ANGELO, S.A., GORDON, A.S., PASCHKIS, K.E., and CANTAROW, A.
(1949). J.clin. Endocrin., 9,653-
D ’ANGELO, S.A., PASCHKIS, K.E., CANTAROW, A., and GORDON, A.S. 
(1951a). Ibid., 11, 761.
D'ANGELO, S.A., PASCHKIS, K.E., GORDON, A.S. and CANTAROW, A. 
(I951t))- Ibid., 11, 1237-
D'ANGELO, S.A., STEVENS, C.E., PASCHKIS, K.E., and CANTAROW, A.
(1953). Proc. Soc. exp. Biol. Med., 83, 181.
ARON, M., and BENOIT, J. (1932). Compt.rend. Soc. Biol., 199,923.
ARTUNKAL, S. (1953). Turk. Tip. Cem. Mec., 19,362.
ARVY, L. , and GABE, M. (1950). Experientia, 6,23.
ASBOE-HANSEN, G. (1950). Ann. rheum. Dis., 9,149*
  (1952). Proc. Soc. exp. Biol. Med., 80,677.
  (1954). Some systemic connective tissue
disorders pertaining to dermatology. 
Munksgaard. Copenhagen.
ASBOE-HANSEN, G., and IVERSEN, K. (1951). Acta Endocrin, 8,90.
ASBOE-HANSEN, G. , IVERSEN, K., and WICHMANN, R. (1952). Ibid, 11,376.
ASHTON, N. (1951). Brit. J. Ophthal., 35, 291.
__________ (1952). Brit. J. Ophthal., 36, 465.
4
ASTWOOD, E.B., SULLIVAN, J. BISSELL, A., and TYSLOWITZ, R.(l943).
Endocrinology, 32, 210.
ATERMAN, K. (1951). Brit. med. J., 2, 609-
___________ (1952a). Lancet, 1, 1143*
___________ (1952b). Proc. Roy. Soc. Med., 45, 241.
___________ (1954a). Acta Endocr. Suppl. Kbk., No.20.
___________ (1954b). Surgery, 35, 443*
ATERMAN, K., and GREENBERG, S.M. (1953)* Endocrinology, 52,510. 
____________________   (1954). Arch. Ophthal., 51, 822.
ATKINSON, D. , LISSER, H. , and SHEPARDSON, H.C. (1928).
Endocrinology, 12, 680.
ATKINSON, W.S. (1949)* Arch. Ophthal., 42, 628.
AYER, J.B., MEANS, J.H., and LERMAN, J. (1934). Endocrinology,
18, 701.
AYKROYD, O.E., and ZUCKERMAN, S. (1938). J.Physiol., 94,13.
/
AZERAD, E. (1948). Sem. H&p. Paris, 24, 565.
BACQ, Z.M., and ISOLA, W. (1946). J.Physiol., 105, 7P*
BAIRD, C., SELLERS, E.A., and FERGUSON, J.K.W. (1950).
Rev. Can. Biol., 9, 62.
BAKER, B.L., and EYERETT, N.B. (1947)* Endocrinology, 41, 144*
BAKER, B.L. , INGLE, D.J., LI, C.H., and EVANS, H.M. (1948).
Amer. J. Anat., 82, 75.
BANGHAM, A.D. (l95l)» Brit. Jour. exp. Path., 52, 77.
BARDRAM, M. J. (1944). Acta Ophthal., 22, 1.
BARGER, G., and DALE, H.H. (1910). J.Physiol., 41, 19.
BARR, D.P., and SHORR, E. (1945)• Ann. int. Med., 25, 754*
BARRETT, H.M., BEST, C.H., and RIDOUT, J.H. (1958).
J. Physiol., 93* 367.
BARTLETT, W. (1949). Ann. Surg., 130, 825.
BASEDOW, C.A.(1840). Woch. f.d.ges. Heilk., 13.
BASTENIE, P.A. (1950). Ann. Sndocrin., 11, 648.
BASTO, L.P. (1950). Bol. clin. Hosp. Lis., 14, 594.
BAUMANN, E.J., and MARINE, D. (1945). Endocrinology, 56, 400.
BAUMANN, E.J., METZGER, N., and MARINE, D. (1944). Ibid., 34,44.
BAXTER, H. (1951). Proc. second clin. ACTH. Conf., Vol.II, 550.
J. and A. Churchill. London.
BEGBIE, J.W. (1868). Edin. med. J., 15, 882.
BEHRMAN, S. (1945). Proc. Roy. Soc. Med., 58, 665.
____________ (1946). Amer. J. Ophthal., 29, 10.
BEIERWALTSS, W.H. (1948). Arch. int. Med., 81, 564.
_________________  (1951). J.clin. Endocrin. Metab., 11, 512.
(1953)« J.clin. Endocrin. Metab., 15, 1090.
_ _ _ _ _ _ _ _ _ _ _  (1954). Ann. int. Med., 40, 968.
BjiIERWALTES, W.H., WOLFSON, W.Q. , JONES, J.R., KNORPP, C.J.
and SIEMIENSKI, J.I. (1950). J.lab. clin. Med., 56, 799.
BENEDICT, W.L. (1935). Proc. Staff. Meet. Mayo Clin., 10, 808.
— ------------   (1936). Ibid., 815,
_______________ (1938). South, med. J., 31, 321.
 _____________ (1950). Amer. J. Ophthal., 33, 1.
BENNETT, J.E. (1954). Arch. Ophthal., 52, 683.
BENUA, R.S., ALBERT, A., and KEATING, F.R. (1952).
J.clin. Endocrin. Metab., 12, 1461.
BSRGFELT, G. (1955). Nord. Med., 53, 939*
BERKMAN, A.T. (1954). Radiology, 62, 406.
BERNARD, C. (1852). Compt. rend. Soc. Biol,, 4, 168.
BSRSON, S.A., and YALOW, R.S. (1952). J.clin. Endocrin. Metab.,
12, 407.
BILLINGSLEY, L.W. , 0*DONOVAN, D.K., and GOLLIP, J.B. (1939).
Endocrinology, 24, 63.
BLAIJ, N.F., and McNAMARA, H. (1930). Proc. Soc. exp. Biol.Med.,
27, 997.
BLOMFIELD, G.W. , JONES, J.C., MACGREGOR, A.G., MILLER, H., and 
WAYNE, E.J. (1951). Brit. med. J., 2, 373-
BLOOM, F. (1952). Proc. Soc. exp. Biol. Med., 79, 651.
BOAS, N.F., LUDWIG, A.W. , and SOFFER, L.J. (1952).
J. Clin. Endocrin. Metab., 12, 965.
BOAS, N.R., and SCOW, R.O., (1954). Endocrinology, 55, 148.
B0G0R0CH, R., and TIMIRAS, S. (l95l). Ibid., 49, 548.
BONAMOUR, G., and ROUGIER, J. (1951). J * LYon> 32, 585.
BOTKIN, A.L., and JENSEN, H. (l95l). Federation Proc., 10, 164.
BOTT, S.C.A. (1950). Proc. Roy. Soc. Med. 43, 904*
BRADY, R.O., and HEDGES, T.R. (1952). j.olin. e ^ o c ^ .  Metab.,
12, 604.
BRAIN. W.R. (1936). Lancet, 1, 182.
___________. (1938). Quart. J. Med., 7,293.
__  (1939)• Lancet, 2, 1217.
____________  (1943). Trans, ophthal. Soc. U.K., 63, 3.
____________ (1945). Proc. Roy. Soc. Med., 38, 666.
___________. (1946). Amer. J. Ophthal., 29, 1029.
____________ (1952). Proc. Roy. Soc. Med., 45, 237.
____________  (1955). Trans, ophthal. Soc. U.K., (in press).
BRAIN, W.R., and others. (1955). Lancet, 1, 6.
BRALEY, A.E. (1948). J. Iowa State Med. Soc., 38, 435.
___________  (1953)* Amer. J. Ophthal., 36, 1286.
___________  (1955). Ibid., 39 (part II), 155.
BRINI, A. (1954)* Bull. Soc. Opht:al. Fr., No.6, 519*
BRISTOWE, J.S. (1886). Trans, ophthal. Soc. U*K., 6,39*
BROCK, S. (l94l)« West. J. Surg. Obstet. Gynaec., 49, 585*
BRODY, E.B. (l94l)» Endocrinology, 29, 916.
BROWNE, J.S.L. (1950). Proc. first clin. ACTH. Conf., p.127. 
BRULL, L. (1953). Rev. med. Liege, 8, 205. The Blakiston Coy.
Philadelphia. Toront
BRUNTON, C.E. (1935). J. Physiol., 84, 334- 
_ _ _ _ _ _ _ _ _  (1938). Brit. J. Ophthal., 22, 257.
(1949). Physiol. Rev., 29, 260.,
BRYAN, A.L., MCDONALD, J.R. , AND CLAGETT, O.T. (.1948). Arch. Path., 46,
CAMPBELL, D.A., and TONKS, E.M. (1955)- Trans, ophthal. Soc. U.K.,
(in press).
CANNON, W.B. (1929). Physiol. Rev., 9,399- ,
CANNON, W.B., BINGER,C.A.L. and FITZ,R.(1915).Amer.J.Physiol.,36,363. 
CARRA, G. (1954). Bull, oculist., 33, 425*
CATTELL, R.B. (1934). Ann. Surg., 100, 284-
CAVALLERO, C., and BRACJINI, C. (1951)* Proc. Soc. exp. Biol,
Med., 78, 141.
CHANDLER, P.A. (1950). Tex. State J. Med. 46, 801.
CHANDLER, G.N. , and HARTFALL, S.J. (1952). Lancet, 1, 847*
CHANG, C.H. (1953)• Amer. J. Ophthal., 36, 392.
CHARLEUX, G. LACROSAZ, and DOMBRE, (1953)* Pediatrie, 8, 945*
✓
CHAVEZ MOATES, J. (1952a). IVth. Cong-. Pan-Amer. Optal., 3, 1753.
  ___________  (1952b). J. clin. Endocrin. Metab., 12, 978.
CH'EN, G. , and VAN DYKE, H.R. (1934). Proc. Soc. exp. Biol.
Med., 32, 484.
CIMA, V. (1951). Bull. 0cul., 30, 342.
CLOSS, K., LOEB, L. , and MACKAY, E. (1931). Proc. Soc. exp. Biol.
Med., 29, 170.
CODE, G.F., and ESSEX, H.E. (1935). Amer. J. Ophthal., 18, 112J. 
COGAN, D.G. (1953). Trans. Amer. ophthal. Soc., 51, 3^8.
COLE, S.L. (1951). Arch. Ophthal., 45, 299.
COLLARD, H.B., MILLS,F.H., RUNDLE, F.fl. , and SHARPEY-SCHAFER, E.P.,
(1940). Clin. Sci., 4, 323.
COLLIER, R. (1954). Arch. Ophthal. (Chicago), 51, 402.
COLLIP, J.B., and ANDERSON, E.M. (1934). Lancet, 1, 76, 784.
COPPER, A.C. (1948). An Introduction to Clinical Orbitonometry.
Leiden.
COOPER, W.W. (1849). Lancet, 1, 551.
COPE, C.L. (1938). Quart. J. Med., 7, 151.
CORDES, F.C. (1954). Amer. J. Ophthal., 38, 1.
CORTELL, R., and RAWSON, R.W. (1944). Endocrinology, 35, 488.
COVITZ, E.E. (1941). Amer. J. Ophthal., 24, 1423*
CRAIG, W.McK. , and DODGE, H.W. (1952). Ann. Surg., 136, 3^6.
(1953). Trans. Amer. Surg. Assoc.,
 ------------------------ ------ ‘70, 70.
CRAMER, ¥. and HORNING, E.S. (1938). Lancet, 1, 72.
CRAWFORD, J.S. (1952). Trans. Canad. ophthal. Soc., 5, 81.
CRILE, G. (1947). Trans. Amer. Assoc. Study Goitre, 84.
CRITCHLEY, C.F., and CAMERON, A.J. (1948). Lancet, 1, 7 5 1 .
CUENDET, J.F., and CRUCHAUD, S. (1953). Ophthalmologica, 125, 377*
CURTIS, A.C., CAWLEY, E.P., and JOHNWICK, E.B. (1949). Arch. Derm.
Syph., 60,518.
DALRYIvIPLE, J. (1834). The Anatomy of the human Eye. (London).
p . 266.
DANIEL, R. (1938). Proc. Staff. Meet. Mayo Clin., 13, 683.
DANIS, P. (1954). Bull. Soc. franc., Opht.al., 67, 436.
DANIS, P., and MAHAUX, J. (1951 )• Bull. Soc. beige ophthal., 97,1.
DAY, R, McC., and WERNER, S.C. (1954). Arch. Ophthal. (Chicago),
52, 85.
DAYTON, G.O., (1952). Amer. J. Ophthal., 35, 101.
_____________ (1953). Ibid., 36, 1049.
DEANE, H.W., and GREL’P, R.O. (1947). Endocrinology, 41, 243.
DSGOWIN, E.L. (1946). J. lab. clin. Med., 31, 483*
DEVITT, J.E., PIROZYNSKI, W.J., and SAMUELS, P.B.(1953).
Proc. Soc. exp. Biol. Med., 83, 335*
DEVOE, A.G. (1954). Arch. Ophthal., 52, 461.
DINSMORE, R.S. (1952). Ann. Surg., 136, 372.
DIXON, G.J. (1941). Brain, 64, 73*
DOBRINER, K . , LIEBERMAN, S., WILSON, H., EKMAN, B . , PEARSON, V., 
and ELIEL, L. (1950). Proc. first clin. ACTH. Conf., p.158.
The Blakiston Coy. Philad&phia.
Toronto.
DOBYNS, B.M. (1945)* Surg. Gynaec. Obstet., 80,526.
  (1946a). Ibid., 82,290.
_ _ _ _ _ (1946b). Ibid., 82,609-
DOBYNS, B.M. (1946c). Surg. Gynaec. Obstet., 82, 717.
------------- (I946d). Trans. Amer. Assoc. Study Goitre, 226.
_____________ (l946e). West. J. Surg., 54, 411.
_____________ (1950). J. clin. Endocrin., 10, 1202.
DOBYNS, B.M., and HAINES, S.F. (1946a). Ibid., 6,633.
_________________ ____________ _ (1946b). J.lab. clin. Med., 31,483.
DOBYNS, B.M. and RAWSON, R.W. (1951)* Endocrinology, 49 j 15*
DOBYNS, B.M. and STEELMAN, S.L. (1953). Ibid., 52, 705.
DOBYNS, B.M. and WILSON, L.A. (1954)* J* clin. Endocrin. Metab.,
14,1393.
BOGGART, J.H. (1949). Ophthalmic Medicine (Churchill,London).p.131.
DOLLSRUP, E., HANSEN, C.J., and M^LGAARD, B. (1953). Nord. Med.,
50, 1161.
DOLLFCJS, M. (1954). Bull Soc. fran^. d'ophthal., 67, 441.
B0N0S0, F. (1953). Rev. med. Chile, 81, 558.
D0N0S0, F., JADRESIC, A., SANZ, R., and LOPEZ, E. (1953).
Ibid., 81, 555.
BOYNE, P.G. (1945). Trans, ophthal. Soc. U.K., 65, 252.
DRESCHER, E.P., and BENEDICT, W.L. (1950). Arch. Ophthal., 44, 109*
DUDGEON, L.S., and URQUART, A.L. (1926). Brain, 49, 182.
DUKE-ELDER, W.S., and GOLDSMITH, A.J.B., (1951)•
Recent Advances in Ophthalmology, IVth.Edition.
(Churchill. London).
DUNNINGTON, J.H. (1947). Erans. Amer. ophthal. Soc., 45, 249.
DVOSKIN, S. (1947). Endocrinology, 41, 220.
VAN DYKE, H.B., and CH’EN, G. (1953) • Proc. Soc. exp. Biol. Med.,
’ ’ 31, 327.
EDEN, K.C., and TROTTER, W.R. (1942). Lancet, 2, 385.
EDITORIAL. (1934). J* Amer. med. Assoc., 102, 2188.
FOSSaTI, P., SILVESTRINI, p., and MELLONI, G. (1953). Fol. Endocrin.
(Pisa), 6, 911.
FRAENKEL-CONRAT, J., FRAENKEL-CONRAT, H., SIMPSON, M. E. and 
EVANS, H.M. (1940). J. biol. Chem., 135, 199.
FRALICK, B. (1947). Trans. Amer. ophthal. Soc., 45, 252.
___________ (1949). Arch. Ophthal., 41, 511.
FRANCK, S. (1937). Compt. rend. Soc. Biol., 125, 573.
FRANCOIS, J. (19513-) • Bull. Soc. beige, Oph^al., 97, 138*
(1951b). Ibid., 97, 194.
FRASER, F.R. (1937). Trans, ophthal. Soc. U.K., 57, 116.
FRASER, R . , and WILKINSON, M. (1953). Brit. med. J., 1, 681.
FREDERICKSON, D.S. (1951 )• J. clin. Endocrin., 11, J60.
FREDERICKSON, D.S., FORSHAM, P.H., and THORN, G.W. (1952).
Ibid., 12, 541.
FRIEDGOOD, H.B. (1930). Amer. J. med. Sci., 180, 836.
 _______________  (1934). Bull. Johns Hopk. Hosp., 54, 48.
_________________ (1940). Arch. Ophthal., 24, 1176.
____________________ (1941). Trans, amer. Assoc. Study Goitre, p.128,
FROMM, G.A., HECKER, E., and SILVA, C.G. (1954). Acta Endocrin.
(kbl)., 16, 197.
FRY, E.G. (1937). Endocrinology, 21, 283*
GABRILOVE, J.L., KERT, M.J., and SOFFER, L.J. (1945).
Ann. int. Med., 23, 537.
GABRILOVE, J.L., LUDWIG, A.W., and SOFFER, L.J. (1952).
J.clin. Endocrin. Metab., 12, 966.
SALLI-MAINIME ,C. (1941). Endocrinology, 29, 674.
 _________________  (1942). Ibid., 30, 166.
GAUNT, R., CORDSEN, M., and LILING, M. (1944). Ibid., 35, 105*
GAS3NER, F.X. , BARRETT, H.W., and GUSTAVSON, R.G. (*947).
Trans. Amer. Assoc. Study Goitre, p.15©.
GEDDA, P.O., and LINDGREN, M. (1954)• Acta med. Scand., 148, 385.
 ----------   (1954). Acta Radiol. (Stockh.), 42,211.
GELLHORN, E. and FELDMAN, J. (l94l)« Endocrinology, 29, 467.
de GENNES, L., BRICAIRE, H., BENZECRY, I., and VILLIAUMEY, J.(l95l).
Presse med., 59, 41*
GINSBURG, S. (1939). Ann. int. Med., 13, 424.
GIVNER, I. (1950). Amer. J. Ophthal., 33? 623*
GIVNER, I., BRUGER, M., and LOWENSTEIN, 0. (1947). Arch.
Ophthal., 37? 211.
GLEY, E. (19IO). Compt. rend. Soc. Biol., 68, 858.
GORDON, A.S., GOLDSMITH, E.D., and CHARIPPER, H.A.(l945).
Endocrinology, 36? 53*
Von GRAEFE, H.A.(l864). Dftsch.Klin. , 16, 158.
GRAVES, R.J. (1935). Lond. med. surg. J., 7? 516.
GREENE, R. (1949). Proc. Roy. Soc. Med., 42, 263.
 _________  (1955). Trans, ophthal. Soc. U.K., In press.
GROBSTEIN, C., and BELLAMY, A.W. (1939). Proc. Soc.' exp. BiriL. Med.,
41, 363.
de GROSZ, S. (1950). Acta ophthal., 28, 1.
GRYNKEWICH, S.E., LAUGHLIN, R.M., HERRON, F.T., and CARMEL, W.J.
(1951). Amer. J. med. Sci., 222, 142".
GRAIS, M.L. (1949). J* Invest. Dermat., 12, 345*
GREER, M.A. (l95l)« New.Eng• J. Med., 244? 385-
HAIK, G.M. (1944). Arch. Surg., 48, 214-
HAINES, S.F. (1928). Endocrinology, 12, 55.
  (1939). Proc. Staff. Meet. Mayo Clin., 14? 831.
  (1950). J. clin. Endocrin., 10. 989*
  (l954). N.Y. State J. Med., 54, 2175*
HAINES, S.F., and KEATING, F.R. (1946). Med. Clin. North Amer.,
JO, 845-
HALMI, N.S. (1952). Proc. Soc. exp. Biol. Med., 80, 175*
HALMI, N.S., and BARKER, S.B. (1952)* Endocrinology, 51? 127•
HALMI, N.S., BOGDANOVE, E.M., SPIRTOS, B.N., and LIPNER, H.J.
(1955)* Endocrinology, 52, 233
HAMILTON, R.R. (1953) • Brit. J. Med., 1, 29.
HAMRE, p., and NICHOLS, M.S. (1929)* Proc. Soc. exp. Biol. Med.,
26, 63.
HANLEY, M.J., and PHILIP, A.J. (1952). New York State J. Med.,
52, 1431.
HARDY, J.D., RIEGAL, C., and ERISMAN, E.P. (l950)» Amer. J. med.
Sci., 220, 290.
HARINGTON, C.R. (1926). Biochem. J., 20, 300.
HARSLjtfF, E., and SORENSEN, C.H.R. (l954). Nord. Med., 51, 550.
HATCH, H.A. (1952). New Eng. J. Med., 246, 856.
HEDGES, T.R., and ROSE, E. (1953)- Arch. Ophthal., 50,- 479*
HEINBECKER, P. (1949). Ann. Surg., 13.0, 8O4.
______________  (l950)« Surg. Clin. N.Amer., 30? 1315*
~__________ (1952). Ann. Surg., 136, 145*
HERMANN, K. (1952). Brit. J. Ophthal., 36, 1.
HERTZ, S., and OASTLER, E.G. (1936). Endocrinology, 20, 520.
HESSER, C. (1913). Anat. Hefte., 49, 1.
HEUER, G.J. (1916). Amer. J. med. Sci., 151? 339*
HIGGINS, G.M., WOODS, K.A., and KENDALL. E.C. (l95l).
Endocrinology/, 48, 175*
HILL, S.R., REISS, R.S., FORSHAM. P.H., and THORN, G.W.; (1950).
J. clin. Endocrin., 10, 1375
HIRSCIi, 0. (1950). Arch. Otolaryng. , 51? 325 -
HOLLINGSWORTH, A. (1952). Proc. Roy. Soc. Med., 45? 243*
HOPE-ROBERTSON, W.J. (1947). Trans, ophthal. Soc. New Zealand, 18.
HOLLOWAY, T.B., PRY, W.E., and WENTWORTH, H.A. (1929).
J. Amer. med. Assoc., 92, 35*
HORHAX.-G. (1952). Ann Surg., 136, 373-
HOSKINS, R. G. (1910). J. Amer. med Assoc., 55? 1724*
_____________  (1949)* J* clin. Endocrin., 9, 1429*
HUNT, W.T. (1947)* 'Trans. Amer. ophthal. Soc., 45? 252.
____________________(1949)* Arch. Ophthal., 41, 509-
IGERSHSIMER, J. (1955)• Arch. Ophthal. (Chicago), 53 > 94* 
IGLSSIAS, F.G. (1948)• Arch. Soc. optal. Hisp-Amer., 8, 1121.
INCH, R.S.M.D., and ROLLAND, C.P. (1953)- Lancet, 2, 1239-
IVERSEN, K. (l954)» Asboe-Hansen’s "Connective tissue in health
and disease". Munksgaard. Copenhagen.
JACKSON, A.S. (1948). Arch. Surg., 56, 586.
JACKSON, H. (1955)• Trans, ophthal. Soc. U.K., (in press).
JACKSON, W.P.V. (1949)* Brit.med. J., 2, 847-
______________  (1950). South Afric. med. J., 24, 582. .
JAEGER, R. (1952). Arch. Ophthal., 48, 652.
JEFFERIES, W. McK. (1949a). J. clin. Endocrin., 9, 913.
__________________  (1949*). Ibid., 9,927.
__________________  (1949c). Ibid., 9,937.
__________________  (1952). Arch. Ophthal., 48, 657*
__________________  (1953). Amer. J. Ophthal., 36, 394*
JOHNSON, T.H. (1947). Trans. Amer. ophthal. Soc., 45, 247*
_____________  (1949). Arch. Ophthal., 41, 509*
JONES, A. (1951). Brit. J. Radiol., 24, 637.
JONNESCO, T . (1997). Ann. d'Ocul., 117, 161.
____________  (1905). Internat. Clin. Phila., 1| 13th series, 136.
JULER, P.A. (191$). Trans, ophthal. Soc. U.K., 33, 58.
____________(1945). Ibid., 65,251.
(1952). Proc. Roy. Soc. Med., 45, 243*
JUNQUEIRA, L.C. (1947)- Endocrinology, 40, 286.
JUSTIN-BESANCON, L., KOHLER, P., and SCHIEF-WERTHEIMER, (1934).
J. Med. franc., 23, 96.
JUSTIR-BESAMCON, L., KOHLER, P., SCHIFF-WERTHEIMER (MMe), and
SOULlf, P. (1951). Bull. Mem. Soc. med. Hop. Paris, 55, I883.
KAPIN, M. (1950). Amer. J. Ophthal., 33, 962.
KAMEL, A., and HAMPI, F. (1949). Bull, ophthal. Soc. Egypt, 42, 2JQ.
KAUL, S.N. (1949). Proc. All-Indian ophthal. Soc., 10, 1.
KEARNS, T.P., HELPERSOh, J.W., and HAILES, S.F. (1955). Amer. J.
Ophthal., 36 , 45*
KEATING, F.R., RAWSON, R.W., PEACOCK, W., and EVANS, R.P. (1945).
Endocrinology, 36, 157*
KELLY, K.H., FELSTEP, E.T., BROWN, P.R., ORTEGA, P., BIERMAN, H.R., 
LOW-BEER, B.U.A., and SHIMKIN, M.B. (l95l)« Nat. Cancer Inst.,
11, 967. '
.KENPALL, E.C. (1915)- J* Amer. med. Assoc., 64, 2042.
_____________  (1919). J. biol. Chem., 39, 125*
KESSEL, L., and HYMAN, H.T. (1923). Amer. J. med. Sci., I65, 515*
KESSEL, L., HYMAN, H.T., and LANPE, H. (1923). Arch. int. Med.,
31, 433.
KEY, S.N., and KEY, S.N. (1950). Texas State J. Med., 46, 31*
KEYES, J.E.L., and PARISI, P.J. (1953). Trans. Amer. Acad.
Ophthal. oto. laryng., 57, 177*
KEYNES, G. (1952). J. Obst. Gynaec., 59, 173-
KING, E.F. (1952). Proc. Roy. Soc. Med., 45, 243*
KINSELL, L.V/., PARTRIDGE, J.W., and FOREMAN, N. (1955).
Ann. int. Med., 38, 913*
KIPPER, A.A., and LOEB, L. (1936). Endocrinology, 20, 201.
KISNEB, W.H., and MAHORNER, H. (l947)» Surg. Gynaec. Obstet.,
84, 326.
KLOTZ, H.P. (1948a). Ann. d'Endocrin., 9, 180.
 _________  (1948b). Ibid., 9,184.
____________  (1948c). Ibid., 9 , 187.
KNUDTZON, K. (1949)* Acta Psych. Neurol., 24/3, 523*
KOEPF, G.F. (1950). New Eng. J. Med., 242, 869.
KOERNER, K.A. (1954). J. Pediat., 45, 464-
KRAVITZ, D., and MOEHLE, W.V. (l94l). Amer. J. Ophthal., 24, 527.
KUHL, W.J'.Jr., and ZIFE, M. (1952). J. clin. Endocrin. Metab. ,
12, 554.
KUNDE, M.M. (1927). Amer. J. Physiol., 82, 195*
KUPFER, C. (1954). Arch. Ophthal., 52, 942.
/
LABBE, M., VILLARET, M., JUSTIN-BESANCON, L., and SCHIFF-WERTHEIMER,
(1933J- Bull. Acad. Me'd., 110, f30.
LABBE, M., VILLARET, M . ,  JUSTIN-BESANTgQN,L., and SOULIE, P.(l93l).
Bull. Mem. Soc. M^ cL.IjSp. Paris, 47, 1897*
LAHEY, F.H. (1926). J. Amer. med. Assoc., 87, 754*
LAMBERG, B.A. (1954)• Acta med. Scand., 148, 225*
LANDSTROM, J* (1907)- Nord. med. Ark., 40, 1.
LAW, F.W. (1952). Proc. Roy. Soc. Med., 45, 245.
LAWFORD, J.B. (1900). Trans, ophthal. Soc. U.K., 20, 251. 
LEBENSOHN, J.E. (1950). Amer. J. Ophthal., 33, 865.
LEBLOND, C.P., ALBERTS, S., and SELYE, H. (1942).
Proc. Soc. exper. Biol. Med., 51, 159*
LEBLOND, C.P., and EARTLY, H. (1952). Endocrinology, 51, 26.
LEDERER, J. (1948a). Ann. d'Endocrin., 9, 60.
___________ (1948b). Ann. d'Ocul., 181, 37.
___________ (l950)» Ann. d ’Endocrin., 11, 53*
LEDERER, J., and HAMBRESIN, L. (1950). Ibid., 11, 634.
________________________________ (1951). Ibid., 12, 73.
LEI TER.’, L. (1950). Amer. J. Ophthal., 33, 623.
LELOUP, J., and OLIVEREAU, M. (1950). Comp. Rend. Soc. Biol., ■ ,
144, 772.
LEVIN, L., and FARBER, R.K. (1950). Proc. Soc. exp. Biol. Med.,
74, 758.
LEVITT, T. (1951)* Lancet, 2, 957.*
LOCKETT, M.F. (1950). Brit. J. Pharm. Chemother. , 5, 485.
L.OEB, L. and BASSETT, R.B. (1929). Proc. Soc. exp. Biol. Med.,
26, 860.
___________________________  (1930). Ibid., 27, 490.
LOEB, L. AND FREIDMAN, H. (1932). Ibid., 29, 648.
LOESER, A. (1937). Proc. Roy. Soc. Med., 30, 1445*
LONG, C.N.H. (1947). Bull. N.Y. Acad. Med., 23, 260.
LOWE, G.H., IVY, A.C., and BROCK, S. (1945)• Endocrinology, 36,130*
LOWENSTEIN, 0., and GIVNER, I. (1942). Arch. Ophthal., 28, 821.
LOWENSTEIN, 0., and LEVINE, A.S. (1944). Ibid., 31, 74.
LUDWIG, A.W., BOAS, N.F., and SOFFER, L.J. (1950).
Proc. Soc. exp. Biol. Med., 73, 137*
(1952). J. clin. Endocrin,
12, 930.
LYLE. T.K. (1952). Proc. Roy. Soc. Med., 45, 238.
McCULLAGH, E.P. (1955). J * clin. Endocrin. Metab. , 13, 818.
McCULLAGH, E.P., RUEDMANN, A.D., and GARDNER, W.J. (1946).
Trans. Amer. Assoc. Study Goitre, 15*
MARINE, D., and ROSEN. S.H. (1935) • Proc. Soc. exp. Biol. Lied.,
30, 901.
_______j_____________________ (1934)* Amer. J. med. Sci., 188,565.
  (1936). Proc. Soc. exp. Biol. Med.,
35, 354.
MARINE, D., ROSEN, S.H., and GIPRA, A. (1933). Ibid,, 30, 649.
MARINE, I)., ROSEN, S.H.,and SPARK, C. (1935). Ibid., 32, 8O3.
MARINE, D ., SPENCE, A.W., and CIPRA, A. (1932). Ibid., 29, 822. 
MARTENS, T.G. (1947). Amer. J. med. Sci., 213, 241.
MARTIN, L. (1948). Lancet, 1, 858.
MARTIN, L., and PENNELL, V.(l94l). Lancet, 1, 39.
MASSOUD, E. (1946). Brit. J. Ophthal., 30, 622.
MEADOWS, S.P. (1952). Proc. Roy. Soc. Med., 45, 229*
MEANS, J.H. (1939). New Eng. J. Med., 221, 820.
  (l940). Canad. med. Assoc. J., 43, 509*
  (1943)* Ann. int. Med., 19, 567.
  (1945). Ibid., 23, 779.
  (1948). Personal communication to Copper A.C..
  (l949)» Trans. Assoc. Amer. Phys. 62, 232.
MEANS, J.H., and • STANBURY, J.B. (1950). Amer. J. Med. Sci.',
220, 357-
MEDINE, M.M. (l95l)* Amer. J. Ophthal., 34, 1587*
MIGEON, C.J., GARDNER, L.I., CRIGLER, J.E., and WILKINS, L.
(1952). Endocrinology, 51, 117•
MILLER, S.J.H. (1953)- Brit. J. Ophthal., 37, 70.
MILLS, E.S., and F ORSEY, R.R. (1949)* Assoc. Amer. Phys., 62,225.
MOFFATT, P.McG. (1943)• Trans, ophthal. Soc. U.K., 63, 19*
_______________  (l95l)* Proc. Roy. Soc. Med., 44, 177*
_______________  (1952). Ann. d'Ocul., 185, 465*
MILLER, P.M. (1955)« Acta ophthal. Scand. suppl., 43*
MOREY, ,,.L. , KIRSCHNER, L., KRAINTZ, L. , MERRILL, P., and 
RAWSON, R.W., (1950)» J* clin. Endocrin., 10, 1282.
MONEY, W.L., KRAINTZ, L., EAGER, J., KIRSCHI®R, L., and 
RAWSOR, R.W., (l95l)* Endocrinology, 48, 682.
MONEY, W.L., LUCAS, V., PAGER, J., and RAWSOR, R.W. (1951).
J. clin. Endocrin., 11, 973*
MOORE, F.R. (1920). Lancet, 2, 701.
________ • (1923)* Trans, ophthal. Soc. U.K., 43, 215*
MORLEY, J. (1936). Brit. med. J., 1, 827.
MOSELEY, A.J., and MERRILL, A.J. (1950). Proc. first clin.
ACTH. Gonf. , p.211. /The Blakiston Coy. 
w Philadelphia, Toronto.
MULLER, H. (1858). Th.V. Siebold Kollicher Zeit. Wissen. Zool.,
9, 541.
MULLER, C.J.B. (1949). South African med. J., 23, 221.
MULYARY, J.H. (1944)- Amer. J. Ophthal., 27, 589.
_____________  (1952). Proc. Roy. Soc. Med., 45, 241•
MUNOZ, R.J., and BARCA, A.Y. (1955)* Arch. Soc. optal. Hisp-Amer.,
15, 180.
MIANT, N.B., POCHIR, E.E., and GOLDIE, E.A.G. (1949). Clin. Sci.,
8, 109.
NAPPZIGER, H.C. (1931)• Ann. Surg., 94, 582.
_____________   (1933). Arch. Ophthal., 9, 1*
________  (1949)» Amer. J. Surg. , 75 , 25*
,  (1952). Ann Surg., 136, 372.
_______________  (1954). Ann. Roy. Coll. Surg., 15, 46.
NELSON, W.D., and HICKMAN, J. (1937)* Proc. Soc. exp. Biol. Med.,
36, 828.
NETHER10N, E.W. (1949). Arch. Derm. Sypji. , 60, 335.
REVIN, S., and KILOS, L.G. (1951)* Sorsby's Systemic Ophthal­
mology, Butterworth and Co., London, p.476.
NUZUM, J.W. Jr., (1953). Surge ly, 33, 550.
OASTLER, E.G.(1953)* Trans, ophthal. Soc. U.K., 73> 627*
OBAL, A. (1950). Artztl. Wschr.l* 5, 8O4.
O'CONNOR, G.B. and PIERCE, G.W. (1935). Amer. J. Ophthal., 18, 51.
OPERET, G. (1954). Bull. Soc. franc. d'Opht.al., 67, 440*
OKIE, M.U., DALEY W.J., and WHITE, W.F. (1952). J. int. Coll.
Surg., 18, I64.
OLSON, J.A. (l95l). Arch. Ophthal., 45, 299*
PAGLIARANI, N. (1952). Rev. Oto-Neuro-Oftal., 27, 479*
PAGLIARINI, N. and CAVICCHI, L. (1950). Ibid., 25, 153.
  (1953). Ibid., 28, 396.
PARKER, W.R. (1922). Arch. Ophthal., 51, 1.
PARRY, C.H. (1825). Collections from the unpublished medical
writings of the late Caleb Hillier Parry, London^ 2, 111.
PASCHKIS, K.E., and CANTAROW, A. (1947)* J* clin. Endocrin., 7, 102.
PASCHKIS, K.E. , CANTAROW, A., and PEACOCK, W.C. (1948). Proc.
Soc. exp. Biol. Med., 68, 485*
PATON, W.D.M. and ZAIMIS, E.J. (l95l)» Brit. J. Pharmacol., 6, 155*
PAUFIQfJE, L. (1954)* Bull. Soc. franc. d'Opthal., 67, 442.
PAUFI4UE, L., and GUI NET, P. (1948). Ann. d'Ocul., 181, 665.
_____________________________  (1949) • Bull. Soc. d'OpWtal. Prance,
9, 1016.
PAUFI^UE, L., GUINET, P., and PAPILLOii, J. (1950). Ann. d'Ocul.,
183, 449.
PAULSON, D.L. (l937)» Proc. Soc. exp. Biol. Med., 36, 604*
(1939). Proc. Staff Meet. Mayo Clinic, 14, 828.
PENNYBACKEK, J. (1955)- Trans, ophthal. Soc. U.K., (in press).
IERLMUTTER, M. , WEISENFELD, S., SL..TER, S., and WALLACE, E.Z.,
(1952). J« clin. Endocrin. ivietab., 12, 208.
PFEIFFER, R.L. (1950)« Bull. N.Y. Acad. Med., 26, 592*
PERRAULI, M .  (1950). Presse med. , 58, 1010.
PERRY, W.F. (l95l)* Endocrinology, 49? 284•
PHILPS, S. (l>55). St. Bart's. Hosp. J., 57, 101.
PIPER, I . Vv. (1952). Med. J. Austral., 1, 515*
PISANO, E. (1955)* G. ital. Oftal., 8, 322.
PLESSIER, P. (1954)» Bull. Soc. franc. d'Opht.al*? 67, 429*
PLOT Z , C.M., HOWES, E.L., BLUNT, J.W. , MEYER, K., and RAGAN , C.
(1950)* Arch. Derm, Syph., 6l, 919*
PLUMMER, ri.S. (1926). The Thyroid Gland, C.V.Mosby, St. Louis* p.82
POCHIN, E.E. (1938a). Clin. Sci., 3, 197.
(193&T?). Trans. ophthal. Soc. U.K., 58? 39*
_________ ' (1939a). Clin. Sci., 4? 79*
____________ (1939L). Ibid., 4 ? 91-
____________ (1944)* Clin. Sci., 5, 75.
(l945)‘ Proc. Roy. Soc. Med., 38, 669*
____________ (1948). Amer. J. Opnthal., 29, IO36.
____________  (1949)- Clin. Sci., 8, 97-
POCHIN, E.E., and' RUNDLE, E.E. (1949)- Ibid., 8., 89*
PONCET, A. (1910). Comp. Rend. Soc. Biol., 68, 861.
POPPEN, J.L. (1950). J. clin. Endocrin., 10, 1231.
 ___  (1953)* Postgrad. Med., 14, 130.
PORTER, G.L., and WALKER, J.S. (1955)- Illinois med. J., 107? 57»
POST, L.T. (1947)* Trans. Amer. ophthal. Soc., 45? 250.
PRUNTY, E.T.G. (1949) • Practitioner, 163, 406.
PURVES, H.D., anc. GRIES3ACH, W.E. (1949)* Brit. J. exp. Path.,
30, 23.
RAGAN, C., HOWES, E.L., PLOT2, C.M., MEYER, K., and BLUNT, J.W.,
(1999)• Proc. Soc. exp. Biol. ^ed., 72, 718.
RAVDIN, I.S., ROSE, E., and MAXWELL, J.D. (1949)• Amer.
med. Assoc., 140, 141*
RAWSON, R.V/. (l949)* Ann. N.Y. Acad. Sci., 50, 491*
_____________  (l95l)* Proc. second clin. ACTH. Conf. , vol. II, 119*
J.and A. Churchill, London.
RAWSON, R.W., GRAHAM, R.M. , and RIDDELL, C.B. (1949)* Ann. int.
Med., 19, 405.
RAY/SON, R.W. , and STARR, P. (1938)* Arch. int. Med., 61, 726.
RAY/SOU, R.V/., TAN1HIEIMER, J.F., and PEACOCK, W. (1944).
Endocrinology, 34? 245*
REEH, M.J., and SIEGER, M. (1953)* Amer. J. Ophthal., 36, 1043*
REISS, R.S., FORSHAM, P.II., and THORN, G.W. (1949). J. clin.
Endocrin., 9? 659*
REISS, R.S., RIGGS, D.S., THORN, G.W., and FCRSKAM, P.H. (1950).
Proc. first ACTH. Conf., 193*
Thd Blakiston Coy., Philadelphia, Toronto. 
RICHTSMEIER, A.J. (1952). Illinois med. J., 101, 189•
RIDLEY, H. (1952). Proc. Roy. Soc* Med., 45? 243*
DE ROBERTIS, E. (1948)* J» clin. Endocrin., 8, 958*
DE ROBERTIS, E., and DEL CONTE, E. (1944)• Rev. Soc. Argent.
Biol. , 20, 88.
ROBERTSON, C. (1945)- Austral. New Zeal. J. ^urg., 14? 268* .
ROPES, M.W., ROBERTSON, W.B., ROSSMEISL, E.C., PEABODY, R.B., 
and BAUER, W. (l947)« Acta med. Scand., 196, 700.
ROSE, E. (1952)* Arch. Ophthal., 48, 657*
__________  (1953)* Amer. J. Ophthal., 36, 395* ' ,
ROSENBERG, I.E. (l95l)» clin. Invest., 30, 1.
ROSI/iAN, D. (1950). N.Y.State J. Med., 50, 1939*
ROWLANDS, I.W., and SHARPEY-SCHAFER, E.P.£1940). Brit. med. J.,
1, 205.
RUEDEi.iANL, A.D. (1931). J. Amer. med. Assoc. 97 > 1700.
_______________  (1947). Ira ns. Amer. opnthal. Soc., 45? 251*
_______________  (l949)« Arch. Ophthal., 41, 510*
RUEDEMANN, A.D., and CORRIGAN, K.E. (1953). Trans. Amer. ophthal.
Soc., 51, 335.
BUNDLE, F.F. (1941)• Lancet, 2, I49.
  (1951)• Brit. med. J., 2, 1433*
BUNDLE, 'F.F., FINLAY-JONES, L.B., and LOAD, K.B., (1953).
Austral. Ann. Med., 2, 128.
RUNDLE, F.F., and POCHIN, E.E. (1944). Clin. Sci., 5, 51.
BUNDLE, F'.F., and WILSON, C.W., (1944a). Ibid., 5, 17.
 __________________________ (1944b). Ibid,, 5, 31.
____________ _ __________________ (1945). Ibid., 5, 177.
RUSSELL, D.S. (1936). J. Physiol., 87, 63 P.
RYAN, H. (1949). Brit . J. Opnthal., 33, 769.
SAID, M.M.E.D. (1952). Bull, ophthal. Soc. Egypt, 45, 229*
SALASSA, R.M. C1950). Proc* Mayo Clin., 25, 497.
SALTER, W.T. (1940)* The Endocrine Function of Iodine. Cambridge.
Harvard Univ. Press.
SALTER, W.T., CORTELL, R.E., and McKAY, E.A. (1945). J. Pharm.
exp. Ther., 85, 310*
SALTER, W.T. and SOLEY, R.H. (1944). Med. Clin. N.America, 28, 484.
SALTZMAN, S.L. and MELLICKER, M.C. (l95l)« Amer. J. Ophthal. 34,372.
SAPPEY, Ph.C (1869). Traite d ’Anatomie Descriptive, Paris. Vol.II.
p.118.
SAUER, G.C., HERRMANN, F., MILBERG., PROSE, P.H., BAER, R.L.,
and SULZBERGER, M.B. (1951). Proc. second clin. ACTH.Conf.,
Vol. II. 521. J. and A.Churchill.
SAVIN, L.H. (1943). Trans, ophthal. Soc. U.K., 63, 9.
___________ (1945). Ibid., 65, 252.
SAYERS, G., BURNS, T.W., TYLER, P.H., Ja GER, B.V., SCHWARTZ, T.B, 
SMITH, E.L., SnmlJELS, L.T., and DAVENPORT, H.W. (1949)*
J. clin. Endocrin., 9* 593*
SCHAFPENBURG, C.A., MASSON , G.M., McCULLAGH, E.P., and HAOUR, P.
(1951). Ibid., 11, 1215.
SCHEIE, H-G., TYNER, G.S., BUESSELER, J.A., and ALEANO, J.E.
(1951). Arch. Ophthal., 45, 301.
SCHLOSSMAN, A.(l953). Eye, Ear, Nose, Throat, Mon., 32, 33O.
SCHOCKAERT, J.A. (l93l). Proc. Soc. exp. Biol. Med., 29, 306.
(1932). Amer. J. Anat., 49, 379*
SCHOCKAERT, J.A., and POSTER, G.L. (1932). J. biol. Chem., 95, 8
SCHRIRE, I. (1948). Clin. Sci., 7, 49.
SCOW, R.O., and SIMPSON, M.E. (1945). Anat. Rec., 91, 209.
SC OWEN, E.P., and SPENCE, A.W. (1934)* Brit. med. J., 2, 8O5.
_______________________________  (1936). J. Physiol., 86, 109.
SEIDLIN, S.M. (1940). Endocrinology, 26, 696.
SEITCHIK, J .IT. (1942). Arch. Ophthal., 27, 762.
SELLERS, E.A., and FERGUSON, J.K.W. (1949). Endocrinology, 45,
SELLERS, E.A., HILL, J.M., and LEE, R.B. (1953). Ibid., 52, 188
SEYERINGHAUS, A.E., SMELSER, G.K., and CLARK, H.M. (1934).
Proc. Soc. exp. Biol. Med., ^1, 1127.
SHANNON, C.E.G., and HUNT, W. (1947). Trans. Amer. ophthal. Soc.
45, 240.
 ______________  (1949). Arch. Ophthal., 41,' 508.
SHAPIRO, S., and MARINE, D. (1921). Endocrinology, 5, 699. 
SHARLIT, H. (1949). Arch. Derm. Syph. , 60, 336.
SHAW, R.C. (1929). Brit. med. J., 1, 495*
SHORR, E., RICHARDSON, H.B., and WOLFF, H.G. (1933). Proc. Soc.
exp. Biol. Med., 31, 207*
SILYESTRINI, P., MELLONI, G., and PASARGIKLIAN, E. 0.953)*
Pol. endocrin. (Pisa), 6, 785*
SIMKIN,-B., PETIT, B.V/., and STARR, P. (1954). Calif. Med.,
80, 72*
SIMKIN B., and STARR, P. (1953)* Proc. Soc. exp. Biol. Med.,
84, 99-
SIMKIN, B., STARR, P., and HANCOCK, C. (1953) • J* clin. Endocrin.
Me tab., 13, 854*
SIMMS, E., PFEIFFENBERGER, M., and HEIiFBECKER, P. (1951).
Endocrinology, 49, 45*
SIMPS OIF, S.L. (1945). Proc. Roy. Soc. Med., 38, 669.
SKELTON, M.O., and GANS, B. (1955). Arch. Bis. Child., 30, 460.
SLOAN, L.W. (1953). Bull N.Y. Acad. Med., 29, 505.
SMELSER, G.K. (1938). Proc. Soc. exp. Biol. Med., 35, 128.
_____________  (1937). Amer. J. Ophthal., 20, 1189•
 _ _ _ _ _  (1938a). Ibid., 21, 1208. p.23.
_____________  (1938b). Endocrinology, 23, 429*
 ____________  (1939a). Amer. J. Ophthal., 22, 1201.
 __________  (1939b). Amer. J. Path., 15, 341.
_____________  (1942). Endocrinology, 30, 51041*
,_________  (1943a). Amer. J. Anat., 72, 149*
_____________  (1943*0* Amer. J. Physiol., 140, 308.
_____________  (1944). Ibid., 142, 396.
_____________  (1947). Amer. J. Ophthal., 30, 917*
SMELSER, G.K., and OZANICS, V. (1949). Amer. J. Ophthal., 32, 1557.
_______________________________  (1951). Ibid., 34, 87.
(1954). Ibid., 38, 107.
_______________________________ (1955). Ibid. , 39, 146.
SOPFER, L.J., VOLTERRA, M ., GABRILOVE, J.L., POLLACK, A.,
and JACOBS, M. (1947). Proc. Soc. exp. Biol. Med., 64, 448.
SOLE!, M.H. (1942). Arch. int. Med., 70, 206.
SOLOMON, D.H., and SHOCK, N.W. (1950). Proc. first ACTH. Conf., 44*
The Blaksiton Coy., Philadelphia, Toronto. 
SPAETH, E.B. (1937)* Arch. Ophthal., 18, 107.
  (1952). Itid., 48, 658.
_____________  (1953a). Amer. J. Ophthal., 36, 396.
  (1953b). J. Maine med. Assoc., 44? 2.
SPINKS,’ A., and B U M ,  J.H.' (1952). Brit. J. Pharmacol., 7, 95.
SPIRTQS, B.N. (1953)' Proc. Soc. exper. Biol. Med., 84, 673*
STALLARD, H.B. (1936). Brit. J. Ophthal., 20 612.
_______________________  (1937). Trans, ophthal. Soc. U.K., 57, 119.
_______________________  (1955)* Ibid., (in press).
STANLEY, M.M., and 1STWOOD, E.B. (1949). Endocrinology, 44? 49*
STARLING-, H.J., DRAKE, C.S., HUNT, B.W., and BRAIN, W.R.(l938).
G-uy! s Hosp. Rep., 88, 117*
VON STELLWAG, G.(I869). Wien. med. Wchnschr., 737.
STOKES, E.H. (1954). Med. J. Austral., 1, 450.
STRONG, J.A. (1949). Lancet, 1, 959.
STUART, E.G. (1951)- Anat. Rec., 109, 351*
STURGIS, C.C. (1953)* Bull. N.Y.Acad. Med., 29, 537.
TALWALKER, U.S. (1949)* Proc. All-India ophthal. Soc., 10, 92.
TAYLOR, N., LARGE, A., and NORTH, P. (1950). Amer. J. med.Sci.,
220, 362.
TERPLAN, K.L., CONSTANTINE, A .B . , KOE PF, G.E. and DAYTON, G .0.
(1951). N.Y.State. J. Med., 51, 2750.
THOMAS, H.M.Jr. (1951). Amer. J. Med., 11, 581.
THOMAS, H.M., and WOOL, A.C. (1936). Johns Ilopk. Hosp, Bull., 59 ?99 •
THOMPSON, N.O., (1946). Trans. Amer. Assoc. Study Goitre, 240.
THOMPSON, V V . O .  and THOM PS ON, P.K. (1944) • Endocrinology, 35? 206.
iHQvipSOA, E.S. (l924)« Amer. J. Ophthal., 7, 27*
THORN, G.W. (1951)- Proc. Second clin. ACTH. Conf. Vol.II, 117.
J.and A.Churchill, London.
THORN', G.W., FORSHAM, P.H., FRAWLEY, T.F., HILL, S.R., ROCHE, M., 
STAEHELIN, P., and WILSON, P.L. (1950). New Eng. J. Ivied.,
242, 865*
THORNER, M.W. (1939)* Arch. int. Med. 64, 330.
UOTILA, V.V. (1939)* Endocrinology, 25, 605.
A_________  (1940). Ibid., 26, 129.
VAIL, D. (l940)» Amer. J. Ophthal., 31, 342.
  (l949)» Postgrad. Med., 5* 439*
VERZAR, F., SAILER, E.,and VILOVIC, U. (1952). J. Endocrin., 8, 308.
VERZAR, F., and VIDOVIC, V. (1952). Ibid., 8, 321.
VILANOVA, X., and CANADELL, V.J.M. (1949). J. clin. Endocrin., 9,
883.
VILLIAMEY, J. (1954). Sem. H6p. Paris, 30, 915.
WALKER, D.G., SIMPSON, M.E., ASLING, C.W., and EVANS, H.M.
(1950). Anat. Rec., 106, 539.
WALLACE, D.P., and REINEKE, E.P. (1949). Endocrinology, 45, 75.
WATRIN, J., MERANL, A., and BGRPENAVE, P. (l95l)»
Ann. Derm. Syph. , 78, 23.
WATSON, E.M. (1946). Canad. med. Assoc. J., 54, 260.
WATSON, E.ivi., and PEARCE, R.H. (1947) • Amer. J. clin. Path.,
17, 507.
______________________________ _  (1949). Ibid., 19,442.
WAYNE, A .J . (1954)- Brit. med. J., 1, 411.
WE SK E R S, R., and DEDOYARL, J. (l95l)« Bull. Soc. beige. Ophthal.,
97, 122.
WERNER, S. (1950). Proc. first clin. ACTH. Conf., p.200.
The Blakiston Coy. Philadelphia. Toronto.
WERNER, S.C., HAMILTON, H., and FRANTZ, V.K. (1951).
Proc. second clin. ACTH. Conf. Vol. II, 521. 
J.and A.Churchill. London.
WERNER, S.C., and SPOONER, M. (1955). Bull. N.Y.Acad. Med., 31, 137.
WHITNALL, S.E. (1932). Anatomy of the Human Orbit. Oxford Univ.
Press.
WHITNALL, S.E., and BEATTIE, J. (1933). J* Anat., 68, 146.
WILLIAMS, A .W . (1953). Brit. J. exper. Path., 34, 621.
 ___________ (1955)- Ibid., 36, 245.
WILSON, L.B. (1935). Arch. Ophthal., 13, 833.
WING, E.S. Jr., and ASPER, S.P. (1952). Bull. Johns Hopk. Hosp.,
90, 201.
WINTER, C.A., SILBER, R.H., and STOERK, H.C. (1950).
Endocrinology, 47, 60.
WONG, A.S. (1953)* Amer. J. Ophthal., 36, 391.
WOLFSON, W.Q., BEIERWALTES, W.E., ROBINSON, W.D. , DUFF, I.F.,
JONES, J.R., iiNORPP, C.T., 3IEMIENSEI, J.S., and EYA, M.
(1950). J. lab. clin. Med., 36, 1005.
WOODBURY, P.M., GHOSH, B.N., and SAYERS, G. (l95l). J. clin.
Endocrin., 11, 761.
WOODS, A.C. (1946). Medicine, 25, 113*
 ________  (1951a). Amer. J. Ophthal., 34, 945*
_ _ _ _ _ _ _ _  (1951b). West. J. Surg., 59, 288.
WORSTER-DROUGHT, C. (1927). Brit. med. J., 1, 50.
 ____________ _ (1934)« Proc. Roy. Soc. Med., 28, 515*
WYBAR, K . C . (1954a). Brit. J. Ophthal., 38, 513.
(1954b). "XVII Concilium ophthalmologicuiii, 1954,
Canada, U.S.A., Acta, Vol.I., p.294* 
University of Toronto Press.
_ _ _ _ _ _ _ _  (1954c). J. Anat. (Lond.), 88, 94.
WYBAR, K.C., and CAMPBELL, F.W. (1952). Trans, ophthal. Soc. U.K.,
72, 105.
ZECKWER, I.T. (1956)• Amer. J. med. Sci., 191, 872.
______________  (1936). Amer. J. Physiol., 117, 518.
ZECKWER, I.T., DAVISON, L.W., KELLER, T.B., and LIVINGOOD, C.S. 
(1935). Amer. J. med. Sci., 190, 145-
ZONDEK, H. (l945)» Acta med. Orient., 4 , 282.
___________ (l95l)« Amer. J. Ophthal., 34, 891.
ZONDEK, H., and TICHO, A. (1945). Brit. med. J., 1, 836.
____________________________ (1951). Lancet, 2, 1018.
In addition to the bibliography above}the following 
papers have been used in this thesis without any reference to them:
WYBAE, K. C. (1951).
_____________  (1952).
 ___________ (1952).
_____________  (1953).
_____________  (1956).
_____________  (1956).
"Exophthalmos in Relation to Endocrine 
Disorder". (Treacher Collins Prize).
Med. Illus., 6, 335*
Proc. Roy. Soc. Med., 45, 242.
Trans, ophthal. Soc. U.K., 73, 639* :
"The Nature of Endocrine Exophthalmos", (in press) 
Advances in Ophthalmology. S. Karger, Basel, New
York,
Trans, ophthal. Soc. U.K. (in preparation).
Appendix.
The Influence of Cortisone on 
Corneal Vascularization in the 
Guinea-pig and in the Rabbit.
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This is a joint investigation which was carried 
out at the Tennent Institute of Ophthalmology and 
Institute of Physiology, Glasgow, with Dr. P.W.Campbell.
It is included in this thesis because, although 
unrelated to exophthalmos, it serves to illustrate the 
different effect which cortisone may exert on different 
animals; a feature of importance in an assessment of 
the experimental influences of the adrenal cortex on 
exophthalmos.
♦
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It is clear from recent experimental and clinical 
reports that cortisone has a measurable effect on the 
rate and extent of invasion of the cornea by new vessels. 
Vessels enter the cornea in response to a wide variety of 
stimuli, but the basic nature of this mechanism is ill- 
understood.
We have studied the action of cortisone on wound 
healing and on new vessel formation in the cornea of the 
guinea-pig. In addition a small-scale experiment was 
carried out on the rabbit. These results are reported 
as five separate series of experiments.
EXPERIMENTAL.
Technique of Injury.
A cautery was made from a loop of 32 S.W.G. platinum 
wire. A predetermined constant current was fed to the 
cautery through a relay which activated the cautery for 
exactly one second. Each cornea was anaesthetized by 
instilling 2 per cent, pontocaine hydrochloride into 
the conjunctival sac. This produced adequate anaesthesia 
and the animals remained quiet during and after the injury.
A standard heat injury was inflicted by holding the 
cautery in contact with each cornea for one second at a 
point 2 mm. from the limbus in guinea-pigs, and 3 nun. from 
the limbus in rabbits. This produced a lesion approximately
-4-
1 mm. in diameter, involving the anterior two-thirds of the 
corneal thickness.
Assessment of Epithelial Healing.
The degree of epithelial healing was assessed by 
instilling two drops of 2 per cent, sodium fluorescein 
solution into the conjunctival sac and allowing it to 
act for one minute, after which the excess was removed with 
Ringer solution. The eye was examined immediately 
thereafter with ultra-violet light. The intensity of 
fluorescence from the injured area was compared against 
a standard scale. A lesion which fluoresced maximally 
was given the value of 5 units and lesser intensities 
were given appropriately smaller values (Campbell and 
Boyd, 1950). Observations were made every 12 hours.
Assessment of Vascularization.
The corneae were examined with a Zeiss binocular loupe 
(magnification X 2.5) under illumination from a hand-slit 
lamp. In Experiment II an assessment was made of the 
length of the new vessels growing into the cornea. Maximal 
vascularization was regarded as full encroachment of new 
vessels on to the lesion and lesser lengths of vessels were 
expressed as percentages of maximum.
-5-
In Series III, IV and V, two additional factors were 
considered; firstly, the breadth of the area of cornea showing 
vascularization, and secondly, the density of the vessels 
within the vascularized area. Each result was again 
expressed as a percentage of maximal vascularization. These 
additional factors were combined with the factor of length 
and the whole was given a numerical representation on a 
percentage basis.
Histological Method.
The entire enucleated eye was fixed in 10 per cent, 
neutral formalin, sectioned by the celloidin method and 
stained with haemalum and eosin.
Series I.
Ten young male and ten young virgin female guinea-pigs 
were used. The average weight of the animals at the start 
of the experiment was 3^0 grams. The twenty animals were 
balanced for weight and sex, and divided into two similar 
groups. All animals were kept in - two large cages, the 
sexes being separated.
Each animal in the control group was given intra- 
peritoneally 0.5 ml* of Aqueous Vehicle No.l (Merck & Co.) 
daily. All animals in the cortisone group were given intra- 
peritoneally 12.5 mgm. of cortisone acetate daily (Merck 
Suspension 25 mg./ml.). Administration of the drugs was
-6-
was started three days "before the corneae were injured.
The aim of this series was to assess the action of 
cortisone on the progress of healing of ddep corneal 
heat injuries. This was measured hy the fluorescein 
technique. The lesions were'examined histologically 
at the termination.of the experiment on the ninth day 
of healing.
Series II.
This was a group of twenty guinea-pigs similar to 
those in Series I, although all the animals were albino. 
The corneae were injured and the animals given cortisone 
and aqueous vehicle as in Series I. The aim of this 
experiment was to assess the influence of cortisone on 
corneal vascularization resulting from heat injuries.
Series III.
This series was an extension of Series II, and the 
same technique was followed throughout, although only 
ten guinea-pigs were involved.
Series IY.
Twenty guinea-pigs were dealt with as in Series I 
with this difference, that cortisone was administered
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subconjunctivally (1.25 mg. every third day, commencing 
three days before infliction of corneal injury.) The 
site of injection was adjacent to the corneal lesion.
The control animals received an equivalent volume (0.05 ml.) 
of aqueous vehicle. In this experiment an assessment 
was made of the influence of local cortisone on the 
formation of new vessels within the cornea.
Series V.
Six albino adult rabbits of comparable weight were 
used in this series. Preliminary work had shown that 
a single thermal injury of the type inflicted in the 
previous experiments was insufficient to induce corneal 
vascularization in every rabbit. The injured area was, 
therefore, re-traumatized on two further occasions, 24 
and 72 hours after the original injury, and this technique 
was followed by new vessel invasion in all the animals. 
Cortisone was administered subconjunctivally (2.5 mgm. 
every second day, commencing three days before infliction 
of corneal injury). The control animals received an 
equivalent volume (0.1 ml.) of aqueous vehicle.
RESULTS
In each series the animals were weighed daily, and 
in no case did the administration of cortisone significantly
retard the normal growth curve.
Series I.
Pig. 1 shows the mean degree of fluorescence obtained 
from the eyes of the ten control and ten cortisone-treated 
guinea-pigs. Cortisone caused a delay in epithelialization 
between the second and sixth day of healing.
Pig. 2 illustrates the histological appearance of 
the corneal wound on the ninth day of healing. Section 
A was taken from a control animal and Section B from a 
cortisone-treated animal. It is apparent that the degree 
of cellular reaction is less well marked in the corneal 
stroma in the guinea-pig which received cortisone. In 
this animal, moreover, the new formation of fibrous tissue 
is less abundant. While most of the other sections 
examined showed this quantitative difference, the histo­
logical results were not entirely uniform, and in a few 
instances the lesions in the cavies injected with cortisone 
resembled those in the controls.
Comment. The results of the fluorescent gradient 
suggest that cortisone delays the epithelialization of 
deep corneal lesions. Epithelial regeneration is, however, 
dependent upon the presence of a suitable collagenous sub­
stratum (Campbell, Ferguson and Garry, 1950). Cortisone 
can affect the regenerating stromal tissues, and its influence
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on epithelialization may therefore he secondary to a 
primary action on the regeneration of underlying fibrous 
tissues.
Series II.
Three eyes in the control series developed an infective 
keratitis, and these eyes have been excluded from the results.
The mean degree of corneal vascularization in the con­
trol and in the cortisone groups is shown in fig. 3* It 
is apparent that in both groups vascularization occurred 
in two phases. This phasing was not due solely to the 
adoption of a mean figure, but was representative of the 
course of events in the individual cornea. Indeed, 32 
eyes out of a total of 37 clearly showed this double phase 
of vascularization.
There was an initial phase of vascularization which 
reached a peak at the end of the second day of healing. 
Thereafter vascularization declined, and by the fourth day 
was only moderate in extent. It was noted that shortly 
after the infliction of the injury there was a localized 
area of corneal oBdema surrounding the lesion and extending 
to the neighbouring limbus. This oedema became less 
obvious after the first few days and then disappeared.
There was no marked difference in the amount of oe dema in 
the control and cortisone groups.
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After the initial phase, vascularization increased 
once more and by the sixth day reached a maximum which 
was higher than the initial peak recorded on the second 
day. This extension of vascularization was due partly 
to the re-opening of the vessels which had become 
attenuated at the end of the initial phase, and partly 
to an ingrowth of new vessels. A gradual decline in 
the degree of vascularization then occurred, and at the 
termination of the experiment on the eighteenth day there 
was only a slight residual vascularization in a few eyes.
It can be seen that although the general form of 
the vascularization in the two groups was similar, there 
were- certain minor differences. The cortisone treated 
group showed slightly less vascularization than the control 
group up to the seventh day of healing, but thereafter the 
degree of vascularization was somewhat greater in the 
cortisone group.
Series III.
This was a confirmatory experiment to Series II.
Pig. 4 shows that, as in Series II, there was a pro­
longation of vascularization in the cortisone-treated 
group, and that there was a similar, though less marked, 
tendency for the vessels to show two phases in their 
passage towards the lesion. The animals in this series
FIG.5.
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tfere not albinos, and, therefore the fine changes in the 
vessels were less obvious than in Series II.
Comment. These experiments show that there is a 
greater persistence of vessels in the corneae of guinea- 
pigs receiving cortisone systemically.
Series IV.
Fig. 5 shows that cortisone applied subconjunctivally 
did not inhibit the rate of formation of new vessels within 
the cornea, and that again there was a greater persistence 
of the new vessels in the cavies receiving cortisone.
It was noted in this series that corneal oedema was 
more marked in the initial phase of healing, and that 
this oedema persisted for a longer time than in Series II 
and III. There was, however, no detectable difference 
in the amount of oedema between the control and cortisone- 
treated eyes. Furthermore, the break between the first 
and second phases of vascularization was less obvious in 
this experiment.
Comment. It would appear that cortisone does not 
inhibit the formation of new vessels in the cornea of the 
guinea-pig irrespective of the route of administration.
Series V.
In contradistinction to the results previously found in 
guinea—pigs, fig. 6 shows that cortisone given subconjunctivally
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to the rabbit caused a diminished vascular response, 
although not a complete inhibition of new vessel formation, 
in the cornea. It was noted that the corneal vessels 
in the eyes receiving cortisone were finer in calibre than 
those in the control eyes. Furthermore, oedema around the 
lesion was somewhat less marked in degree and extent in 
the cortisone-treated group.
Comment. This result confirms the results of Jones 
and Meyer (1950), Ashton, Cook and Langham (l95l)> Lister 
and Greaves (l95l)» and Irvine and Irvine (l95l)> who 
found an inhibiting influence of cortisone on new vessel 
formation in the cornea of the rabbit.
DISCUSSION
There is evidence to suggest that the presence of 
oedema in the cornea is an important factor in the 
establishment of corneal vascularization. Cogan (1949) 
considered that oedema, by opening up the interlemellar 
spaces of the corneal stroms, facilitates the ingrowth 
of new vessels from the limbal plexus. Conversely, 
the subsidence of oedema may produce some degree of 
occlusion of the vessels. We have noted a close 
relationship between the degree of corneal oedema and 
the extent of vessel invasion.
In our experiments the entry of new vessels into
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the cornea was preceded invariably by oedema of the corneal 
stroma. Furthermore, in the experiments using guinea- 
pigs in which cortisone or aqueous vehicle was administered 
intraperitoneally, the progress of vascularization was not 
strictly continuous. The temporary diminution in the 
extent of vessel invasion which was seen about the third 
day after injury, coincided with a subsidence of the 
corneal oedema around the lesion. In the experimerit 
using guinea-pigs in which the drugs were administered 
subconjunctivally, there was no obvious diminution of 
vascularization around the third day. This experiment, 
however, was characterized by a greater and more persistent 
degree of corneal oedema, which was probably the result of 
the increased local trauma and irritation of the repeated 
conjunctival manipulations. The increased duration of 
oedema presumably diminished the tendency for vessel 
regression around the third day.
In the guinea-pig, cortisone does not lessen either 
the degree of corneal oedema or the extent of new vessel 
ingrowth. On the other hand, in the rabbit, cortisone 
exerts a well-marked depressant effect on new vessel 
formation. This is associated with a slight decrease 
in the amount of corneal oedema and there may well be
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a relationship between this and the decreased vascularization.
It is, however, unlikely that oedema is the sole factor 
determining vascularization throughout the whole period of 
vessel invasion. In all our experiments vascularization 
of the cornea continued and increased in the later stages, 
desrjite the fact that by that time corneal oedema was 
diminishing and in some instances practically absent.
There would appear to be some ’stimulus’ from the injured 
area which attracts vessels into the cornea. The nature 
of this ’stimulus' is not known. It has been suggested 
that it is some chemical substance, perhaps allied to 
histamine, but there has never been any precise evidence 
for this hypothesis. Irvine and Irvine (1951) considered 
that some other factor, such as tissue necrosis, must 
play a part in the stimulation of new vessel formation, 
in addition to the influence of cedema of the corneal 
stroma. The healing of the traumatized area of the 
cornea is associated with an increase in the number of 
aerobic cells, and therefore, there may be a relative 
anoxia in that zone. This may have some bearing on 
vascularization.
It may be that cortisone in the guinea-pig, by 
causing a delay in the regenerating process within the 
healing area, maintains the 'stimulus' for vascularization
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for a more prolonged time, and, therefore, indirectly 
causes an increase in vascularization. On the other 
hand, in the rabbit, cortisone exerts a depressant 
effect on vascularization throughout the entire period 
of healing, and this may indicate a more direct action 
of the drug on the vascular response. In any case 
these results disclose a fundamental difference between 
the guinea-pig and the rabbit in the action of cortisone 
on the new vessel formation.
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